0001136261-11-000563.txt : 20111101 0001136261-11-000563.hdr.sgml : 20111101 20111101150356 ACCESSION NUMBER: 0001136261-11-000563 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20111101 DATE AS OF CHANGE: 20111101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MICROVISION INC CENTRAL INDEX KEY: 0000065770 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 911600822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34170 FILM NUMBER: 111171134 BUSINESS ADDRESS: STREET 1: 6222 185TH AVE NE CITY: REDMOND STATE: WA ZIP: 98052 BUSINESS PHONE: 425-936-6847 MAIL ADDRESS: STREET 1: 6222 185TH AVE NE CITY: REDMOND STATE: WA ZIP: 98052 10-Q 1 form10q.htm 10-Q September 30, 2011 10-Q Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549




FORM 10-Q



[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2011

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to _________

Commission file number    0-21221

MicroVision, Inc.
(Exact name of Registrant as Specified in its Charter)

 
Delaware
91-1600822
  (State or Other Jurisdiction of Incorporation or Organization) 
(I.R.S. Employer Identification Number)

6222 185th Avenue NE
Redmond, Washington    98052

(Address of Principal Executive Offices, including Zip Code)

(425) 936-6847
(Registrant's Telephone Number, including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES    x        NO    ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES    x        NO    ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer    ¨

Accelerated filer    x

Non-accelerated filer    ¨
(Do not check if a smaller reporting company)

Smaller reporting company    ¨

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). YES    ¨        NO    x

As of October 26, 2011, 117,833,000 shares of the Company's common stock, $0.001 par value, were outstanding.



 

Page

Part I: Financial Information

 

Item 1. Financial Statements:

 
   

Consolidated Balance Sheets as of September 30, 2011 and December 31, 2010 (unaudited)

2

Consolidated Statements of Operations for three and nine months ended September 30, 2011 and 2010 (unaudited)

3

Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2011 and 2010 (unaudited)

4

Consolidated Statements of Cash Flows for the nine months ended September 30, 2011 and 2010 (unaudited)

5

Notes to Consolidated Financial Statements (unaudited)

6

   

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

12

Item 3. Quantitative and Qualitative Disclosures About Market Risk

18

Item 4. Controls and Procedures

19

   

Part II: Other Information

 

Item 1A. Risk Factors

19

Item 6. Exhibits

26

Signatures

27

Exhibit Index

28

1


MicroVision, Inc.
Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)

      September 30,     December 31,
      2011     2010
Assets            
Current assets            
     Cash and cash equivalents   $ 9,369    $ 19,413 
     Investment securities, available-for-sale         13 
     Accounts receivable, net of allowances of $308 and $588     877      1,116 
     Costs and estimated earnings in excess of billings on uncompleted contracts     257      137 
     Inventory     4,443      6,075 
     Current restricted investments         306 
     Other current assets     1,120      564 
          Total current assets     16,074      27,624 
             
Property and equipment, net     2,736      4,169 
Restricted investments     1,019      1,189 
Intangible assets     2,094      2,233 
Other assets     30      18 
               Total assets   $ 21,953    $ 35,233 
             
Liabilities and Shareholders' Equity            
Current liabilities            
     Accounts payable   $ 6,301    $ 7,665 
     Accrued liabilities     4,432      4,135 
     Billings in excess of costs and estimated earnings on uncompleted contracts     50      81 
     Current portion of capital lease obligations     40      40 
     Current portion of long-term debt     91      85 
          Total current liabilities     10,914      12,006 
Capital lease obligations, net of current portion     84      114 
Long-term debt, net of current portion     91      159 
Deferred rent, net of current portion     253      697 
Other long-term liabilities         424 
          Total liabilities     11,342      13,400 
             
Commitments and contingencies            
             
Shareholders' Equity            
     Preferred stock, par value $.001; 25,000 shares authorized; 0 and            
          0 shares issued and outstanding        
     Common stock, par value $.001; 200,000 shares authorized; 117,793 and            
          102,471 shares issued and outstanding     118      102 
     Additonal paid-in capital     415,560      400,791 
     Accumulated other comprehensive loss     (35)     (30)
     Accumulated deficit     (405,032)     (379,030)
          Total shareholders' equity     10,611      21,833 
               Total liabilities and shareholders' equity   $ 21,953    $ 35,233 

The accompanying notes are an integral part of these financial statements.

2


MicroVision, Inc.
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)

      Three Months Ended     Nine Months Ended
      September 30,     September 30,
      2011     2010     2011     2010
Product revenue   $ 1,525    $ 1,080    $ 3,315    $ 3,465 
Contract revenue     314      221      798      592 
     Total revenue     1,839      1,301      4,113      4,057 
                         
Cost of product revenue     2,483      4,059      7,708      8,555 
Cost of contract revenue     237      53      931      202 
     Total cost of revenue     2,720      4,112      8,639      8,757 
                         
Gross margin     (881)     (2,811)     (4,526)     (4,700)
                         
Research and development expense     3,641      5,920      11,446      16,961 
Sales, marketing, general and administrative expense     3,306      3,555      10,182      11,260 
Gain on disposal of fixed assets     (4)         (11)    
     Total operating expenses     6,943      9,475      21,617      28,221 
Loss from operations     (7,824)     (12,286)     (26,143)     (32,921)
Interest income         15      36      94 
Interest expense     (9)     (15)     (34)     (48)
Gain on derivative instruments, net         446          875 
Other income (expense)     34      (10)     139      (40)
Net loss   $ (7,790)   $ (11,850)   $ (26,002)   $ (32,040)
                         
Net loss per share - basic and diluted   $ (0.07)   $ (0.13)   $ (0.25)   $ (0.36)
                         
Weighted-average shares outstanding - basic and diluted     109,238      89,376      106,061      88,948 

The accompanying notes are an integral part of these financial statements.

3


MicroVision, Inc.
Consolidated Statements of Comprehensive Loss
(In thousands)
(Unaudited)

      Three Months Ended     Nine Months Ended
      September 30,     September 30,
      2011     2010     2011     2010
Net loss   $ (7,790)   $ (11,850)   $ (26,002)   $ (32,040)
                         
Other comprehensive gain (loss):                        
Unrealized gain (loss) on investment securities,                         
     available-for-sale     (1)     (1)     (5)    
Comprehensive loss   $ (7,791)   $ (11,851)   $ (26,007)   $ (32,038)

The accompanying notes are an integral part of these financial statements.

4


MicroVision, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

      Nine Months Ended
      September 30,
      2011     2010
Cash flows from operating activities            
     Net loss   $ (26,002)   $ (32,040)
     Adjustments to reconcile net loss to net cash used in operations:            
          Depreciation     1,941      1,127 
          Amortization of intangible assets     139     
          Gain on disposal of property and equipment     (11)    
          Non-cash stock-based compensation expense     2,759      2,806 
          Gain on derivative instruments         (875)
          Inventory write-downs     944      3,830 
          Non-cash deferred rent     (297)     (207)
          Change in:            
               Accounts receivable, net     239      (888)
               Costs and estimated earnings in excess of billings on uncompleted contracts     (120)     63 
               Inventory     688      (10,617)
               Other current assets     (344)     (178)
               Other assets     (12)    
               Accounts payable     (1,518)     2,384 
               Accrued liabilities     150      (575)
               Billings in excess of costs and estimated earnings on uncompleted contracts     (31)    
               Other long-term liabilities     (330)     139 
               Net cash used in operating activities     (21,805)     (35,028)
             
Cash flows from investing activities            
     Sales of investment securities         100 
     Purchases of restricted investment securities         (305)
     Decrease in restricted investment     476     
     Proceeds on sale of property and equipment     11     
     Purchases of property and equipment     (492)     (1,659)
               Net cash used in investing activities     (5)     (1,864)
             
Cash flows from financing activities            
     Principal payments under capital leases     (30)     (51)
     Principal payments under long-term debt     (62)     (58)
     Net proceeds from issuance of common stock and warrants     11,858      12,634 
               Net cash provided by financing activities     11,766      12,525 
Net decrease in cash and cash equivalents     (10,044)     (24,367)
Cash and cash equivalents at beginning of period     19,413      43,025 
Cash and cash equivalents at end of period   $ 9,369    $ 18,658 
             
Supplemental disclosure of cash flow information            
     Cash paid for interest   $ 34    $ 48 
             
Supplemental schedule of non-cash investing and financing activities            
     Other non-cash additions to property and equipment   $ 211    $ 273 
     Issuance of common stock for prepayment of salaries   $ 212    $

The accompanying notes are an integral part of these financial statements.

5


MicroVision, Inc.
Notes to Consolidated Financial Statements
September 30, 2011
(unaudited)

1. MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION

Management's Statement

The Consolidated Balance Sheet as of September 30, 2011, the Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2011 and 2010, and Consolidated Statements of Cash Flows for the nine months ended September 30, 2011 and 2010 have been prepared by MicroVision, Inc. ("we" or "us") and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at September 30, 2011 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the "SEC"). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010. The results of operations for the three and nine months ended September 30, 2011 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.

We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from development contract revenues and product sales. At September 30, 2011, MicroVision had $9.4 million in cash, cash equivalents and investment securities available-for-sale.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through January 2012. We will require additional cash to fund our operating plan past that time. We are introducing new products into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. If the level of sales anticipated by our financial plan is not achieved or our working capital requirements are higher than planned, we will need to raise additional cash sooner or take actions to reduce operating expenses. We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include reducing our planned investment in working capital to fund revenue growth and delaying development projects resulting in reductions in staff, operating costs, capital expenditures and investment in research and development.

We have received a report from our independent public accounting firm regarding the consolidated financial statements for the year ended December 31, 2010 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. Our consolidated financial statements have been prepared on a going concern basis.

In August 2010, we entered into a committed equity financing facility with Azimuth Opportunity, Ltd. ("Azimuth"). During 2011 we completed two draws from this facility and raised a total of $5.6 million before placement agent and other issuance costs from the sale of approximately 4.5 million shares of our common stock. In July 2011, we cancelled this facility.

In May 2011, we entered into a committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $40.0 million or 21,018,431 of our shares of common stock over a 24-month term, which began on July 8, 2011. In August 2011, we raised $1.5 million before placement agent and other issuance costs from the sale of approximately 1.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $ 38.5 million or 19.2 million shares of common stock remaining available under the facility.

In September 2011, we entered into a another committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $35.0 million or 22,030,737 of our shares of common stock over a 24-month term, which began on September 13, 2011. In September 2011, we raised $5.0 million before placement agent and other issuance costs from the sale

6


of approximately 7.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $30 million or 14.4 million shares of common stock remaining available under this facility.

We may use these facilities as part of our plan to raise additional cash, though we may not be able to sell shares under either facility in the amounts desired or at all. We are not obligated to use these facilities and remain free to enter into and consummate other equity and debt financing transactions. See Note 10 for more information.

Principles of Consolidation

Our consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. ("MicroVision Singapore"), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in advanced research and development activities and operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the nine months ended September 30, 2011.

2. NET LOSS PER SHARE

Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares. Diluted net loss per share for the three and nine months ended September 30, 2011 and 2010 is equal to basic net loss per share because the effect of all potential common stock outstanding during the periods, including options, warrants and nonvested equity shares is anti-dilutive. The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):

      Three Months Ended     Nine Months Ended
      September 30,     September 30,
      2011     2010     2011     2010
Numerator:                        
Net loss available for common shareholders - basic and diluted   $ (7,790)   $ (11,850)   $ (26,002)   $ (32,040)
                         
Denominator:                        
Weighted-average common shares outstanding - basic and diluted       109,238      89,376      106,061      88,948 
                         
Net loss per share - basic and diluted     $ (0.07)   $ (0.13)   $ (0.25)   $ (0.36)

On September 30, 2011 and 2010, we excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive: publicly traded warrants exercisable for 6,025,000 and 6,025,000 shares of common stock, respectively, options and private warrants exercisable into a total of 10,195,000 and 12,536,000 shares of common stock, respectively, and 1,017,000 and 485,000 shares of nonvested equity shares, respectively.

3. CASH EQUIVALENTS, INVESTMENT SECURITIES AVAILABLE-FOR-SALE AND FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between informed market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-level fair value inputs hierarchy, and requires an entity to maximize the use of observable valuation inputs and minimize the use of unobservable inputs. When estimating fair values, we use market data, assumptions and risks we believe market participants would use in measuring the fair value of the asset or liability, including the risks inherent in the inputs and the valuation techniques. The authoritative guidance establishes a three-level fair value inputs hierarchy, and requires us to use observable valuation inputs where possible.

Our cash equivalents and investment securities available-for-sale are comprised of money market savings accounts and equity securities. The corporate equity securities are valued using inputs and common methods with sufficient levels of transparency and observability to be classified at Level 2.

7


The valuation inputs hierarchy classification for our assets measured at fair value on a recurring basis are summarized below as of September 30, 2011. This table does not include cash held in our money market savings accounts. As of September 30, 2011, we did not have any liabilities measured at fair value on a recurring basis.

As of September 30, 2011:     Level 1     Level 2     Level 3     Total
Assets                        
     Corporate equity securities         8,000          8,000 
    $   $ 8,000    $   $ 8,000 

 

As December 31, 2010:     Level 1     Level 2     Level 3     Total
Assets                        
     Corporate equity securities         13,000          13,000 
    $   $ 13,000    $   $ 13,000 

4. INVENTORY

Inventory consists of the following:

      September 30,     December 31,
      2011     2010
Raw materials   $ 3,151,000    $ 3,924,000 
Finished goods                                                       1,292,000      2,151,000 
    $ 4,443,000    $ 6,075,000 

The inventory at September 30, 2011 and December 31, 2010 consisted of raw materials primarily for our accessory pico projectors and PicoP display engine, and finished goods primarily composed of our accessory pico projectors. Historically our cost has been higher than our selling price for our accessory pico projectors and we have recognized write downs for lower of cost or market adjustments primarily comprised of adjustments to reflect our current estimated selling prices for our inventory. During the three and nine months ended September 30, 2011, we recognized zero and $944,000 in write downs for lower of cost or market adjustments.

Inventory is stated at the lower of cost or market, with cost determined on a net realizable value basis. Management periodically assesses the need to provide for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required. In addition, we reduce the value of our inventory to our estimated scrap value when management determines that it is not probable that the inventory will be consumed through normal production during the next twelve months.

5. SEVERANCE ARRANGEMENTS

In January 2011, we reduced our workforce by approximately 20%, recorded an expense of $372,000 and paid $341,000 related to the severance agreements for these employees during the first half of 2011. The remaining payments of $31,000 for outplacement services expired unused and during the three months ended September 30, 2011 we reduced the recorded expense related to severance agreements accordingly.

8


6. SHARE-BASED COMPENSATION

We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The following table shows the amount of stock-based employee compensation expense included in the consolidated statements of operations:

      Three Months Ended     Nine Months Ended
      September 30,     September 30,
      2011     2010     2011     2010
Cost of contract revenue   $ 56,000    $ 5,000    $ 97,000    $ 12,000 
Cost of product revenue     60,000      7,000      100,000      37,000 
Research and development expense     337,000      274,000      1,075,000      1,084,000 
Sales, marketing, general and administrative expense     447,000      415,000      1,337,000      1,657,000 
Total share-based employee compensation expense   $ 900,000    $ 701,000    $ 2,609,000    $ 2,790,000 

As part of our 2011 plan to conserve cash used in operations, we implemented two share-based compensation programs during the three months ended June 30, 2011 under which we issued shares of our common stock as compensation instead of cash.

In May 2011, we issued 418,000 shares of our common stock as incentive awards to non-executive employees under the 2006 Incentive Plan. The shares were valued using our closing stock price on the date of grant. We expensed $560,000 of share-based employee compensation for these awards at grant in May 2011.

In June 2011, we implemented a voluntary program in which certain non-executive senior professional employees could elect to receive a portion of their 2011 salary in stock instead of cash. In June 2011 we issued 510,000 shares of our common stock under the 2006 Incentive Plan as prepayment of salary for future service. The shares were valued using our closing stock price on the date of grant. The total share-based compensation expense for these awards was $627,000, of which $179,000 was amortized during the three months ended June 30, 2011 and the remaining $448,000 was amortized during the three months ended September 30, 2011 for service completed as of that date. In September 2011, we issued 241,000 shares of our common stock under this program. A total of $212,000 of share-based compensation expense for these awards will be amortized during the fourth quarter of 2011. Program participants who voluntarily leave employment prior to completion of the service period must repay the pro-rata portion of the prepaid salary for the uncompleted service period.

Options Activity and Positions

The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of September 30, 2011:

              Weighted      
              Average      
          Weighted   Remaining      
          Average   Contractual     Aggregate
          Exercise   Term     Intrinsic
Options   Shares     Price   (years)     Value
Outstanding as of September 30, 2011   7,898,000    $ 3.24    5.8    $
                     
Exercisable as of September 30, 2011   6,024,000    $ 3.57    5.0    $

As of September 30, 2011, our unamortized share-based employee compensation was $2.3 million which we plan to amortize over the next 2.3 years, and our unamortized nonvested equity share-based employee compensation was $968,000 which we plan to amortize over the next 1.7 years.

9


7. LONG-TERM NOTES

Tenant Improvement Loan Agreement

During 2006, we entered into a loan agreement with the lessor of our corporate headquarters in Redmond, Washington to finance $536,000 in tenant improvements. The loan carries a fixed interest rate of 9% per annum, is repayable over the initial term of the lease, which expires in 2013, and is secured by a letter of credit. The balance of the loan was $182,000 at September 30, 2011.

8. WARRANTS

Prior to 2011, we had common stock warrants outstanding that were issued in connection with certain notes. The warrants met the definition of derivative instruments that must be accounted for as liabilities because we could not engage in certain corporate transactions affecting the common stock unless we made a cash payment to the holders of the warrants. During 2010 these warrants expired unexercised. We recorded changes in the fair values of the warrants in the statement of operations each period. We valued the warrants at September 30, 2010 using the Black-Scholes option pricing model with the following assumptions: expected volatility of 80%; expected dividend yield of 0%; risk free interest rate of 0.15%; and contractual lives of 0.2 years. The change in value of the warrants of $338,000 and $829,000 for the three and nine months ended September 30, 2010, respectively, was recorded as a non-operating gain and is included in "Gain on derivative instruments, net" in the consolidated statement of operations.

9. COMMITMENTS AND CONTINGENCIES

Litigation

We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our consolidated financial position, results of operations or cash flows.

10. COMMITTED EQUITY FINANCING FACILITY

In August 2010, we entered into a committed equity financing facility (CEFF) with Azimuth, under which we could sell to Azimuth up to the lesser of $60.0 million or 17,771,901 of our shares of common stock over a 24-month term, which began on September 9, 2010. During 2011, we completed two draws from this facility and raised a total of $5.6 million in gross proceeds from the sale of approximately 4.5 million shares of our common stock. In July 2011, we cancelled this facility.

In May 2011, we entered into a CEFF with Azimuth, under which we may sell to Azimuth up to the lesser of $40.0 million or 21,018,431 of our shares of common stock over a 24-month term, which began on July 8, 2011. We paid Azimuth 225,000 shares of our common stock in consideration for entering into the CEFF with us. In August 2011, we raised $1.5 million in gross proceeds from the sale of approximately 1.6 million shares of our common stock under this facility.

From time to time over the agreement term, and at our sole discretion, we may present Azimuth with draw-down notices requiring Azimuth to purchase shares of our common stock over 10 consecutive trading days (the "Draw-Down Period") at a pre-determined purchase price. The per share purchase price is the daily volume-weighted average price (VWAP) of our common stock on each trading day of the Draw-Down Period, less a discount ranging from 3.50% to 10.0%. The discount is determined by a minimum threshold price that we specify which cannot be less than $0.75. If the daily VWAP of our common stock falls below the threshold price on any trading day during a Draw-Down Period, Azimuth will not purchase the pro rata portion of shares for that day. We will determine, in our sole discretion, the timing, the dollar amount and the price per share of each draw under this facility, subject to certain conditions.

We can require Azimuth to purchase the greater of the daily allocation amount specified in the draw-down notice or a percentage of the daily trading volume of our common stock for each trading day during the Draw-Down Period, subject to certain limitations. The total dollar amount of each draw is subject to certain agreed-upon limitations based on the market price of our common stock at the time of the draw. We are allowed to present Azimuth with up to 24 draw-down notices during the agreement term. Only one draw-down notice is allowed per Draw-Down Period with a minimum of five trading days required between each Draw-Down Period.

10


In September 2011, we entered into another CEFF with Azimuth, under which we may sell to Azimuth up to the lesser of $35.0 million or 22,030,737 of our shares of common stock over a 24-month term, which began on September 13, 2011. This facility provides additional flexibility in the types and timing of draw downs, compared to the May 2011 CEFF. In September 2011, we raised $5.0 million in gross proceeds from the sale of approximately 7.6 million shares of our common stock under this CEFF.

As in our May 2011 CEFF, from time to time over the term of our September 2011 CEFF, we may present Azimuth with draw-down notices requiring Azimuth to purchase shares of our common stock over the Draw-Down Period at a pre-determined purchase price. Once presented with a draw-down notice, Azimuth must purchase a pro rata portion of the shares on each trading day during the Draw-Down Period on which the daily VWAP for our common stock exceeds the threshold price specified in the draw-down notice. We can require Azimuth to purchase the greater of the daily allocation amount specified in the draw-down notice or a percentage of the daily trading volume of our common stock for each trading day during the Draw-Down Period, subject to certain limitations.

The per share purchase price for these shares is the daily VWAP of our common stock on each day of the Draw-Down Period, less a discount ranging from 3.5% to 6.5%. The discount is determined by the threshold price that we specify in the draw-down notice. If the daily VWAP of our common stock falls below the threshold price on any trading day during a Draw-Down Period, Azimuth will not be required to purchase the pro rata portion of shares for that day. However, Azimuth may elect to buy the pro-rata portion of shares allocated to that day at the threshold price less the discount described above.

The agreement also provides that from time to time, and at our sole discretion, we may grant Azimuth the option to purchase additional shares of our common stock during each Draw-Down Period up to an aggregate amount we specify. If Azimuth exercises this option, we would sell to Azimuth the shares of our common stock at the greater of the daily VWAP of our common stock on the day Azimuth exercises its option or the threshold price for the option we determined, less the same discount applied to the fixed amount in the draw-down notices. We are allowed to present Azimuth with up to 24 draw-down notices during the 24-month term, with only one draw-down notice allowed per Draw-Down Period and a minimum of five trading days required between each Draw-Down Period, unless we and Azimuth otherwise agree.

Reedland Capital Partners is acting as placement agent and receives a fee for its services equal to 1% of the aggregate dollar amount of common stock purchased by Azimuth upon settlement of any draws under these facilities.

11. RECEIVABLES FROM RELATED PARTIES

Our accounts receivable balance at September 30, 2011 and revenue for the nine months ended September 30, 2011, include $409,000 from a sale of PicoP engines to Walsin Lihwa Corporation which has informed us of its plans to integrate the engines into its product scheduled for commercial release in China in late 2011. Based on filings with the SEC as of September 30, 2011, Walsin Lihwa beneficially owns approximately 8.4% of our common stock as determined in accordance with SEC rules, through its wholly owned subsidiary Max Display Enterprises Limited.

12. NEW ACCOUNTING PRONOUNCEMENTS

In May 2011, the FASB issued a new accounting standard on fair value measurements that clarifies the application of existing guidance and disclosure requirements, changes certain fair value measurement principles and requires additional disclosures about fair value measurements. The standard is effective for interim and annual periods beginning after December 15, 2011. Early adoption is not permitted. We do not expect this adoption to have a material impact on our financial statements.

In June 2011, the FASB issued a new accounting standard on the presentation of comprehensive income. The new standard requires the presentation of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The new standard also requires presentation of adjustments for items that are reclassified from other comprehensive income to net income in the statement where the components of net income and the components of other comprehensive income are presented. The standard is effective for fiscal years, and interim periods within these years, beginning after December 15, 2011. Early adoption is permitted. The adoption of this standard will have no material impact on our financial statements.

11


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The information set forth in this report in Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," and Item 3, "Quantitative and Qualitative Disclosure about Market Risk," includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is subject to the safe harbor created by that section. Such statements may include, but are not limited to, projections of revenues, income or loss, capital expenditures, plans for product development and cooperative arrangements, future operations, financing needs or plans of MicroVision , as well as assumptions relating to the foregoing. The words "anticipate," "believe," "estimate," "expect," "goal," "may," "plan," "project," "will" and similar expressions identify forward-looking statements, which speak only as of the date the statement was made. Factors that could cause actual results to differ materially from those projected in our forward-looking statements include the following: our ability to obtain financing; market acceptance of our technologies and products; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified in this report under the caption "Item 1A - Risk Factors."

Overview

We are developing high-resolution miniature laser display and imaging engines based upon our proprietary PicoP® display engine technology. Our PicoP technology utilizes our widely patented expertise in two-dimensional Micro-Electrical Mechanical Systems (MEMS), lasers, optics and electronics to create a high-quality video or still image from a small form factor device with lower power needs than conventional display technologies. Our strategy is to develop and supply PicoP display engines to original equipment manufacturers (OEMs) that would embed them into a variety of consumer, automotive, enterprise and industrial products.

The primary objective for consumer applications is to provide users of mobile consumer devices such as smartphones, media players, tablet PCs, and other consumer electronic products with a large-screen viewing experience produced by a small embedded projector. These potential products would allow users to watch movies and videos, play video games, and display images and other data onto a variety of surfaces, freeing users from the limitations of a small, palm-sized screen. During the third quarter of 2011, we fulfilled an initial order of approximately $0.5 million and received a follow-on order for $3.5 million from ESPlus Company Ltd., a Korean consumer electronics manufacturer, for PicoP engines. ESPlus released its product, a mobile media player which has an embedded PicoP display engine, at the Korean Electronics Show in October 2011.

The PicoP could be further modified to be embedded into a pair of glasses to provide the mobile user with a see-through or occluded personal display to view movies, play games or access other content.

The PicoP with some modification could be embedded into a vehicle or integrated into a portable stand-alone aftermarket device to create a high-resolution head-up display (HUD) that could project point-by-point navigation, critical operational, safety and other information important to the vehicle operator. During the second quarter of 2011, we entered into a development agreement with a major automotive manufacturer to incorporate our PicoP head-up display (PicoHUD™) technology into its test vehicles. It is anticipated that the first phase will be followed by a series of milestones that may result in introduction of the HUD into a production vehicle in 2014. The prototypes are intended for installation in early test vehicles for specific upcoming models already identified on the automobile manufacturer's production roadmap.

The enterprise products employing our technology would allow users in field-based professions such as service repair or sales to view and share information such as schematics for equipment repair and sales data and orders within CRM applications on a larger, more user-friendly interface. We also see potential for embedding the PicoP laser display engine in industrial products where our displays could be used for 3D measuring and digital signage, enhancing the overall user experience of these applications.

12


We currently market and sell our SHOWWX™ line of accessory pico projectors through a network of global distributors as well as directly to end users through our website. In the future, we plan to add distribution channels and geographic locations for our PicoP-based products. We continue to enter into a limited number of development agreements with commercial and U.S. government customers to develop advanced prototypes and demonstration units based on our light scanning technologies.

Results of Operations

            % of           % of            
            product           product            
(in thousands)     2011     revenue     2010     revenue     $ change     % change
Three months ended September 30                                    
Pico projector revenue   $ 1,488      97.6    $ 985      91.2    $ 503      51.1 
Bar code revenue     37      2.4      95      8.8      (58)     (61.1)
Total product revenue   $ 1,525      100.0    $ 1,080      100.0    $ 445      41.2 
                                     
            % of           % of            
            product           product            
(in thousands)     2011     revenue     2010     revenue     $ change     % change
Nine months ended September 30                                    
Pico projector revenue   $ 3,128      94.4    $ 3,150      90.9    $ (22)     (0.7)
Bar code revenue     187      5.6      315      9.1      (128)     (40.6)
Total product revenue   $ 3,315      100.0    $ 3,465      100.0    $ (150)     (4.3)

Product revenue.

Our product sales generally include acceptance provisions. We recognize product revenue upon acceptance of the product by the customer or expiration of the contractual acceptance period, after which there are no rights of return. We have entered into agreements with resellers and distributors, as well as selling directly to the public. Sales made to resellers and distributors are recognized using either the sell-through method or upon expiration of the contractually agreed-upon acceptance period, depending on our ability to reasonably estimate returns. Some of the agreements with resellers and distributors contain price-protection clauses, and revenue is recognized net of these amounts. Sales made directly to the public are recognized either upon expiration of the contractual acceptance period after which there are no rights of return, or net of estimated returns and allowances. Provisions are made for warranties at the time revenue is recorded.

Our quarterly revenue may vary substantially due to the timing of product orders from customers, production constraints and availability of components and raw materials.

Pico projector revenue includes the sales of our SHOWWX™ line of accessory pico projectors and related accessories, and PicoP engines. Pico projector revenue was higher for the three months ended September 30, 2011 than the same period in 2010, as a result of increased sales of our PicoP engines compared to the prior year and a one-time sale of our pico projectors to a single customer. During the third quarter of 2011, we shipped an order of approximately $500,000 to ESPlus Company Ltd., a Korean consumer electronics manufacturer, which supported initial production of its mobile media player product launched at the Korean Electronics Show in October 2011.

Bar code revenue was lower during 2011 than the same periods in 2010, due to our decision to stop marketing our bar code product during 2009 and focus on commercializing the PicoP technology. We do not expect to increase our investment in the bar code product in the future.

The backlog of product orders at September 30, 2011 was approximately $4.2 million and is scheduled for delivery within one year. Product backlog at September 30, 2011 includes an order of $3.5 million from ESPlus Company Ltd. scheduled for shipment during the fourth quarter of 2011.

13


Contract revenue.

            % of           % of            
            contract           contract            
(in thousands)     2011     revenue     2010     revenue     $ change     % change
Three months ended September 30                                    
Government revenue   $ 81      25.8    $     -     $ 81      100.0 
Commercial revenue     233      74.2      221      100.0      12      5.4 
Total contract revenue   $ 314      100.0    $ 221      100.0    $ 93      42.1 
                                     
            % of           % of            
            contract           contract            
(in thousands)     2011     revenue     2010     revenue     $ change     % change
Nine months ended September 30                                    
Government revenue   $ 254      31.8    $ 71      12.0    $ 183      257.7 
Commercial revenue     544      68.2      521      88.0      23      4.4 
Total contract revenue   $ 798      100.0    $ 592      100.0    $ 206      34.8 

We earn contract revenue from performance on development contracts with the U.S. government and commercial customers and from the sale of prototype units and evaluation kits based on our PicoP display engine. Our contract revenue from development contracts in a particular period is dependent upon when we enter into a contract, the value of the contracts we have entered into and the availability of technical resources to perform work on the contracts. Our contract revenue from sales of prototype units and evaluation kits may vary substantially due to the timing of orders from customers and potential constraints on resources.

We recognize contract revenue as work progresses on long-term, cost plus fixed fee, and fixed price contracts using the percentage-of-completion method, which relies on estimates of total expected contract revenue and costs. We have developed processes that allow us to make reasonable estimates of the cost to complete a contract. When we begin work on the contract and at the end of each accounting period, we estimate the costs required to complete the contract and compare these estimates to costs incurred to date. Since our contracts generally require some level of technology development, the actual costs required to complete a contract can vary from our estimates. Recognized revenues are subject to revisions as actual cost becomes certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known. In the future, revisions in these estimates could significantly impact recognized revenue in any one reporting period. We recognize contract revenue on the sale of prototype units and evaluation kits upon acceptance of the deliverables by the customer or expiration of the contractual acceptance period, after which there are no rights of return. While we anticipate future revenue from these units, quarterly revenue may vary substantially due to the timing of orders from customers and potential constraints on resources.

Contract revenue was higher during the three and nine months ended September 30, 2011 than the same periods in 2010, due to increased activity on government and commercial contracts compared to the prior year. We expect that we will enter into few new development contracts in 2011 as we continue to focus our resources on commercialization of our PicoP-based products.

Our backlog of development contracts, including orders for prototype units and evaluation kits, at September 30, 2011 was $933,000, all of which is scheduled for completion or delivery during the next twelve months.

Cost of product revenue.

            % of           % of            
            product           product            
(in thousands)     2011     revenue     2010     revenue     $ change     % change
Three months ended September 30   $ 2,483      162.8    $ 4,059      375.8    $ (1,576)     (38.8)
Nine months ended September 30     7,708      232.5      8,555      246.9      (847)     (9.9)

Our cost to produce accessory pico projector units during the three and nine months ended September 30, 2011 were substantially higher than product revenue. Cost of product revenue includes the direct and allocated indirect cost of manufacturing products sold to customers. Direct costs include labor, materials and other costs incurred directly in the manufacture of these products. Indirect costs include labor and other overhead costs associated with operating our manufacturing capabilities and capacity. Our overhead, which includes the costs of procuring, inspecting and storing material,

14


and facility and depreciation costs, is allocated to cost of product revenue based on the level of effort supporting production. In the event that we maintain production capacity in excess of production requirements, cost of product revenue may also include manufacturing overhead associated with the excess capacity.

Cost of product revenue for the three and nine months ended September 30, 2011, included write downs of zero and $944,000, respectively, compared to $2.0 million and $3.8 million, respectively for the same periods in 2010. The write downs included lower of cost or market adjustments to reflect our current estimated selling prices for our inventory in stock at the end of each quarter. During the third quarter of 2011, we sold inventory which had been previously written down to the lower of cost or market. Accordingly, cost of product revenue for the three months ended September 30, 2011, did not include approximately $1.7 million of previously recognized write downs associated with this inventory. During the three and nine months ended September 30, 2010, cost of product revenue also included $500,000 and $521,000, respectively, of warranty expense primarily associated with our PicoP display engine.

During the three and nine months ended September 30, 2011, we expensed approximately $247,000 and $945,000, respectively, of manufacturing overhead associated with production capacity in excess of production requirements. We did not expense any overhead associated with excess capacity as cost of product revenue in the comparable periods of 2010. We classified overhead cost allocated to the accessory pico projector as research and development expense until February 2010, when we determined that the product's design and production processes were mature enough to support commercial production and we began classifying overhead cost to cost of product revenue.

The decrease in cost of product revenue for the three and nine months ended September 30, 2011, compared to the same period in 2010, was primarily a result of approximately $1.7 million of previously written down inventory that was sold in the third quarter of 2011. The cost of product revenue as a percentage of product revenue can fluctuate significantly from period to period, depending on the product mix and volume and the level of overhead expense. The increase in the cost of product revenue as a percentage of product revenue in 2011, compared to the same periods in 2010, was primarily attributed to manufacturing overhead associated with production capacity in excess of production requirements.

Cost of contract revenue.

            % of           % of            
            contract           contract            
(in thousands)     2011     revenue     2010     revenue     $ change     % change
Three months ended September 30   $ 237      75.5    $ 53      24.0    $ 184      347.2 
Nine months ended September 30     931      116.7      202      34.1      729      360.9 

Cost of contract revenue includes both the direct and allocated indirect costs of performing on development contracts and producing prototype units and evaluation kits. Direct costs include labor, materials and other costs incurred directly in performing on a contract or producing prototype units and evaluation kits. Indirect costs include labor and other costs associated with operating our research and development department and building our technical capabilities and capacity. Cost of contract revenue is determined by the level of direct and indirect costs incurred, which can fluctuate substantially from period to period.

Cost of contract revenue for the three and nine months ended September 30, 2011 includes a provision for estimated losses on uncompleted contracts of $(111,000) and $186,000, respectively, compared to zero in the comparable periods of 2010. We recognize any estimated losses on contracts in full as soon as identified. The losses are primarily a result of our decision to share costs with our customer for development of advanced in-vehicle HUD prototypes in anticipation of follow-on revenue opportunities and excess material cost associated with minimum order quantities for materials required to complete one of our development contracts.

Cost of contract revenue and the cost of contract revenue as a percentage of revenue were higher during the three and nine months ended September 30, 2011 than the same periods in 2010 as a result of the provision for estimated losses and higher labor expense resulting from a change in the labor resources allocated to the contracts.

The cost of contract revenue as a percentage of contract revenue can fluctuate significantly from period to period, depending on the contract cost mix and the levels of direct and indirect costs incurred.

15


Research and development expense.

(in thousands)     2011     2010     $ change     % change
Three months ended September 30   $ 3,641    $ 5,920    $ (2,279)     (38.5)
Nine months ended September 30     11,446      16,961      (5,515)     (32.5)

Research and development expense consists of compensation-related costs of employees and contractors engaged in internal research and product development activities, direct material to support development programs, laboratory operations, outsourced development and processing work, and other operating expenses. We allocate our research and development resources based on the business opportunity of the available projects, the skill mix of the resources available and the contractual commitments we have made to customers.

The decrease in research and development expense during the three and nine months ended September 30, 2011, compared to the same periods in 2010, is primarily attributable to decreased subcontractor costs associated with advanced research and decreased payroll costs due to reductions in staffing levels, compared to the prior year.

In 2011, we have been aggressively managing our operating expenses as part of our strategy to simplify operations and significantly reduce our 2011 cash requirements as we focus our efforts on development of the next-generation of our PicoP technology based on direct green lasers. As a result, our research and development expense has decreased for the first nine months of 2011 compared to same period in 2010.

We believe that a substantial level of continuing research and development expense will be required to develop additional commercial products using the PicoP technology. Accordingly, we anticipate our level of research and development spending will continue to be substantial.

Sales, marketing, general and administrative expense.

(in thousands)     2011     2010     $ change     % change
Three months ended September 30   $ 3,306    $ 3,555    $ (249)     (7.0)
Nine months ended September 30     10,182      11,260      (1,078)     (9.6)

Sales, marketing, general and administrative expense includes compensation and support costs for marketing, sales, management and administrative staff, and for other general and administrative costs, including legal and accounting services, consultants and other operating expenses. The decrease in cost during 2011 compared to the same periods in 2010 is primarily due to decreased payroll costs due to reductions in staffing levels.

In 2011, we have been aggressively managing our operating expenses as part of our strategy to simplify operations and significantly reduce our 2011 cash requirements as we focus our efforts on development of the next-generation of our PicoP technology based on direct green lasers. As a result, our sales, marketing, general and administrative expense has decreased for the first nine months of 2011 compared to the same period in 2010.

Interest income.

(in thousands)     2011     2010     $ change     % change
Three months ended September 30   $   $ 15    $ (6)     (40.0)
Nine months ended September 30     36      94      (58)     (61.7)

The decrease in interest income for the three and nine months ended September 30, 2011 compared to the same periods in 2010 resulted primarily from lower average cash, investment securities balances and interest rates.

16


Interest expense.

(in thousands)     2011     2010     $ change     % change
Three months ended September 30   $ (9)   $ (15)   $     (40.0)
Nine months ended September 30     (34)     (48)     14      (29.2)

Gain on derivative instruments, net.

(in thousands)     2011     2010     $ change     % change
Three months ended September 30   $   $ 446    $ (446)     (100.0)
Nine months ended September 30         875      (875)     (100.0)

Prior to 2011, we had common stock warrants outstanding that were issued in connection with certain notes. The warrants met the definition of derivative instruments that must be accounted for as liabilities because we could not engage in certain corporate transactions affecting the common stock unless we made a cash payment to the holders of the warrants. During 2010 these warrants expired unexercised. We recorded changes in the fair values of the warrants in the consolidated statements of operations each period. We valued the warrants at September 30, 2010 using the Black-Scholes option pricing model with the following assumptions: expected volatility of 80%; expected dividend yield of 0%; risk free interest rate of 0.15%; and contractual life of 0.2 years. The changes in value of the warrants of $338,000 and $829,000 for the three and nine months ended September 30, 2010 were recorded as non-operating gains and are included in "Gain on derivative instruments, net" in the consolidated statements of operations.

Liquidity and Capital Resources

We have incurred significant losses since inception. We have funded our operations to date primarily through the sale of equity and debt securities and, to a lesser extent, from development contract revenues and product sales. At September 30, 2011, we had $9.4 million in cash, cash equivalents and investment securities available-for-sale.

We anticipate lowering our cash used in operations in 2011 significantly, through a combination of:

  • sharing development and commercialization costs of the next-generation PicoP technology based on direct green lasers with our development partners;
  • limiting our future investment into advancement of the current-generation PicoP technology based on synthetic green lasers;
  • moving future product development to original design manufacturers;
  • lowering our working capital requirements through a recently completed restructuring of inventory cycles with major suppliers; and
  • reducing our operating costs through a 20% workforce reduction completed in January 2011, in addition to other measures.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through January 2012. We will require additional cash to fund our operating plan past that time. We are introducing new products into an emerging market, which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. If the level of sales anticipated by our financial plan is not achieved or our working capital requirements are higher than planned, we will need to raise additional cash sooner or take actions to reduce operating expenses. We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include reducing our planned investment in working capital to fund revenue growth and delaying development projects resulting in reductions in staff, operating costs, capital expenditures and investment in research and development.

17


In August 2010, we entered into a committed equity financing facility with Azimuth Opportunity, Ltd. ("Azimuth"). During 2011 we completed two draws from this facility and raised a total of $5.6 million before placement agent and other issuance costs from the sale of approximately 4.5 million shares of our common stock. In July 2011, we cancelled this facility.

In May 2011, we entered into a committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $40.0 million or 21,018,431 of our shares of common stock over a 24-month term, which began on July 8, 2011. In August 2011, we raised $1.5 million before placement agent and other issuance costs from the sale of approximately 1.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $ 38.5 million or 19.2 million shares of common stock remaining available under the facility.

In September 2011, we entered into another committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $35.0 million or 22,030,737 of our shares of common stock over a 24-month term, which began on September 13, 2011. In September 2011, we raised $5.0 million before placement agent and other issuance costs from the sale of approximately 7.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $30 million or 14.4 million shares of common stock remaining available under this facility. However, we may not be able to sell shares under either facility in the amounts desired or at all.

We have received a report from our independent public accounting firm regarding the consolidated financial statements for the year ended December 31, 2010 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. Our consolidated financial statements have been prepared on a going concern basis.

Cash used in operating activities totaled $21.8 million during the nine months ended September 30, 2011, compared to $35.0 million during the same period in 2010. During the nine months ended September 30, 2011, the decrease in net cash used in operating activities was primarily driven by lower inventory purchases for commercialization of PicoP-based products as well as savings resulting from steps taken to lower our 2011 cash use as described above.

Net cash used in investing activities totaled $5,000 for the nine months ended September 30, 2011 compared to $1.9 million during the nine months ended September 30, 2010. During the nine months ended September 30, 2011, we used cash of $492,000 for capital expenditures, compared to $1.7 million during the same period in 2010. During the nine months ended September 30, 2011, the decrease in cash used in investing activities was primarily a result of fewer costs associated with a new enterprise resource planning system and production equipment purchases compared to one year ago.

Net cash provided by financing activities totaled $11.8 million for the nine months ended September 30, 2011, compared to $12.5 million for the same period in 2010. During the nine months ended September 30, 2011 we completed four draws from our committed equity financing facilities, for a total of $12.1 million before placement agent and other issuance costs from the sale of 13.7 million shares of our common stock.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate and Market Liquidity Risks

As of September 30, 2011, all of our cash, cash equivalents and investment securities available-for-sale have variable interest rates or are equity investments traded in active markets. Therefore, we believe our exposure to the market and interest rate risk is not material. Our investment policy generally directs that the investment managers should select investments to achieve principal preservation, adequate liquidity and return.

The values of cash equivalents and investment securities available-for-sale by maturity date as of September 30, 2011, are as follows:

(amount in thousands)     Amount     Percent  
Cash and cash equivalents   $ 9,369      99.91  %
Less than one year         0.09  %
One to two years         -    
Greater than five years                                                           -   %
    $ 9,377      100.00  %

18


Foreign Exchange Rate Risk

All of our development contract payments are made in U.S. dollars. However, in the future we may enter into additional development contracts in foreign currencies that may subject us to foreign exchange rate risk. We have purchase orders and supply agreements in foreign currencies and may enter into such arrangements from time to time in the future. We believe our exposure to currency fluctuations related to these arrangements is not material. We intend to enter into foreign currency hedges to offset material exposure to currency fluctuations when we can adequately determine the timing and amounts of the exposure.

ITEM 4. CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) of the Exchange Act) as of the end of the period covered by this report and, based on this evaluation, our principal executive officer and principal financial officer have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)) of the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

ITEM 1A - RISK FACTORS

Risk Factors Relating to the MicroVision Business

We have a history of operating losses and expect to incur significant losses in the future.

We have had substantial losses since our inception. We cannot assure you that we will ever become or remain profitable.

  • As of September 30, 2011, we had an accumulated deficit of $405.0 million.
  • We incurred consolidated net losses of $292.0 million from inception through 2008, $39.5 million in 2009, and $47.5 in 2010, and a net loss of $26.0 million in the nine months ended September 30, 2011.

The likelihood of our success must be considered in light of the expenses, difficulties and delays frequently encountered by companies formed to develop and market new technologies. In particular, our operations to date have focused primarily on research and development of our technology platform and development of demonstration units. We are unable to accurately estimate future revenues and operating expenses based upon historical performance.

We cannot be certain that we will succeed in obtaining additional development contracts or that we will be able to obtain substantial customer orders for our products. In light of these factors, we expect to continue to incur substantial losses and negative cash flow at least through 2011 and likely thereafter. We cannot be certain that we will achieve positive cash flow at any time in the future.

We will require additional capital to fund our operations and to implement our business plan. If we do not obtain additional capital, we may be required to curtail our operations substantially. Raising additional capital may dilute the value of current shareholders' shares.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through January 2012. We will require additional cash to fund our operating plan past that time. We are introducing new products into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. If the level of sales anticipated by our financial plan is not achieved or our working capital requirements are higher than planned, we will need to raise additional cash sooner or take actions to reduce operating expenses. We plan to obtain additional cash through the issuance of equity or debt securities.

19


Our capital requirements will depend on many factors, including, but not limited to, the rate at which we can, directly or through arrangements with original equipment manufacturers, introduce products incorporating the PicoP display engine and image capture technologies and the market acceptance and competitive position of such products. If revenues are less than we anticipate, if the mix of revenues varies from anticipated amounts or if expenses exceed the amounts budgeted, we may require additional capital earlier than expected to fund our operations. In addition, our operating plan provides for the development of strategic relationships with systems and equipment manufacturers that may require additional investments by us.

Additional capital may not be available to us, or if available, on terms acceptable to us or on a timely basis. Raising additional capital may involve issuing securities with rights and preferences that are senior to our common stock and may dilute the value of current shareholders' shares. If adequate funds are not available on a timely basis we intend to consider limiting our operations substantially to extend out funds as we pursue other financing opportunities and business relationships. This limitation of operations could include reducing our planned investment in working capital to fund growth and delaying development projects resulting in reductions in staff and operating costs as well as reductions in capital expenditures and investment in research and development.

If we sell shares of our common stock under our committed equity financing facilities, our existing stockholders will experience immediate dilution and, as a result, our stock price may go down.

In May 2011, we entered into a committed equity financing facility, or financing arrangement, under which we may sell up to $40 million of shares of our common stock to Azimuth over a 24-month period subject to a maximum of 21,018,431 shares, including the 225,000 shares of common stock we issued to Azimuth in May 2011 as compensation for their commitment to enter into the financing arrangement. In September 2011, we entered into another committed equity financing facility under which we may sell up to $35 million of shares of our common stock to Azimuth over a 24-month period subject to a maximum of 22,030,737 shares of common stock. The sale of shares of our common stock pursuant to these financing arrangements will have a dilutive impact on our existing stockholders. Azimuth may resell some or all of the shares we issue to them under the financing arrangement and such sales could cause the market price of our common stock to decline, which decline could be significant.

We may not have access to the full amount available under the committed equity financing facility.

Although the committed equity financing facilities with Azimuth provides for access to up to $75 million, before Azimuth is obligated to purchase any shares of our common stock pursuant to a draw down notice, certain conditions specified in the purchase agreement must be met. Some of such conditions are not in our control. There is no guarantee that these conditions will be met nor is there any guarantee that any of the other conditions in the purchase agreement will be met that would enable a draw down of any portion of the amounts available under the equity line with Azimuth.

If we cannot manufacture products at competitive prices, our financial results will be adversely affected.

We are currently negotiating component pricing with suppliers for our current and future products. The cost per unit for PicoP-based accessory projectors currently exceeds the level at which we could expect to profitably sell these products. If we cannot lower our cost of production, we may face increased demands on our financial resources, possibly requiring additional equity and/or debt financing to sustain our business operations.

We cannot be certain that our technology platform or products incorporating our PicoP display engine will achieve market acceptance. If products incorporating the PicoP display engine do not achieve market acceptance, our revenues may not grow.

Our success will depend in part on customer acceptance of the PicoP display engine. The PicoP display engine may not be accepted by manufacturers who use display technologies in their products, by systems integrators who incorporate our products into their products or by end users of these products. To be accepted, the PicoP display engine must meet the expectations of our potential customers in the consumer, defense, industrial, and medical markets. If our technology fails to achieve market acceptance, we may not be able to continue to develop our technology platform.

20


Our planned future products are dependent on advances in technology by other companies.

We rely on and will continue to rely on technologies, such as light sources, MEMS and optical components that are developed and produced by other companies. The commercial success of certain of our planned future products will depend in part on advances in these and other technologies by other companies. We may, from time to time, contract with and support companies developing key technologies in order to accelerate the development of them for our specific uses. There are no guarantees that such activities will result in useful technologies or components for us.

We are dependent on a small number of customers for our revenue. Our quarterly performance may vary substantially and this variance, as well as general market conditions, may cause our stock price to fluctuate greatly and potentially expose us to litigation.

Since 2010, most of our revenues have been generated from product sales to a limited number of customers and distribution partners. Our quarterly operating results may vary significantly based on:

  • commercial acceptance of our PicoP-based products;
  • the rate at which our distributors can achieve sell through of our products;
  • changes in evaluations and recommendations by any securities analysts following our stock or our industry generally;
  • announcements by other companies in our industry;
  • changes in business or regulatory conditions;
  • announcements or implementation by our competitors of technological innovations or new products;
  • the status of particular development programs and the timing of performance under specific development agreements;
  • economic and stock market conditions; or
  • other factors unrelated to our company or industry.

In one or more future quarters, our results of operations may fall below the expectations of securities analysts and investors and the trading price of our common stock may decline as a consequence. In addition, following periods of volatility in the market price of a company's securities, shareholders often have instituted securities class action litigation against that company. If we become involved in a class action suit, it could divert the attention of management, and, if adversely determined, could require us to pay substantial damages.

We or our customers may fail to perform under open orders, which could adversely affect our operating results and cash flows.

Our backlog of open orders totaled $5.1 million as of September 30, 2011. We may be unable to meet the performance requirements, including performance specifications or delivery dates, required by such purchase orders. Further, our customers may be unable or unwilling to perform their obligations there under on a timely basis or at all if, among other reasons, our products and technologies do not achieve market acceptance, our customers' products and technologies do not achieve market acceptance or our customers otherwise fail to achieve their operating goals. To the extent we are unable to perform under such purchase orders or to the extent customers are unable or unwilling to perform, our operating results and cash flows could be adversely affected.

It may become more difficult to sell our stock in the public market.

Our common stock is listed for quotation on The NASDAQ Global Market. On October 26, 2011, we received a deficiency notice from The NASDAQ Stock Market advising us that for 30 consecutive trading days preceding the date of the notice, the bid price of our common stock had closed below the $1.00 per share minimum required for continued listing on The NASDAQ Global Market pursuant to NASDAQ's listing requirements. In accordance with NASDAQ's listing rules, we have 180 calendar days, or until April 23, 2012, to regain compliance with this requirement. During this initial 180-day compliance period, we can regain compliance if the bid price of our common stock closes at $1.00 or higher for a minimum of ten consecutive business days. If we are unable to continue to meet NASDAQ'S listing maintenance standards for any reason, our common stock could be delisted from The NASDAQ Global Market. If our common stock were delisted, we likely would seek to list the common stock on the NASDAQ Capital Market, the American Stock Exchange or on a regional stock exchange. Listing on such other market or exchange could reduce the liquidity of our common stock. If our common stock were not listed on the NASDAQ Capital Market or an exchange, trading of our common stock would be conducted in the over-the-counter market on an electronic bulletin board established for unlisted securities or directly through market makers in our common stock. If our common stock were to trade in the over-the-counter market, an investor would find it more difficult to dispose of, or to obtain accurate quotations for the price of, the common stock. A delisting from The NASDAQ Global Market and failure

21


to obtain listing on such other market or exchange would subject our securities to so-called penny stock rules that impose additional sales practice and market-making requirements on broker-dealers who sell or make a market in such securities. Consequently, removal from The NASDAQ Global Market and failure to obtain listing on another market or exchange could affect the ability or willingness of broker-dealers to sell or make a market in our common stock and the ability of purchasers of our common stock to sell their securities in the secondary market. In addition, when the market price of our common stock is less than $5.00 per share, we become subject to penny stock rules even if our common stock is still listed on The NASDAQ Global Market. While the penny stock rules should not affect the quotation of our common stock on The NASDAQ Global Market, these rules may further limit the market liquidity of our common stock and the ability of investors to sell our common stock in the secondary market. The market price of our stock has mostly traded below $5.00 per share during 2011, 2010 and 2009. On October 26, 2011, the closing price of our stock was $0.75.

Our lack of financial and technical resources relative to our competitors may limit our revenues, potential profits, overall market share or value.

Our current products and potential future products will compete with established manufacturers of existing products and companies developing new technologies. Many of our competitors have substantially greater financial, technical and other resources than we have. Because of their greater resources, our competitors may develop products or technologies that are superior to our own. The introduction of superior competing products or technologies could result in reduced revenues, lower margins or loss of market share, any of which could reduce the value of our business.

We may not be able to keep up with rapid technological change and our financial results may suffer.

The information display industry has been characterized by rapidly changing technology, accelerated product obsolescence and continuously evolving industry standards. Our success will depend upon our ability to further develop our technology platform and to cost effectively introduce new products and features in a timely manner to meet evolving customer requirements and compete with competitors' product advances.

We may not succeed in these efforts because of:

  • delays in product development;
  • lack of market acceptance for our products; or
  • lack of funds to invest in product development and marketing.

The occurrence of any of the above factors could result in decreased revenues, market share and value.

We could face lawsuits related to our use of the PicoP display engine or other technologies. Defending these suits would be costly and time consuming. An adverse outcome in any such matter could limit our ability to commercialize our technology and products, reduce our revenues and increase our operating expenses.

We are aware of several patents held by third parties that relate to certain aspects of light scanning displays and image capture products. These patents could be used as a basis to challenge the validity, limit the scope or limit our ability to obtain additional or broader patent rights of our patents or patents we have licensed. A successful challenge to the validity of our patents or patents we have licensed could limit our ability to commercialize our technology and the PicoP display engine and, consequently, materially reduce our revenues. Moreover, we cannot be certain that patent holders or other third parties will not claim infringement by us with respect to current and future technology. Because U.S. patent applications are held and examined in secrecy, it is also possible that presently pending U.S. applications will eventually be issued with claims that will be infringed by our products or our technology. The defense and prosecution of a patent suit would be costly and time consuming, even if the outcome were ultimately favorable to us. An adverse outcome in the defense of a patent suit could subject us to significant costs, to require others and us to cease selling products that incorporate the PicoP display engine, to cease licensing our technology or to require disputed rights to be licensed from third parties. Such licenses, if available, would increase our operating expenses. Moreover, if claims of infringement are asserted against our future co-development partners or customers, those partners or customers may seek indemnification from us for damages or expenses they incur.

22


If we fail to manage expansion effectively, our revenue and expenses could be adversely affected.

Our ability to successfully offer products and implement our business plan in a rapidly evolving market requires an effective planning and management process. The growth in business and relationships with customers and other third parties has placed, and will continue to place, a significant strain on our management systems and resources. We will need to continue to improve our financial and managerial controls, reporting systems and procedures and will need to continue to train and manage our work force.

Our products may be subject to future health and safety regulations that could increase our development and production costs.

Products incorporating the PicoP display engine could become subject to new health and safety regulations that would reduce our ability to commercialize the PicoP display engine. Compliance with any such new regulations would likely increase our cost to develop and produce products using the PicoP display engine and adversely affect our financial results.

Our dependence on sales to distributors increases the risks of managing our supply chain and may result in excess inventory or inventory shortages.

We expect the majority of our distributor relationships for our accessory pico projector and its accessories to involve the distributor taking inventory positions and reselling to multiple customers. With these distributor relationships, we would not recognize revenue until the distributors sell the product through to their end user customers. Our distributor relationships may reduce our ability to forecast sales and increases risks to our business. Since our distributors would act as intermediaries between us and the end user customers, we would be required to rely on our distributors to accurately report inventory levels and production forecasts. This may require us to manage a more complex supply chain and monitor the financial condition and credit worthiness of our distributors and the end user customers. Our failure to manage one or more of these risks could result in excess inventory or shortages that could adversely impact our operating results and financial condition.

Our future growth will suffer if we do not achieve sufficient market acceptance of our products to compete effectively.

Our success depends, in part, on our ability to gain acceptance of our current and future products by a large number of customers. Achieving market acceptance for our products will require marketing efforts and the expenditure of financial and other resources to create product awareness and demand by potential customers. We may be unable to offer products consistently, or at all, that compete effectively with products of others on the basis of price or performance. Failure to achieve broad acceptance of our products by potential customers and to effectively compete would have a material adverse effect on our operating results.

Our operating results may be adversely impacted by worldwide political and economic uncertainties and specific conditions in the markets we address.

In the recent past, general worldwide economic conditions have experienced a downturn due to slower economic activity, concerns about inflation, increased energy costs, decreased consumer confidence, reduced corporate profits and capital spending, and adverse business conditions. Any continuation or worsening of the current global economic and financial conditions could materially adversely affect (i) our ability to raise, or the cost of, needed capital, (ii) demand for our current and future products and (iii) our ability to commercialize products. We cannot predict the timing, strength, or duration of any economic slowdown or subsequent economic recovery, worldwide, or in the display industry.

Because we plan to continue using foreign contract manufacturers, our operating results could be harmed by economic, political, regulatory and other factors in foreign countries.

We currently use a contract manufacturer in Asia to manufacture our accessory pico projector product, and we plan to use foreign manufacturers to manufacture future products, where appropriate. These international operations are subject to inherent risks, which may adversely affect us, including:

  • political and economic instability;
  • high levels of inflation, historically the case in a number of countries in Asia;
  • burdens and costs of compliance with a variety of foreign laws;
  • foreign taxes;

23


  • changes in tariff rates or other trade and monetary policies; and
  • changes or volatility in currency exchange rates.

If we have to qualify a new contract manufacturer or foundry for our products, we may experience delays that result in lost revenues and damaged customer relationships.

We rely on single suppliers to manufacture our PicoP display engine, our SHOWWX products and our MEMS chips in wafer form. The lead time required to establish a relationship with a new contract manufacturer or foundry is long, and it takes time to adapt a product's design to a particular manufacturer's processes. Accordingly, there is no readily available alternative source of supply for these products and components in high volumes. This could cause significant delays in shipping products if we have to change our source of supply and manufacture quickly, which may result in lost revenues and damaged customer relationships.

If we experience delays or failures in developing commercially viable products, we may have lower revenues.

We have begun sales of units incorporating the PicoP display engine. However, we must undertake additional research, development and testing before we are able to develop additional products for commercial sale. Product development delays by us or our potential product development partners, or the inability to enter into relationships with these partners, may delay or prevent us from introducing products for commercial sale. We intend to rely on third-party developments or to contract with other companies to continue development of green laser devices we will need for our products.

Our success will depend, in part, on our ability to secure significant third-party manufacturing resources.

We are developing our capability to manufacture products in commercial quantities. Our success depends, in part, on our ability to provide our components and future products in commercial quantities at competitive prices. Accordingly, we will be required to obtain access, through business partners or contract manufacturers, to manufacturing capacity and processes for the commercial production of our expected future products. We cannot be certain that we will successfully obtain access to sufficient manufacturing resources. Future manufacturing limitations of our suppliers could result in a limitation on the number of products incorporating our technology that we are able to produce.

If our licensors and we are unable to obtain effective intellectual property protection for our products and technology, we may be unable to compete with other companies.

Intellectual property protection for our products is important and uncertain. If we do not obtain effective intellectual property protection for our products, processes and technology, we may be subject to increased competition. Our commercial success will depend in part on our ability and the ability of our licensors to maintain the proprietary nature of the PicoP display and other key technologies by securing valid and enforceable patents and effectively maintaining unpatented technology as trade secrets. We try to protect our proprietary technology by seeking to obtain United States and foreign patents in our name, or licenses to third-party patents, related to proprietary technology, inventions, and improvements that may be important to the development of our business. However, our patent position and the patent position of our licensors involve complex legal and factual questions. The standards that the United States Patent and Trademark Office and its foreign counterparts use to grant patents are not always applied predictably or uniformly and can change. Additionally, the scope of patents are subject to interpretation by courts and their validity can be subject to challenges and defenses, including challenges and defenses based on the existence of prior art. Consequently, we cannot be certain as to the extent to which we will be able to obtain patents for our new products and technology or the extent to which the patents that we already own or license from others protect our products and technology. Reduction in scope of protection or invalidation of our licensed or owned patents, or our inability to obtain new patents, may enable other companies to develop products that compete with ours on the basis of the same or similar technology.

We also rely on the law of trade secrets to protect unpatented know-how and technology to maintain our competitive position. We try to protect this know-how and technology by limiting access to the trade secrets to those of our employees, contractors and partners with a need to know such information and by entering into confidentiality agreements with parties that have access to it, such as our employees, consultants and business partners. Any of these parties could breach the agreements and disclose our trade secrets or confidential information, or our competitors might learn of the information in some other way. If any trade secret not protected by a patent were to be disclosed to or independently developed by a competitor, our competitive position could be materially harmed.

24


We could be exposed to significant product liability claims that could be time-consuming and costly, divert management attention and adversely affect our ability to obtain and maintain insurance coverage.

We may be subject to product liability claims if any of our product applications are alleged to be defective or cause harmful effects. For example, because some of our PicoP displays are designed to scan a low power beam of colored light into the user's eye, the testing, manufacture, marketing and sale of these products involve an inherent risk that product liability claims will be asserted against us. Product liability claims or other claims related to our products, regardless of their outcome, could require us to spend significant time and money in litigation, divert management time and attention, require us to pay significant damages, harm our reputation or hinder acceptance of our products. Any successful product liability claim may prevent us from obtaining adequate product liability insurance in the future on commercially desirable or reasonable terms. An inability to obtain sufficient insurance coverage at an acceptable cost or otherwise to protect against potential product liability claims could prevent or inhibit the commercialization of our products.

Our development agreements have long sales cycles, which make it difficult to plan our expenses and forecast our revenues.

Our development agreements have lengthy sales cycles that involve numerous steps including determination of a product application, exploring the technical feasibility of a proposed product, evaluating the costs of manufacturing a product and manufacturing or contracting out the manufacturing of the product. Our long sales cycle, which can last several years, makes it difficult to predict the quarter in which contract signing and revenue recognition will occur. Delays in entering into development agreements could cause significant variability in our revenues and operating results for any particular quarterly period.

Our development contracts may not lead to products that will be profitable.

Our development contracts, including without limitation those discussed in this document, are exploratory in nature and are intended to develop new types of products for new applications. These efforts may prove unsuccessful and these relationships may not result in the development of products that will be profitable.

If we lose our rights under our third-party technology licenses, our operations could be adversely affected.

Our business depends in part on technology rights licensed from third parties. We could lose our exclusivity or other rights to use the technology under our licenses if we fail to comply with the terms and performance requirements of the licenses. In addition, certain licensors may terminate a license upon our breach and have the right to consent to sublicense arrangements. If we were to lose our rights under any of these licenses, or if we were unable to obtain required consents to future sublicenses, we could lose a competitive advantage in the market, and may even lose the ability to commercialize certain products completely. Either of these results could substantially decrease our revenues.

We are dependent on third parties in order to develop, manufacture, sell and market our products.

Our strategy for commercializing our technology and products incorporating the PicoP display engine includes entering into cooperative development, manufacturing, sales and marketing arrangements with corporate partners, original equipment manufacturers and other third parties. We cannot be certain that we will be able to negotiate arrangements on acceptable terms, if at all, or that these arrangements will be successful in yielding commercially viable products. If we cannot establish these arrangements, we would require additional capital to undertake such activities on our own and would require extensive manufacturing, sales and marketing expertise that we do not currently possess and that may be difficult to obtain. In addition, we could encounter significant delays in introducing the PicoP display engine or find that the development, manufacture or sale of products incorporating the PicoP display engine would not be feasible. To the extent that we enter into cooperative development, sales and marketing or other joint venture arrangements, our revenues will depend upon the performance of third parties. We cannot be certain that any such arrangements will be successful.

Loss of any of our key personnel could have a negative effect on the operation of our business.

Our success depends on our executive officers and other key personnel and on the ability to attract and retain qualified new personnel. Achievement of our business objectives will require substantial additional expertise in the areas of sales and marketing, research and product development and manufacturing. Competition for qualified personnel in these fields is intense, and the inability to attract and retain additional highly skilled personnel, or the loss of key personnel, could reduce our revenues and adversely affect our business.

25


ITEM 6. Exhibits

31.1

Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Chief Financial Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Chief Executive Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Chief Financial Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

XBRL Instance Document

101.SCH*

XBRL Taxonomy Extension Schema

101.CAL*

XBRL Taxonomy Extension Calculation Linkbase

101.DEF*

XBRL Taxonomy Extension Definition Linkbase

101.LAB*

XBRL Taxonomy Extension Label Linkbase

101.PRE*

XBRL Taxonomy Extension Presentation Linkbase

*

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

26


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MICROVISION, INC.

Date: November 1, 2011

BY:

/s/ Alexander Y. Tokman

   

Alexander Y. Tokman

   

Chief Executive Officer
(Principal Executive Officer)

Date: November 1, 2011

BY:

/s/ Jeff Wilson

   

Jeff Wilson

   

Chief Financial Officer
(Principal Financial Officer, Principal Accounting Officer)

 

 

 

 

27


EXHIBIT INDEX

The following documents are filed herewith.

Exhibit
Number

Description

31.1

Chief Executive Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Chief Financial Officer Certification Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Chief Executive Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Chief Financial Officer Certification pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

XBRL Instance Document

101.SCH*

XBRL Taxonomy Extension Schema

101.CAL*

XBRL Taxonomy Extension Calculation Linkbase

101.DEF*

XBRL Taxonomy Extension Definition Linkbase

101.LAB*

XBRL Taxonomy Extension Label Linkbase

101.PRE*

XBRL Taxonomy Extension Presentation Linkbase

*

Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

 

 

 

28


EX-31.1 2 exh31-1.htm CEO 302 CERTIFICATE September 30, 2011 10-Q Exhibit 31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Alexander Y. Tokman, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MicroVision, Inc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles:

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 1, 2011

/s/ Alexander Y. Tokman


Alexander Y. Tokman
Chief Executive Officer


EX-31.2 3 exh31-2.htm CFO 302 CERTIFICATE September 30, 2011 10-Q Exhibit 31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO
RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jeff T. Wilson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MicroVision, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 1, 2011

/s/ Jeff T. Wilson


Jeff T. Wilson
Chief Financial Officer


EX-32.1 4 exh32-1.htm CEO 906 CERTIFICATE September 30, 2011 10-Q Exhibit 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as chief executive officer of MicroVision, Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1)    the Company's Form 10-Q for the quarter ended September 30, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)    the information contained in the Company's Form 10-Q for the quarter ended September 30, 2011 fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2011

/s/ Alexander Y. Tokman


Alexander Y. Tokman
Chief Executive Officer


EX-32.2 5 exh32-2.htm CFO 906 CERTIFICATE September 30, 2011 10-Q Exhibit 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as chief financial officer of MicroVision, Inc. (the "Company"), does hereby certify that to the undersigned's knowledge:

1)    the Company's Form 10-Q for the quarter ended September 30, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)    the information contained in the Company's Form 10-Q for the quarter ended September 30, 2011 fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2011

/s/ Jeff T. Wilson


Jeff T. Wilson
Chief Financial Officer


GRAPHIC 6 logo.jpg LOGO begin 644 logo.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`,@"T`P$1``(1`0,1`?_$`)L``0`"`@,!`0$````` M```````("08'!`4*`P(+`0$``@,!`0$`````````````!@@#!0<"!`$0```& M`@$#`P,#`P,%``````$"`P0%!@<(`!$2"1,4"B$5%B(7&#$C&3(D&D$EE]=8 M$0`"`@$#`@0$`P<%```````!`@`#!!$%!B$2,4$3!U%A<2*!,D)28B-C%#05 MD7*B,PC_V@`,`P$``A$#$0`_`/?QQ$XSQZSCVRSV0=MF+-N7O<.WBZ39L@3J M!>]9=8Y$DB]P@'4P@'4>8KKJ<>HW9#JE*C4LQ"J!\R=`/QF*Z^G&J:_(=:Z% M&I9B%4#XDG0#\9T4?=:;+.DV,5;:S)O50$4F@&%-NV=J*G`!'Z M]`Y\./O>S9=HHQ,O%MN/@J6HS'Z`,3-?C;[LF9:,?$S,6V\^"I;6S'Z!6),R M;FSFUCB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB)JS(EZEH1>. MJ-)C$)W(5C076B6;OO\`L\'&HF!)Q9K,=%9!9.);*F[$D2'(J]7#TR&*4JJJ M44Y)OV7@/7M&QU+D0016IZ*H(:QOM4@!F6)\DW_,P;*] MGV*I2I-:MKZ=2#H;[R""*P>BJ"&M;[5(`9ET3(ZAQU_<%E\T7^V7^:/_ M`'/3]PW:0L:J8OU2AHE1LO%Q[8AOZ%;M6_=_4P"81,,"R?9ZCD-@S.;;CE[A MFGKIJ%K0_"M""B*/@J)KXGJ29`,GV:Q>16#,YQN&9N.<>NFH6I#\*JRIK11\ M$1-?$]23*_I'1"8S)8;\^I4S&U.JX\G9B"@'BT:LY>72Q5Y=0JK)B+9PS"-8 MD43*FH^$5>QP;L(B<2*=E?;O8;-YCN&X7[+?7B;5MU]E53%"S9-U).JKH5[$ MU`!M^[1SH$8JW;7/*_\`/V9S?+]`B:*AO\`<)M13`Q3G*(6.]N-RW?$]NL6S*#Y>1A6VU6:L6M:FJVQ04U_ M,]:=H"D_>J%00S`BR_MKN.\X7MOBME!\S)P+;J;-6+6O35;8H["?S65IV`*Q M^]:RH(9@1*:-DF,Q'L96,=)/8Z2:H/F+M`W#*PU!'U M$YO,\SQQ$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1-*EF:YCE6VW[), MK'5Z3M%B>QT<5VL#I^O7:\NM&5J*@6#,KJ2DE7[!N:4.U:IJK`J].)B`)1[8 M2,W;>-OE\@Y+;7C9.5D,B=Q[F--)*4I4J]SN74&\H@9M;6U'0Z089NV<9?,Y M#R>ZO'RLO)9$#'N;EK*M:9*2=2[Q5 M99VY1]DHHHJ*I;LIJ50P!+OZMEYO=VL8LUC MKZ1)8D=IG[L''MSX[M-6)?G*N'BJ6[*:E4,-398;;+S>[M8Q9K'7TB2Q([3. M1@",7C,14\7)>Q:80E;6)1$1,"5RGI2V-BJ=?U%4(UF2%$H_4@AV_3ITYD]O M<5\7A^%Z@T>Y7O\`PR+7O&OS[;`"/+P\IE]N\:S&X=A&T:/>MF1^&3;9D+K\ M^VT`CR\/*=7AUX6.L.6L?)&`6%0N192%1*4Y4V$-=&ZLN$:GU$Q!(VFV[\Y> MT0[2*E#M#H`C\G#+AC;AN_'4_P"C#S>^L==$KR0;.P?[;!:1IY,!H-.OR\+N M&-N6\<<3^WP\T65#KHE>2IL[!Y=+5M(T\`P&@TZU&?(?\J.2O%)I)6\I8*84 MN3SME[,$)B2A!>HMY.PE;C%:Q:K9;[R>":24.26<03&N(,FR2RXH$?2K=55% MPBFHD:?2?R(GQB_,/M%Y/JGMA0-PGM3F;6=U"-AZHP,1E++N&+A^K,^Y;(G;>Q,9 MPB7J:A>:+$5=T`\>^<_)QES'.!M@MUJ39YJH5^`J-^=1-^_'KPG`1$Q!0U9A MKDM!K3]5LM;?KI.%46XO)4Y&O5),Q4D2=>V7E-\>FC-ACZ=M7MABG$5UDV*, MHVHTE(R5BO2<4Z$"LY9_2J7&62TQ42_'K[=TZ:(H..P_IG-Z9^U$ZW4_RP>/ M3>*?O-9U8V:J>6)?&=/4OU^(SKM_K$?5*U33**AE"I_JXB=+FGSL>([7O(UEQ+E;>;$,+D M&G23N%M^)+8+?CQ1Y]P_F.?PA*8]?2,JTC6MU91T)(Y!J5(MKM@9>IMLHJ2F8( M'+LS#1[.H5!DZH&1K6TCI(K([Q5G"LT\>)13AV)&8*R@VQ\]1.PL&?)^ M$>.(E`B/N(>"57<>BX/&+^HB>A:D^8;QH9#U\R#M76-N\;J:]XMN$;CZ[Y1G M&=PJ$#&7J88M)2+J#%"W5F"E['9'T<^2739QC9XN9(W=V]`-T1(V?\D+PE?_ M`'OC_P#\?9O_`/5_$2WEFEHR? MC):;BW#ES'U5U!09E8:#=.U$Y!VU5;MD156*F02F,B:,V&\VGBIU6R9.X5JUM:[/-#'`%F#U1!XD/T.F40' MB))/4_?73G>:H6*\ZF[#8YS97J>Z19W`U7E%FLU4%72;I9@>V56?:P]JK+63 M18N#M%WS)!!V5NL*)U`24[42!TW\BOPKUZ8E(*1WZQ>=_#2#N,>GB:MEFP1A MG3%<[9<8^<@<>R4)+LQ53'TW+1PNV6+T,FU_>S\O8_AWW7[G]E_'?6Z_3)XYQKD[98*OSUCK]:/&-$7Z]?B??H/:"K]H6.@56!_&')5E4D.AU73D' M1BJG[^^D%7.,C;/?3=#SK&OR<#'ONJI[%#FJON#8I],Z:U>@W<57JSOZI#-K MK1/'Y[E[5[^;L>>8N1E8&-D74T&M0YIK[PV(?3)&M7H,&*IU:Q_5(=N[6PQK MD\\I/EN>+:ED2;AY!L+RZQSZGS,-#S;-BV2;I2U7>31615;DP9MBD*V;D.E) MMR@D8Q5R("-AZN4'+W#_`#?%<3[)1L>RNNU54`64-;VZY**``B`K>@ M"$BP)+(U)N^R7!QGA<>ME.A5KV%3$@]5:I69V!&H[#TUZ23;UNN+ MOO$K'V2X.-P5<>ME.A5LAA420>JM4K,[`CN7L/37I,&BLR,<93\KB_*JS*(= MP[567H\W$QSE&$L=$47<)PK1)H55ZLQG(!-N,>X3,.?15,/1=!NG8T4`,4.T#HF+U$0$`TGM%N&1R#/W_DS@C$R M<]*Z]?Y*,QT/F`+E74=-5(UU!`T?L_N61R+<>0\H8$8>3GI57K_)1F;0^8`N M5-1TU4C4D'3Q=_,-M\WL/O%XR_'S3G2A9^8CUK)[5$YE6[JR[-97KV&Z*+QL MGW"=Y$*XP?&2*(=X)2)N@=%`Z]KG;Y&'+.[C'P(^9#S:1M)@5DGF4-=8-OK3 M#)1AW<,;,^1V^!K[CN9DU7Y?34K-#@[_`&F0?`4X(.G,09B0I3JD!)$JK\A& MH=PU&TBT(Q?D!I.63=GR-Y`N6[F?V^0?SP>2_ M/'DQEL.VUEZQ?J5/WC5#'F':6 MK8V>NN@'Q MW9K<^J:[XM/O2?Q]9%VBCMC;71(2P9LQ_D')N(+-;:?*4FXSK!_8L:.L>56W MLVA&T,I&E$S$3.BF7.NH9$@1\:_7[PWQWC6S/LWOLPTNR)DYWE+)`7<^SB>* M+K8,98TI=10W$2I76#RQ7_$'A6R?XK\#-[5+[(;;;@V*%:GK$6[<2L3K] MD2@8BKTU2JW[-H"LI;LP7R+W4-'F.B>N.TZ:UKP0_&7V M^K[M2/1V.S'@QQ%Y\N,8JB:2D\S;*C!8/;5*M2A#%>.:_B&'OPLHTZ!BEZLG MLN1)!1VX`$2J[`7B01VO^-+JSB6+V2PCK3FG)FT.3-[("O9ZNS:E4[*!FS.Z MZ]PC.5=G55E(QTYQY$1;V/EF\?)(H)J@W43*5T=9%$PC0/9^AZS[M:Q>,?R8 M^(;Q59?ELK6;$V)L<[*X'P'JI=KJLO?+`3'M"R'<+-28J\4/)35S:&Z)9A4H MURP1Z/N'SQ-PX*""R)MO$F0K#L1\E#R];R5%`LX7QV:S;=S.-G*Z9EXU&_8& MP^TU6J\5&I(IK@Z+/OR6"01.!#I+ID65*(F.D!D3&?BUX`\7&2L`[>;6>1)U MJ/D[,A1]'@+Y*9./5\PNW4-ZF0+5:I1)Q.KM5%Q/7U M4TUR='`'1(<>+S,U1`%1([:I$%/])ES=42/ZO*Y)IBTJHBU]T[M4-&&`6$M%-"D,+^ MYLBI/R65K^NVM?M9- M"UM854^Y%1Y/XFRS5,L5EE,U]VW3=E0(23A?5(#N+=)@":R(H_I.+6[8F9M[J+@H#U:CN1AT(T^&O@?P.AU$ZMQ#E^TNC=V;OMH ML_M\EM""Y`!]*_0D"Y1]VI%@U;U%U&]\2S\;/?D?#7KIW=F[[<>S^VR6T(+G M0'TLH^_4BP:MZBUI;`U3;39#,F.ZZEB][04*^SEHIW9',1(I5:/;R3I MHO+2LK;6[B3A))-LE'IBU:LW2RBIN[T@,*@]M9_<':?=OW*YEMVVC:GV],=+ M*VN-;BA`[*;+'R`7J<`(.Q*W8L=>T$L=*M^X^T>\7N=S?;=MKVFS;J\=+*VN M:MQ0BNRFRRS(!>IPH1?3KKL8L=>P$L=+:<4XV@L1T"MX_KOJ*L(!EZ2S]P4I M7DQ*.55'DO-O^T1+[R7DEU5SE+^A,3]A``A2@%M^*<:P.(.;;J MDE*&LC1V$\VJ:Y8283]X!%6IRJNA%10#"(\D4DDPO9?PA^.7;S;VI;MY]PL^ MO&:ZJC44UDUKM:6-"N"U!,`TQU>*0RD48FPF@B)(I^B;TVCYNW30>HN40,F9 M$S;:+Q#Z+;E;18BW#V&QK9+QG#!K>@,\<2II3(]79N:5"3[" ML2C/9Y?;V\1KN)F\B2 MN0+I*1I&+NFPN/3)QE,=S1ZE%F0I5?;1J1D693)MRFZ#W',842(VROQR/$/M M=F6[9]RKK&X;Y-R3,.[)?I:A92RECV*M-ID53.):TOZO5;='5EM8)MT8[)GV'J;3-&5VCU7* MMJJ["ERMGEK$A:R3DNH%8C$6:"*ZYT&Z11],A1,811+@"8XHO[NR-%^Q!65JM*QD0J\C*/'CY8B29#JF*F0"HE;&N_Q\O%7J[M&.WN)]>%FF68 MZQ/;=2&MCO5PM=$QE:)!1=9>>H5+FY5U%1\DV7A$JB4[`&IDDA31 M)W[LZ.Z[^0G"*^N^T-:GK?BEU:J_,:3$1=-G7"#C-$W2KS M`P'>R:W:DS10(!4$B)E1-F7#Q@ZK^8?Z]U[K]??U^O$2=_$ M355EPMCRS2REB5AUH2SJ'!52S522D*Q-+K`'8"\@O#.&J$RJ"7Z`%ZFYZ%Z` M'3H7I$]SX3QS=,L[B])HW0G4W4.]%A/QU-%Y<\E/VQ``IFZEXEV`J].G M3U'L(>*E/H(!_I7*`_T'J`B`Y4XO3H$NS=SLJ'DFNN5>*U M$!+L[=+*A^DY5B:_5JO3L_T<:^>LV0DF5)--(HG$J1")E%551902D*!0%198 MZBRIQ`/J8YC&,/U$1'DE50BA!KH!IU))Z?$G4D_,DD^ EX-101.INS 7 mvis-20110930.xml INSTANCE DOCUMENT 0000065770 2009-12-31 0000065770 2010-12-31 0000065770 2010-06-30 0000065770 2011-09-30 0000065770 2011-07-01 2011-09-30 0000065770 2010-07-01 2010-09-30 0000065770 2011-01-01 2011-09-30 0000065770 2010-01-01 2010-09-30 0000065770 2010-09-30 0000065770 2011-10-26 xbrli:shares iso4217:USD iso4217:USD xbrli:shares false --12-31 2011-09-30 Q3 2011 2011-09-30 2011-01-01 10-Q 0000065770 Yes Accelerated Filer Microvision Inc 911600822 No No 7665000 6301000 1116000 877000 4135000 4432000 -30000 -35000 400791000 415560000 35233000 21953000 27624000 16074000 211000 273000 40000 40000 114000 84000 43025000 19413000 9369000 18658000 -10044000 -24367000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>9. COMMITMENTS AND CONTINGENCIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>Litigation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our consolidated financial position, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 102000 118000 -7791000 -11851000 -26007000 -32038000 237000 53000 931000 202000 314000 221000 798000 592000 2720000 4112000 8639000 8757000 697000 253000 1941000 1127000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>2. NET LOSS PER SHARE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares. Diluted net loss per share for the three and nine months ended September 30, 2011 and 2010 is equal to basic net loss per share because the effect of all potential common stock outstanding during the periods, including options, warrants and nonvested equity shares is anti-dilutive. The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="font-weight: bold; text-align: center">Three Months Ended</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="font-weight: bold; text-align: center">Nine Months Ended</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2011</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2010</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2011</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2010</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Numerator:</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Net loss available for common shareholders - basic and diluted</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(7,790)</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(11,850)</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(26,002)</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(32,040)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Denominator:</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Weighted-average common shares outstanding - basic and diluted &#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right">109,238&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right">89,376&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right">106,061&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right">88,948&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Net loss per share - basic and diluted &#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.07)</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.13)</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.25)</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.36)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On September 30, 2011 and 2010, we excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive: publicly traded warrants exercisable for 6,025,000 and 6,025,000 shares of common stock, respectively, options and private warrants exercisable into a total of 10,195,000 and 12,536,000 shares of common stock, respectively, and 1,017,000 and 485,000 shares of nonvested equity shares, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>3. CASH EQUIVALENTS, INVESTMENT SECURITIES AVAILABLE-FOR-SALE AND FAIR VALUE MEASUREMENTS </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between informed market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-level fair value inputs hierarchy, and requires an entity to maximize the use of observable valuation inputs and minimize the use of unobservable inputs. When estimating fair values, we use market data, assumptions and risks we believe market participants would use in measuring the fair value of the asset or liability, including the risks inherent in the inputs and the valuation techniques. The authoritative guidance establishes a three-level fair value inputs hierarchy, and requires us to use observable valuation inputs where possible.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our cash equivalents and investment securities available-for-sale are comprised of money market savings accounts and equity securities. The corporate equity securities are valued using inputs and common methods with sufficient levels of transparency and observability to be classified at Level 2.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The valuation inputs hierarchy classification for our assets measured at fair value on a recurring basis are summarized below as of September 30, 2011. This table does not include cash held in our money market savings accounts. As of September 30, 2011, we did not have any liabilities measured at fair value on a recurring basis.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td>As of September 30, 2011:</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-weight: bold">Assets</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>&#160;&#160;&#160;&#160; Corporate equity securities</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">8,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">8,000&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">8,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">8,000&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td>As December 31, 2010:</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Total</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="font-weight: bold">Assets</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>&#160;&#160;&#160;&#160; Corporate equity securities</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">13,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">13,000&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">13,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">13,000&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p> 0 446000 0 875000 -881000 -2811000 -4526000 -4700000 -.07 -.13 -.25 -.36 -1518000 2384000 -239000 888000 150000 -575000 -31000 2000 -688000 10617000 120000 -63000 9000 15000 34000 48000 34000 48000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>4. INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Inventory consists of the following:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="font-weight: bold; text-align: center">September 30,</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2011</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2010</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Raw materials</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">3,151,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">3,924,000&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Finished goods &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,292,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">2,151,000&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">4,443,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">6,075,000&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The inventory at September 30, 2011 and December 31, 2010 consisted of raw materials primarily for our accessory pico projectors and PicoP display engine, and finished goods primarily composed of our accessory pico projectors. Historically our cost has been higher than our selling price for our accessory pico projectors and we have recognized write downs for lower of cost or market adjustments primarily comprised of adjustments to reflect our current estimated selling prices for our inventory. During the three and nine months ended September 30, 2011, we recognized zero and $944,000 in write downs for lower of cost or market adjustments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Inventory is stated at the lower of cost or market, with cost determined on a net realizable value basis. Management periodically assesses the need to provide for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required. In addition, we reduce the value of our inventory to our estimated scrap value when management determines that it is not probable that the inventory will be consumed through normal production during the next twelve months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 6075000 4443000 944000 3830000 9000 15000 36000 94000 13400000 11342000 35233000 21953000 12006000 10914000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>7. LONG-TERM NOTES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Tenant Improvement Loan Agreement</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">During 2006, we entered into a loan agreement with the lessor of our corporate headquarters in Redmond, Washington to finance $536,000 in tenant improvements. The loan carries a fixed interest rate of 9% per annum, is repayable over the initial term of the lease, which expires in 2013, and is secured by a letter of credit. The balance of the loan was $182,000 at September 30, 2011.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 11766000 12525000 -5000 -1864000 -21805000 -35028000 -7790000 -11850000 -26002000 -32040000 6943000 9475000 21617000 28221000 -7824000 -12286000 -26143000 -32921000 564000 1120000 18000 30000 -1000 -1000 -5000 2000 -297000 -207000 -34000 10000 -139000 40000 492000 1659000 0 0 11858000 12634000 0 100000 4169000 2736000 137000 257000 30000 51000 3641000 5920000 11446000 16961000 1189000 1019000 -379030000 -405032000 1839000 1301000 4113000 4057000 85000 91000 3306000 3555000 10182000 11260000 2759000 2806000 21833000 10611000 109238000 89376000 106061000 88948000 588000 308000 .001 .001 25000000 25000000 0 0 .001 .001 200000000 200000000 102471000 117793000 102471000 117793000 4000 -0 11000 -0 139000 1000 -476000 -0 11000 0 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>5. SEVERANCE ARRANGEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In January 2011, we reduced our workforce by approximately 20%, recorded an expense of $372,000 and paid $341,000 related to the severance agreements for these employees during the first half of 2011. The remaining payments of $31,000 for outplacement services expired unused and during the three months ended September 30, 2011 we reduced the recorded expense related to severance agreements accordingly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>10. COMMITTED EQUITY FINANCING FACILITY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In August 2010, we entered into a committed equity financing facility (CEFF) with Azimuth, under which we could sell to Azimuth up to the lesser of $60.0 million or 17,771,901 of our shares of common stock over a 24-month term, which began on September 9, 2010. During 2011, we completed two draws from this facility and raised a total of $5.6 million in gross proceeds from the sale of approximately 4.5 million shares of our common stock. In July 2011, we cancelled this facility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2011, we entered into a CEFF with Azimuth, under which we may sell to Azimuth up to the lesser of $40.0 million or 21,018,431 of our shares of common stock over a 24-month term, which began on July 8, 2011. We paid Azimuth 225,000 shares of our common stock in consideration for entering into the CEFF with us. In August 2011, we raised $1.5 million in gross proceeds from the sale of approximately 1.6 million shares of our common stock under this facility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">From time to time over the agreement term, and at our sole discretion, we may present Azimuth with draw-down notices requiring Azimuth to purchase shares of our common stock over 10 consecutive trading days (the &#34;Draw-Down Period&#34;) at a pre-determined purchase price. The per share purchase price is the daily volume-weighted average price (VWAP) of our common stock on each trading day of the Draw-Down Period, less a discount ranging from 3.50% to 10.0%. The discount is determined by a minimum threshold price that we specify which cannot be less than $0.75. If the daily VWAP of our common stock falls below the threshold price on any trading day during a Draw-Down Period, Azimuth will not purchase the pro rata portion of shares for that day. We will determine, in our sole discretion, the timing, the dollar amount and the price per share of each draw under this facility, subject to certain conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We can require Azimuth to purchase the greater of the daily allocation amount specified in the draw-down notice or a percentage of the daily trading volume of our common stock for each trading day during the Draw-Down Period, subject to certain limitations. The total dollar amount of each draw is subject to certain agreed-upon limitations based on the market price of our common stock at the time of the draw. We are allowed to present Azimuth with up to 24 draw-down notices during the agreement term. Only one draw-down notice is allowed per Draw-Down Period with a minimum of five trading days required between each Draw-Down Period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In September 2011, we entered into another CEFF with Azimuth, under which we may sell to Azimuth up to the lesser of $35.0 million or 22,030,737 of our shares of common stock over a 24-month term, which began on September 13, 2011. This facility provides additional flexibility in the types and timing of draw downs, compared to the May 2011 CEFF. In September 2011, we raised $5.0 million in gross proceeds from the sale of approximately 7.6 million shares of our common stock under this CEFF.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As in our May 2011 CEFF, from time to time over the term of our September 2011 CEFF, we may present Azimuth with draw-down notices requiring Azimuth to purchase shares of our common stock over the Draw-Down Period at a pre-determined purchase price. Once presented with a draw-down notice, Azimuth must purchase a pro rata portion of the shares on each trading day during the Draw-Down Period on which the daily VWAP for our common stock exceeds the threshold price specified in the draw-down notice. We can require Azimuth to purchase the greater of the daily allocation amount specified in the draw-down notice or a percentage of the daily trading volume of our common stock for each trading day during the Draw-Down Period, subject to certain limitations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The per share purchase price for these shares is the daily VWAP of our common stock on each day of the Draw-Down Period, less a discount ranging from 3.5% to 6.5%. The discount is determined by the threshold price that we specify in the draw-down notice. If the daily VWAP of our common stock falls below the threshold price on any trading day during a Draw-Down Period, Azimuth will not be required to purchase the pro rata portion of shares for that day. However, Azimuth may elect to buy the pro-rata portion of shares allocated to that day at the threshold price less the discount described above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The agreement also provides that from time to time, and at our sole discretion, we may grant Azimuth the option to purchase additional shares of our common stock during each Draw-Down Period up to an aggregate amount we specify. If Azimuth exercises this option, we would sell to Azimuth the shares of our common stock at the greater of the daily VWAP of our common stock on the day Azimuth exercises its option or the threshold price for the option we determined, less the same discount applied to the fixed amount in the draw-down notices. We are allowed to present Azimuth with up to 24 draw-down notices during the 24-month term, with only one draw-down notice allowed per Draw-Down Period and a minimum of five trading days required between each Draw-Down Period, unless we and Azimuth otherwise agree.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Reedland Capital Partners is acting as placement agent and receives a fee for its services equal to 1% of the aggregate dollar amount of common stock purchased by Azimuth upon settlement of any draws under these facilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 262700000000 306000 0 2233000 2094000 424000 0 -0 305000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>11. RECEIVABLES FROM RELATED PARTIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our accounts receivable balance at September 30, 2011 and revenue for the nine months ended September 30, 2011, include $409,000 from a sale of PicoP engines to Walsin Lihwa Corporation which has informed us of its plans to integrate the engines into its product scheduled for commercial release in China in late 2011. Based on filings with the SEC as of September 30, 2011, Walsin Lihwa beneficially owns approximately 8.4% of our common stock as determined in accordance with SEC rules, through its wholly owned subsidiary Max Display Enterprises Limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 13000 8000 81000 50000 159000 91000 1525000 1080000 3315000 3465000 2483000 4059000 7708000 8555000 -330000 139000 62000 58000 -12000 0 212000 0 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>6. SHARE-BASED COMPENSATION </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The following table shows the amount of stock-based employee compensation expense included in the consolidated statements of operations:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="font-weight: bold; text-align: center">Three Months Ended</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="font-weight: bold; text-align: center">Nine Months Ended</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td colspan="4" style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">September 30,</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2011</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2010</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2011</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">2010</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Cost of contract revenue</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">56,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">5,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">97,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">12,000&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Cost of product revenue</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">60,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">7,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">100,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">37,000&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Research and development expense</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">337,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">274,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">1,075,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">1,084,000&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Sales, marketing, general and administrative expense</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">447,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">415,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,337,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,657,000&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td>Total share-based employee compensation expense</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">900,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">701,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,609,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,790,000&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As part of our 2011 plan to conserve cash used in operations, we implemented two share-based compensation programs during the three months ended June 30, 2011 under which we issued shares of our common stock as compensation instead of cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2011, we issued 418,000 shares of our common stock as incentive awards to non-executive employees under the 2006 Incentive Plan. The shares were valued using our closing stock price on the date of grant. We expensed $560,000 of share-based employee compensation for these awards at grant in May 2011.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In June 2011, we implemented a voluntary program in which certain non-executive senior professional employees could elect to receive a portion of their 2011 salary in stock instead of cash. In June 2011 we issued 510,000 shares of our common stock under the 2006 Incentive Plan as prepayment of salary for future service. The shares were valued using our closing stock price on the date of grant. The total share-based compensation expense for these awards was $627,000, of which $179,000 was amortized during the three months ended June 30, 2011 and the remaining $448,000 was amortized during the three months ended September 30, 2011 for service completed as of that date. In September 2011, we issued 241,000 shares of our common stock under this program. A total of $212,000 of share-based compensation expense for these awards will be amortized during the fourth quarter of 2011. Program participants who voluntarily leave employment prior to completion of the service period must repay the pro-rata portion of the prepaid salary for the uncompleted service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Options Activity and Positions</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of September 30, 2011:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Weighted</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Average</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Weighted</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Remaining</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Average</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Contractual</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Aggregate</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Exercise</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Term</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">Intrinsic</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid">Options</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Shares</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Price</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">(years)</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="font-weight: bold; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">Value</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Outstanding as of September 30, 2011</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">7,898,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">3.24&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">5.8&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">-&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercisable as of September 30, 2011</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">6,024,000&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">3.57&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">5.0&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">$</td> <td style="text-align: right">-&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">As of September 30, 2011, our unamortized share-based employee compensation was $2.3 million which we plan to amortize over the next 2.3 years, and our unamortized nonvested equity share-based employee compensation was $968,000 which we plan to amortize over the next 1.7 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>1. MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Management's Statement</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Consolidated Balance Sheet as of September 30, 2011, the Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2011 and 2010, and Consolidated Statements of Cash Flows for the nine months ended September 30, 2011 and 2010 have been prepared by MicroVision, Inc. (&#34;we&#34; or &#34;us&#34;) and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at September 30, 2011 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the &#34;SEC&#34;). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010. The results of operations for the three and nine months ended September 30, 2011 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from development contract revenues and product sales. At September 30, 2011, MicroVision had $9.4 million in cash, cash equivalents and investment securities available-for-sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through January 2012. We will require additional cash to fund our operating plan past that time. We are introducing new products into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. If the level of sales anticipated by our financial plan is not achieved or our working capital requirements are higher than planned, we will need to raise additional cash sooner or take actions to reduce operating expenses. We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include reducing our planned investment in working capital to fund revenue growth and delaying development projects resulting in reductions in staff, operating costs, capital expenditures and investment in research and development.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We have received a report from our independent public accounting firm regarding the consolidated financial statements for the year ended December 31, 2010 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. Our consolidated financial statements have been prepared on a going concern basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In August 2010, we entered into a committed equity financing facility with Azimuth Opportunity, Ltd. (&#34;Azimuth&#34;). During 2011 we completed two draws from this facility and raised a total of $5.6 million before placement agent and other issuance costs from the sale of approximately 4.5 million shares of our common stock. In July 2011, we cancelled this facility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2011, we entered into a committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $40.0 million or 21,018,431 of our shares of common stock over a 24-month term, which began on July 8, 2011. In August 2011, we raised $1.5 million before placement agent and other issuance costs from the sale of approximately 1.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $ 38.5 million or 19.2 million shares of common stock remaining available under the facility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In September 2011, we entered into a another committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $35.0 million or 22,030,737 of our shares of common stock over a 24-month term, which began on September 13, 2011. In September 2011, we raised $5.0 million before placement agent and other issuance costs from the sale of approximately 7.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $30 million or 14.4 million shares of common stock remaining available under this facility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">We may use these facilities as part of our plan to raise additional cash, though we may not be able to sell shares under either facility in the amounts desired or at all. We are not obligated to use these facilities and remain free to enter into and consummate other equity and debt financing transactions. See Note 10 for more information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><u>Principles of Consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. (&#34;MicroVision Singapore&#34;), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in advanced research and development activities and operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the nine months ended September 30, 2011.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>12. NEW ACCOUNTING PRONOUNCEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In May 2011, the FASB issued a new accounting standard on fair value measurements that clarifies the application of existing guidance and disclosure requirements, changes certain fair value measurement principles and requires additional disclosures about fair value measurements. The standard is effective for interim and annual periods beginning after December 15, 2011. Early adoption is not permitted. We do not expect this adoption to have a material impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">In June 2011, the FASB issued a new accounting standard on the presentation of comprehensive income. The new standard requires the presentation of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The new standard also requires presentation of adjustments for items that are reclassified from other comprehensive income to net income in the statement where the components of net income and the components of other comprehensive income are presented. The standard is effective for fiscal years, and interim periods within these years, beginning after December 15, 2011. Early adoption is permitted. The adoption of this standard will have no material impact on our financial statements.</p> -344000 -178000 <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>8. WARRANTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Prior to 2011, we had common stock warrants outstanding that were issued in connection with certain notes. The warrants met the definition of derivative instruments that must be accounted for as liabilities because we could not engage in certain corporate transactions affecting the common stock unless we made a cash payment to the holders of the warrants. During 2010 these warrants expired unexercised. We recorded changes in the fair values of the warrants in the statement of operations each period. We valued the warrants at September 30, 2010 using the Black-Scholes option pricing model with the following assumptions: expected volatility of 80%; expected dividend yield of 0%; risk free interest rate of 0.15%; and contractual lives of 0.2 years. The change in value of the warrants of $338,000 and $829,000 for the three and nine months ended September 30, 2010, respectively, was recorded as a non-operating gain and is included in &#34;Gain on derivative instruments, net&#34; in the consolidated statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p> 117833000 EX-101.SCH 8 mvis-20110930.xsd SCHEMA DOCUMENT 0001 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0006 - Disclosure - Management's Statement and Principles of Consolidation - Note 1 link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - Net Loss per Share - Note 2 link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - Cash Equivalents, Investment Securities Avaliable-for-Sale and Fair Value Measurments - Note 3 link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - Inventory - Note 4 link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - Severance Arrangements - Note 5 link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - Shared-Based Compensation - Note 6 link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - Long-Term Notes - Note 7 link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - Warrants - Note 8 link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - Commitments and Contingencies - Note 9 link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - Committed Equity Financing Facility - Note 10 link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - RECEIVABLES FROM RELATED PARTIES - Note 11 link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Note 12 link:presentationLink link:calculationLink link:definitionLink 0018 - Document - Document Information link:presentationLink link:calculationLink link:definitionLink 0019 - Document - Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 mvis-20110930_cal.xml CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 mvis-20110930_def.xml DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 mvis-20110930_lab.xml LABELS LINKBASE DOCUMENT Statement [Table] Statement [Line Items] Statement, Scenario [Axis] Assets Current assets Cash and cash equivalents Investment securities, available-for-sale Accounts receivable, net of allowances of $308 and $588 Costs and estimated earnings in excess of billings on uncompleted contracts Inventory Current restricted investments Other current assets Total current assets Property and equipment, net Restricted investments Intangible assets Other assets Total assets Liabilities and Shareholders Equity Current liabilities Accounts payable Accrued liabilities Billings in excess of costs and estimated earnings on uncompleted contracts Current portion of capital lease obligations Current portion of long-term debt Total current liabilities Capital lease obligations, net of current portion Long-term debt, net of current portion Deferred rent, net of current portion Other long-term liabilities Total liabilities Commitments and contingencies Stockholders equity Preferred stock, par value $.001; 25,000 shares authorized; 0 and 0 shares issued and outstanding Common stock, par value $.001; 200,000 shares authorized; 117,793 and 102,471 shares issued and outstanding Additional paid-in capital Accumulated other comprehensive loss Accumulated deficit Total shareholders' equity Total liabilities and shareholders' equity Statement of Financial Position [Abstract] Allowance for doubtful accounts receivable, current Stockholders equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Product revenue Contract revenue Total revenue Cost of product revenue Cost of contract revenue Total cost of revenue Gross margin Research and development expense Sales, marketing, general and administrative expense Gain on disposal of fixed assets Total operating expenses Loss from operations Interest income Interest expense Gain on derivative instruments, net Other income (expense) Net loss Net loss per share - basic and diluted Weighted-average shares outstanding - basic and diluted Net loss Other comprehensive gain (loss): Unrealized gain (loss) on investment securities, available-for-sale Comprehensive loss Cash flows from operating activities Adjustments to reconcile net loss to net cash used in operations: Depreciation Amortization of intangible assets Gain on disposal of property and equipment Non-cash stock-based compensation expense Gain on derivative instruments Inventory write-downs Non-cash deferred rent Change in: Accounts receivable, net Costs and estimated earnings in excess of billings on uncompleted contracts Inventory Other current assets Other assets Accounts payable Accrued liabilities Billings in excess of costs and estimated earnings on uncompleted contracts Other long-term liabilities Net cash used in operating activities Cash flows from investing activities Sales of investment securities Purchases of restricted investment securities Decrease in restricted investment Proceeds on sale of property and equipment Purchases of property and equipment Net cash used in investing activities Cash flows from financing activities Principal payments under capital leases Principal payments under long-term debt Net proceeds from issuance of common stock Net cash provided by financing activities Net decrease in cash and cash equivalents Cash and cash equivalents, at beginning of period Cash and cash equivalents, at end of period Supplemental disclosure of cash flow information Cash paid for interest Supplemental schedule of non-cash investing and financing activities Other non-cash additions to property and equipment Issuance of common stock for prepayment of salaries Organization Consolidation Abstract Management's Statement and Principles of Consolidation Earnings Per Share [Abstract] Net Loss Per Share Fair Value Disclosures Cash Equivalents, Investment Securities Available-for-Sale and Fair Value Measurements Inventory Disclosure Inventory Notes to Financial Statements Severance Arrangements - Note 5 Disclosure Of Compensation Related Costs Share-Based Compensation Debt Disclosure Long-Term Notes Warrants Warrants Commitments And Contingencies Disclosure Footnote Commitments and Contingencies Committed Equity Financing Facility - Note 10 RECEIVABLES FROM RELATED PARTIES - Note 11 NEW ACCOUNTING PRONOUNCEMENTS - Note 12 Document Information Document Name Document Title Document Subtitle Document Synopsis Document Type Amendment Flag Amendment Description Pre-Effective Amendment Number Post-Effective Amendment Number Registration Statement Amendment Number Document Description Document Creation Date Document Effective Date Document Period Start Date Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Document Version Document Copyright Information Contained File Information, File Name Contained File Information, File Description Contained File Information, File Type Contained File Information, File Number Entity Information Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Entity Data Universal Numbering System Number Entity Other Identification Type Entity Other Identification Value Entity Information, Former Legal or Registered Name Entity Information, Date to Change Former Legal or Registered Name Entity Legal Form Entity Home Country ISO Code Parent Entity Legal Name Entity Accounting Standard Entity Reporting Currency ISO Code Entity Incorporation, State Country Name Entity Incorporation, Date of Incorporation Approximate Date of Commencement of Proposed Sale to Public Entity Number of Employees Current Fiscal Year End Date Former Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float [EntityCommonStockSharesOutstanding] Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Stockholders' Equity Attributable to Parent [Abstract] Revenues Cost of Revenue Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Other Nonoperating Expense Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Accounts Receivable Increase (Decrease) in Unbilled Receivables Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets Increase (Decrease) in Other Noncurrent Assets Increase (Decrease) in Accounts Payable, Trade Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Billing in Excess of Cost of Earnings Increase (Decrease) in Other Noncurrent Liabilities Net Cash Provided by (Used in) Operating Activities Increase (Decrease) in Restricted Cash and Investments Increase (Decrease) of Restricted Investments Payments to Acquire Other Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Long-term Capital Lease Obligations Repayments of Secured Debt Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Inventory Disclosure [Text Block] Derivatives and Fair Value [Text Block] EX-101.PRE 12 mvis-20110930_pre.xml PRESENTATION LINKBASE DOCUMENT XML 13 R3.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Product revenue$ 1,525$ 1,080$ 3,315$ 3,465
Contract revenue314221798592
Total revenue1,8391,3014,1134,057
Cost of product revenue2,4834,0597,7088,555
Cost of contract revenue23753931202
Total cost of revenue2,7204,1128,6398,757
Gross margin(881)(2,811)(4,526)(4,700)
Research and development expense3,6415,92011,44616,961
Sales, marketing, general and administrative expense3,3063,55510,18211,260
Gain on disposal of fixed assets(4)0(11)0
Total operating expenses6,9439,47521,61728,221
Loss from operations(7,824)(12,286)(26,143)(32,921)
Interest income9153694
Interest expense(9)(15)(34)(48)
Gain on derivative instruments, net04460875
Other income (expense)34(10)139(40)
Net loss$ (7,790)$ (11,850)$ (26,002)$ (32,040)
Net loss per share - basic and diluted$ (0.07)$ (0.13)$ (0.25)$ (0.36)
Weighted-average shares outstanding - basic and diluted109,23889,376106,06188,948

XML 14 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Comprehensive Loss (USD $)
In Thousands
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Net loss$ (7,790)$ (11,850)$ (26,002)$ (32,040)
Unrealized gain (loss) on investment securities, available-for-sale(1)(1)(5)2
Comprehensive loss$ (7,791)$ (11,851)$ (26,007)$ (32,038)
XML 15 R1.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Balance Sheets (USD $)
In Thousands
Sep. 30, 2011
Dec. 31, 2010
Cash and cash equivalents$ 9,369$ 19,413
Investment securities, available-for-sale813
Accounts receivable, net of allowances of $308 and $5888771,116
Costs and estimated earnings in excess of billings on uncompleted contracts257137
Inventory4,4436,075
Current restricted investments0306
Other current assets1,120564
Total current assets16,07427,624
Property and equipment, net2,7364,169
Restricted investments1,0191,189
Intangible assets2,0942,233
Other assets3018
Total assets21,95335,233
Accounts payable6,3017,665
Accrued liabilities4,4324,135
Billings in excess of costs and estimated earnings on uncompleted contracts5081
Current portion of capital lease obligations4040
Current portion of long-term debt9185
Total current liabilities10,91412,006
Capital lease obligations, net of current portion84114
Long-term debt, net of current portion91159
Deferred rent, net of current portion253697
Other long-term liabilities0424
Total liabilities11,34213,400
Commitments and contingencies  
Preferred stock, par value $.001; 25,000 shares authorized; 0 and 0 shares issued and outstanding00
Common stock, par value $.001; 200,000 shares authorized; 117,793 and 102,471 shares issued and outstanding118102
Additional paid-in capital415,560400,791
Accumulated other comprehensive loss(35)(30)
Accumulated deficit(405,032)(379,030)
Total shareholders' equity10,61121,833
Total liabilities and shareholders' equity$ 21,953$ 35,233
XML 16 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 17 R12.htm IDEA: XBRL DOCUMENT v2.3.0.15
Long-Term Notes - Note 7
9 Months Ended
Sep. 30, 2011
Debt Disclosure 
Long-Term Notes

7. LONG-TERM NOTES

Tenant Improvement Loan Agreement

During 2006, we entered into a loan agreement with the lessor of our corporate headquarters in Redmond, Washington to finance $536,000 in tenant improvements. The loan carries a fixed interest rate of 9% per annum, is repayable over the initial term of the lease, which expires in 2013, and is secured by a letter of credit. The balance of the loan was $182,000 at September 30, 2011.

XML 18 R17.htm IDEA: XBRL DOCUMENT v2.3.0.15
NEW ACCOUNTING PRONOUNCEMENTS - Note 12
9 Months Ended
Sep. 30, 2011
Notes to Financial Statements 
NEW ACCOUNTING PRONOUNCEMENTS - Note 12

12. NEW ACCOUNTING PRONOUNCEMENTS

In May 2011, the FASB issued a new accounting standard on fair value measurements that clarifies the application of existing guidance and disclosure requirements, changes certain fair value measurement principles and requires additional disclosures about fair value measurements. The standard is effective for interim and annual periods beginning after December 15, 2011. Early adoption is not permitted. We do not expect this adoption to have a material impact on our financial statements.

In June 2011, the FASB issued a new accounting standard on the presentation of comprehensive income. The new standard requires the presentation of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The new standard also requires presentation of adjustments for items that are reclassified from other comprehensive income to net income in the statement where the components of net income and the components of other comprehensive income are presented. The standard is effective for fiscal years, and interim periods within these years, beginning after December 15, 2011. Early adoption is permitted. The adoption of this standard will have no material impact on our financial statements.

ZIP 19 0001136261-11-000563-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001136261-11-000563-xbrl.zip M4$L#!!0````(`(5X83\C0Y#F83D``*J]`0`1`!P`;79I.?4+./:O:.W)))^R$_,)__FF-R`M_GZL:\>F?JMW M3NJ=$[V9DTM`@U#,N6CW6O1'5?_I?N`[_`3_)J!V5YS<"_[^*"'8S*QY_NC8 MT#3]^+^?+OK6F$UHE;LBH*[%CN):#G>_9=73.YW.L7P;%UTIB47T$";^U@7B%9N'&L7BX5Y9E%FZHHCXO:+%5.,*LV\NZ.X<4Q-DY5 MTZNF'A?WV7`MY.8QO(T+/(#N#)UO$A7O5$WM*.X@:%0G0IKN#1L2:8\G8]E*2*J*5;2. MJ=7NA7T4O4;>[X\$GTP=,*[CF)3J,);G!NP^(-Q^?T1%U1L""6"I&P"RIM7F MG.<5F!OPX&'^=/Z%$',6T9LT_25*\<-(*^M5=2JNAJ!K3?%XM4J*!=BQ MDK1FPH9?HY*D`#M54JJCOSXE10+L1DD??6^B>+3`?P;>JU48*,4/<";T\T*< MF-+BW4HUF+`E*B7U'+\I5<]:0L_:Z]>SMHV>M6?0LYP,O"E[UO?5GO6W9<_% M];Q3>UZ,]*]0M\LC_>X&L?E(#VR,YNM54B1`>4H*7:XT),;49Z(7L,DMK%E6 M-#1A5(0^^SDR>UDX)AR_6V:'E-?P^MP_7\L@6JJ>0)FMZ8/X?42X5AJ;WT'K MK&H:*5SBTA*W>Q*OBZ-,(\VBFF!ZSEQOPMW'V#ZN_33?+,+Q^R4M9*G59OSD M=`+N"OX//CIT1"(;NL%%[Z:!=$@=P7XZ7B&0I'P6^CX^YL*BSA^,^EWE%W,S MJ<8+J$W4DAS//2M$)-WAD%D!OV.%V"4'S+74LM@I3->R3WZ$9R(WR]_-958K ME-:S0Q448X8_9[&;4\IBIK`4;;EUJERBMIY=/QYU"S)4(_<&>EDLT8'DY@/> M^?=E#E@]2;8K7?\9O/&ITW-M=O\;>\A-/SG*K*66P4YUCALV]?R`NR.UH9N; MZQ_H;1ZCMLKU(W>8?P9J'7E^?A%/+8LYZ"N9322%).LEDJL<;]B("U"%&^#& M=6Z6GQ:;?Z3G6DF&RQ17.=[2^UXTSELT``+@Z`$[H@O$JO>1OT$LOR2Y%997-5^8XO[G>S.W#6..YS.X)$180FEX$EB\M3$>723AO\ MVA,`^2&S+S@=<(<'G(FGZJ>NFRL6D\WB25AR::9>-XVML823T$%W>A6,P7EZ MDZG/QLP5,&,!9^=-V(4GQ.D=Y0YJ^*/G]ZG#^LP*?4GWU/XS%`$.9:#\JR'X MIJTU"F*FA2@;VPN)GZL1JZOVM'/Q;9OC``*31LKMGGM&ISR@#G":>&X_\*QO MVW2=PCRB_N5ND)=YF:"SMED?:46S3-`7,)=C5P.'C^2$]>F#KY:%;@V7 MIV/*YU%V@.G24TI^TCRNG@?7@E,IT/)-Z)Z,3(Q/71O_Z?X5PA30@4+B-#BC MOO\`*T\9D+2$+C..8G.KFIK12,',P?7I4`NU<0=FHR\(,E=K=\QFYT45F6<< M:3<;[5V!5+M)X#9]M/!SIOXM98RIPA!33_>F_!C*QE]XN*D:=;/9*@\_3-FX MG/D*)`$`H:68:\&D^)P+R_%P2_P60']PTG/(31L5_W2"=U,B@@>'O3\:0J43 MHFO3@-SR"1/DDLW(C3>A;D4]J)`^@!V^(Q/JC[A;]?EH##6T^0.'#?'WHW^. M@G=(>H`_=&KD[.K3I][MI^[E;9^<7I[#[Y>WOP[!C05T:HSX@(!W\R*R"!1^XH&`=N7#J43P2AKDWD M=,4=22R>3X(QV$O`7&83A\Y$R&%:S5UXS(CK^6"/8`NA#T;M#Q9CR$\`21H`:I>.&-HA&3"'LSLF M)!*DYLOM+5BX`2E8QG%8P2&U,;T#;E`S`$T`36ICF#(C3'Y&()Y+`"!:K/`< M;LMMT"%W*=@V`O"$7,%4@+H('1`.Y/"FN%V*(RD!#5C0GR2&H>/-1.TE&F[! M,]';"_78K/X>+=&>.)!JR_LH:<+;,,ZW@-';11FG-P/B13[\YH1HA->X_^ZY MIT'@\T$8X![!K8>S*<#H>XX#17J`%DPE6.,"5T*Z-COQ5GK%7S+*%U!"5KS5 M(R.QWFZ\-2T4GX\834UKO3$M%)_5F(9FKO3KW6H!/_59@.B.N2$[\TKJVH:9 M;LP5/EM"*=S!4EM9Y2$I;.0=,]W/2U1*P>V:E7$K-Q01E2G%3LST9D.*R38@ M"EN(862WRU-`%#:.5B?=\4O11#&S:'2RS6(]"`&^J$R#,%I&:ELLR:(P_\*V M4-?UM`J>PK^P&;2;9J=<^8M90+O52'ON#?S/V9#AENX-S,//X%\>E+`!V>PL M(]C$Y*F`\MED:@@I!@B&;UAKX0!=BH'@UET*S8)#4>Z%S0-Z1[IQUG/O4M_% MM>UU%#^YGQLH1HU<=F_)Q56_3ZZ[-Z3_Z^E-]\5V33Y0P2WBLH#`$E:0*88* MH^X(%[`4=RSU?9?@5H/:I,"MB!E#DLRN4EC[TQ$CKHH:@L6\)=>%B@:LY\,` M(WQQTDCLT,=_L+X?AUX1%>DK:N2<.R$R>@R)Q"#1D*V1X+Y+0+_AC]S%#1(5 MIR$)VH@#IK[S_8PAH0YN7`08T`0_/D@$\V)B_C6[`L2B"?*2&RJ)Z$F&-7"_X+2`EJ4H42V`LPN1-U88+XG$1CT#E([W@(5+9QC89>O[<&G#/BBE*W&4$(`9C09AK0]4^ MFP9,MHBI5>0);ED0NS^V*S"D#NXJ#=:9X8!9-!1,MLV:)I%`EC2^QNPB8TLV M5*2'REQ3FS2"B*$,K\8M4B.W8]DL4\_%1E"[>,-(&J1DKU?A#!9(A`I0I8,[ M7>1?B_3];Y"+D4(Q9S'#&EELP5`/X5?Y]2VXY_ M+^Q'9MP.QEA4^_%HP13Y^3$Q:=#02ZO4X2/WA`R\(/`F[T`3UK>1#[W+KEJ> MX_DG9#;F`5N000U)2##.Q]I0!B@O+=]T?U M)4U7E:="S3CV.Y)D8#%<+$L.M[(K?5(]J(L]Z"U+>XGN8IVP\D?_8&[%&V#@ M^3;SJTHGH!L'E$+T6@,ZNMR3?T?R-]&2_SZH(E,5!TLM0J',)L'YQ.,<\],K M(L=NJ):L'>U@$P>;V&03N_9=O`YK/%`X4'@Y"H5Z9.!-BW?'>"E* MX\!\7,TO;9>,P87@>:SJZDKVY=3UPY:>TJ@9Z"IM+P11EQWC@OB_6I561_OW M6Y5.UROMQML5SVA6-,UXL^*91D6K+[?>8#0:EKKS>[>:#7=?,/" M&8TW+)S9?&S7[5C&7"T]VE4`Z;*VGB]$],K=%,97(3.&P6I.:$?1F1AJIX+: M5"AD9K3CT/,N2<2R!1:EUO. M`PE\BL&(\Q@_=L]\BXOYMP^8H!J-"EX(@U(M?HL7:\.ET$MY>'6J^G%[@ MX?D*Z5U^Z?;E27K2[YY]ONG=X@EZ5/CIE]/>Q>F'BV[UX]5-M0\5Y%'[CZ>] M&P+5/W?)I^YI__--5QW#ETH<+*OS65H/&X#78\[[[TUINZ( M8;>P6.0<:!#UW0$&@F-F/#PB#KV00B?&I$AX"GR*>8*@IV#J2C$$KT")$^6* M>\`#\5!6^G75N5U!+7GD8,""&3H#[@+!"=`%Q-^`(IZ%YQ:?8I>L*?T*(D)K M7"'#)0%H5*.*UR]!=96<6!Z0E\C%.(9NLX#Y$RFM*NM)^.$D\@;1^?H5]DIX MB0'CFD$65(X*2U_(/Q>V1DX1%;,I[XUCIR,CWX#'0K` M5/F_L7TF])Y/^-\J/CM4>0F\@6"^3'4`_)) M':\T5&5Y@(KX;M%0Y+\C1@*;#VI M_(S6D@@B"C,48)X!(GN$V.'<(U09(58.47`YG,F.N9A52#3SL(8J=)>J@#HR M.09&Z4.;8$<=XAD%]A!;@J!W,B-&=`Q$T8]'R3GM.-;?GWJ8W'>U@.0BE9\\ MI))H\&@8GS!H51L4RX,Q].#A$*P0Q9!-*,=[Z='`/IEK/2J4SPE,O?Z'49S#!QI`&-KN>=,AFK+6RY$X,O+[L4E"ZY]%J0N MR=TVMWPB;75>OF7B+9Z+OKY\H?9+@"Z1T=;+8E[\*J!ZPVB6)WG!&WCJF-X^)_/%G=K(3MU!%G)W M=#6_0.V:^3*ANSPT4=PLIM%QBU[`)K'8BSV=)R MB*.;^R3.9MO-(8[1V"=Q-O>&'.*8S3+%6;J1L^>>1I&]U_1!WF"%9\1*NNNT MD;HL+Q_S\B`7OY[)3%UU7#;B&WG01WTR*^7ZMM2M-7DXEX6V^)#?SFL.!<'Z M(;,O$H'FI=SWTM`>!YMB7!;8XL-G(S6;*@?M!QY=8M>]MQA,S8;J4J+X5&(Y M)IRZG*TPBIV(L<7%;CL6HN?>P3S8\\NR[VKST=Z88/ED?,5O/-*:>JM,@)]= M,'P';X^*?4M)CL)XS%%D<"X-;G%7T33+@*NNM>S>3YF[]FKT8@NO]$"VQ&$+ M`(577WK:A3X506%3,M.3CQ)T4,PZZFF?D`O!-9Y2WJ$"D'Y1WF6)GLU;^9V' M?;^DOEZ31^LO;Z]N_I![AB]Q-'ZNK?A&+A&?'IYGQSC6&SF#```0<1N&]_IJ87=&LZ`W]%7WU M72=%QZB_4%0$/OK(74SB89.1A_D@\L9@O96?OCN!W\K(LR9ZH&)TC'WQ"<\A ML+'9"1Z"JG87J5*OU.O?1]11LZ*U&OL:EO.\R^E;F3XK7E+38%U2RG@!(O'$ M!YOB);A*_^0GYU^)F[/GR8DLW*M&-E-N>5#`^Y-9P%;E<;J&9]?$YF+JT`?" M7`#*5'JMX?*(/B0)S"PF5ZG(,:@*I M@S%5B8L$DWOL*LO>&B$DA)0@,Z;R%?G,\D:N3*HT\\'C@$W.7)5MSO%F\6WJ M0N8[B](C4?O/4*7?6KYY/)%C*UDD\(#)T`'>$H<4*?1E8K0HMQO461)#S.68 MMWF-G"]2LA6[=%SF:%J(*4'\S7Q/$OBA4Y?30,P#M87\SYUS:[&MQ`5PD*JC MZO+Z-%H)12&NJ'QC\D4B=:',/X7I5WT&ON?O>1HX%J6B(I^H2T]*AXJ"17W_`=MV MGF5O418(8#M@[B^0?B"AR>?!DKN:<4?E61S(_6H18G)*L&$O M'(VALC^A#M8'M#*36N+2>A?&!1+,F',76_G>9&G=M!V\=NL8DYXGMXI/Q=50 M;E7K1M74-V]5-[65S[T+JD4YYMJ8K\-$HSC'K^A%SL&)E/)Q`-Q3-H0YF^V` M%/Y28+;-]">_/$B4GU3Q._'7A9U\.NW<>4W]%MK%UUX&Y;LJ=1&K2S:%ZYM7E`4S77@8F(;\<^G[%H';U>E+WGCFYA M4G+.!L%^?H]MU4OU=ONS2=R>77;[;_85UDD'[ M\&!%=3J"E07^*H&%:R'N&&>TUD%K5%Z+ MY[F+E,5C1NV_0NH'>+X53#A60-6#H_RNL=J.N&DPK.F7TV5;&D!$CZ MT809[!RFPCC%CC^6.QB=4\&],&M,V/U4YJ\&2&##IEIVXSH(CR%'"[O!`^J' M!4&T%H+G/%!H!]21HL6D$?P,EM4_Z&U#7:"0M:VP-Q/NS(Z>]@8P,3V#]KQ6 M:S'[P\-G6)#WW(^R5:&53_&R!^5.,H*HRPD-TUO-91_Z-%"[%[%XF)[1,!K/ M+Z*:*"U1*RCJ\O#2%%#PXT#8,?4L@ MI;N+]O^W=[7/:2-)_U]1I9*ZW2K,(<"`L\\]5<3!.>\EQH_MW=1]%$A@W0J) MTTLKI_W>X6D[*#N-9N.MKM0>]` MU%0Q(^8Z!:J#-Z5-RL4ZH=E`#;CZ(8.-[1L<.,\Y&ZM#5YM\1Z\Z5W%1:O:; MP)_N&QH9K)L^';PR!;N%,MA25H>P3=!6$]Y;GW"LD MJZ%ZW(,#:SQ[L+[?TM-7OF2D'N-CKB[I(-0>ER\5[.!_!5_VO:G]6?FR9R'B M"[,%K0]4\4%?O`WQ>_'SK6?Y\="W M\85HN5#E;WSBUK7$#HS!UPM?IJP M%66LAM$+TNY>S MP'L1BB?Q>+;^;*X;**S,W'7370$0H+66TQ6(+];Q?;*RNF;O(D_AVEGVI6BW M(%<_E_-2AB*M_%^^M^$A-XVB,5G(>6HM]TD^RKM1NT]5'Y&X,/*^'R*4X M:<8S]35KZ<:6]QE=Z?'$<^]%V'?'#^IZ8'0''3RV\>CEYFU?*R@T\JK M6/E9RU]F3;-3QUK+WO97O(GB6>\YB0NSF_9]J!EDHZ2K(U>;>[>T=+/TW%3X M],GQG=#RP,@.[056DL4AH0'7>GAWEN/P!WS(' M[6,SN>21;Q($\OXD(_3J!_!0;8R]PR?(2:TG<:&?BV(5SU6=H@H9#'E=VHVB ME6SV:W_J)0CJ=!N$^(UA#/[#)*%"WH<`/0>\:P4"2+&@"J.,96S#@9<]!.HA MZ.66N:,2]G*0XH=9YE?"F''LX3?0D[ESDV#F\'A&HA"-DSB*+1^G(&3B\B8\ MHG&*())%L4"[DPT8EJ*G]L5LMNZ;%S.XZ/1[)[26S19JV\;T6KD[U-$W9H-Q MV[(Q@XMNC4(V1.P[#`]?!>''()G$L\1;Q3_>.U,GA_)::M;:2=XQ?%4CR=DW MC5LK'(?W5"M.SQNW`GM]-_9N16IOMEKFNN>4=5/71_`JT5Y4 ME7>8MR92]U;B_4@]B/JV6GGEV##CGL25U]QZJ:M/:[_ESUUPM.OD7.[)8?.4^Q-8 M*>>D*GGYA-GQK/!!K)[TQFX_#VZRT^0UTKR78%8D=S4%Z+!)D#E-+S%]S927 M9G9-5`<1G&Y++Z"DC`^.[\S<.#KU)@CG3>-^]/OH;GAS.3*&=_#_3Z,OHYN' M;=@;!\>O,WZU_,0*GW5H/L1ILPFOXBD(_Y@%H4"-0S`'?`K^3M!L'G[G78.@ M_$*$^K-\A(2@=Y!@9KSM]`6,@V\;2VR0\;;3)8Q6^(9'K]9Q0,@/D8.A*X2" M4!@:#/@'?X2Q>+,=`6FAH;'-W)"0&+T9SH?T,[!$Z"S@C"'T0I&YP_3PY`QE M&"\]:\I`(Y$3?B.00\:SL$&&DXB68^O8;P1RR"!^P49\0YV'\:.3\DFT7($SMKP/9G@)L@=DY==?C*OAY?5G^-416XL8PV2>@"BB(2S"AYF"B^W&L8!$<1B@:2:Q M*(R9-45,H6?CI\O1U=7/#`XY_(^[@!M?`Z01MDL@KCSA=3WQ&)X3Y4=\RDB6 M4ID0;X:Q5M[V6LV6L<">7X&/<)EFO]'OFXV+EBDQ(`FPE)Q^!JK$FP`P"26` M8&`LH]T](W$G%!@)_#)QYHAVZFO"?\'0K@H65%D3A"'U'!+WI\"P0^L)=!LD MBDB(']TH73XJ7&@19*D%RXDMCY9QWNRI5;B^,<>>K(C/2`<(C<56Q/+([F0M M5+=YKKZ'"U1`:MF``K?TT\S1).43.Q"Y61(?3E04:-+Y9&5DZZ4&BR M,D,$Y>1F`2/L)#7=G-2TP6R:@T:W8QJE)(8WN$AJB,D#`>=C?'7X=)!$M=N$ ML5RX6V(FE]Z,(]<6@"UDTXDK*'K$%EP4,B8%8THBVN%45<5IQP+WUM0$I;24 MF9J(;I8RHP>AO.B]!1L*XH M6$M8,7Y)[B$Q''7]#-%[$9"5#EC&AL4]DA]$G-HDG#YBX>'Z#6=SA30*\&AG MFF#B@Q&'%H5&;.LY,G["!3`T=Z?[RT>%G7(R%))]IV+N*"@(\ M9C\"$;*(*/57`=R,R,XN8^7:%F(M?PN\9.&('B=HOO@M3H!`__3[U^'MSX62 M##\X%NB&MA")AY5?0(.4U+#8"X(]P+8B<[05/RJO2IT8,9/\YPP_A@UFK'"$:4ID#XT;0 MOW(K<7S04@0]@_WFM`(D2@@:>YBP4IB$S!"-H'C40#-0*/1$MPN?F3<4FK$= M>)X%YF]!O$:5X=EQ3:D

2TW:@:19:@843)!%'!<1.G.)8R#'L"H0J ME!E0B@7KVUI30<=!7JTT5WY5M0K8[L$.QYS7SYK$'DEVHS,;BM!W/`XK1SH6 MF57[+%D&F7$1UYMQOY$J@68N]*!`=P20-5OLF6(?R2Y*%[+[28)_DT'.*8@Z M\MO=`NNL,2A[##2-L8_8]W[!=L&:Y;0HYGG.TJ0"BE!:&R!]MF*\)6PXF(;X M"7'UB:WYX8[@>:4N[AK_"QCQ*(1_U1/+>^\[>V&=\YP7!G=IN&#V._W-7EAZ M5.[NNR-TH[P]Z_ZX0)"/%(P[B/_,<[Z[$_Z[4.'X>>EP#P,VBM(.D$X0>G^# M;@%6F%[YI3]+/AKY905\EJZ9SHJRKAD1T]_BGADKKAF1]<+"-HSDB9/A3D.L M4//7TDTF_@M\3OQFEHOB^P=QTM+>$2MW@"(3NY/3-<9`B"#38=L!7\J3V)"$ M<3`&O7DUD%5XX)-T",(+'*X-)P-^GO4FY]N(AABRF4C*`><[BV61<[/U]"-3 M7N+(%8MC#^181ZXACUL^]6HZZN'`LDJ6(B,E<`-;ZNU+>=G#L MC;5./?GT/?A_UJ679&3=^B+!RSOT:\6OM!,OK@%[.O+&BA,_<5*7("_\>167 M!TZA7_]W\$W`**53H"ET/"%YD^19#GFVYIH@-$J>73RN\L7DJK6;(>UFK%^] MX`R=ANX$+X83L)#'D.W4H[.\*$B/=EJ0.F"DWXH_,YSSEHO_/+2T$P47'2R) M?_J>:>[#AM-72(>N'>57!KY\T]N))3FI;7U#MP'#^D11>;&K17&/J'$X]-03"84 M_%_Y?L6WJ[DCP@XA)2.CW3)F#@L.BECZR/7OQ"*I-]])\4WU:>5RFY%CJ=!T MS*2W%QG>=.+88Q.#3CC8?@[V2Z\:CT]QM7"=T^F;M/.;F'Q,LQWW_8*U)C6_UMM&V66VNBC+1\Q->(14^%&E`*NNVUW5NV M3%DOL65%L3J=^1RF:S\5:T2$!X-1>]K7AA2JS=/73WSY+FJM?(^P?19PQXD= M>&`_/X!G'%G40?#DDY,P]''B=GCW<+VU M1]"!3^XQ]U"E)=!4Q`Y]=>!88](13HE^ M/#9HS3Z(#YK==^(NM!HBLS(A"WP>H80GVD@B!@D)87E10[7EQ-4_@9O&TV%; MT&02N;:+F6M?K._&1]$!>(2Q>>I[&P&IX"'3M@RL"USP$0(SVQS+)9M]NG&1OBG9B4ZZU M22F*!!R*WLJJNB#E(2%6QZXX_1Y`+QMG!RF*!/P-.JE1'N6P,HI1OAM5T4Q5 MJ:F`A#QH'8R:\K"`'?.@O"GI_G5[Y:E!?1K/Z*_W&.^N0V3:W4&^*BLS204: M2@M*MY73X/UI*"T>_7ZN[KX6/I03BD$>Y&@+#:MW!H7(SE9W7=_:RC>NSDKK MY]TIJ)OZ\N5,G7RKZ.K$Z]B<&K17+5SNY5'Q"J?:@Z+RP*2#*A1MY6^-M71G M9KO!B\L@8Z%D86%$S\&ZJ%./E?SDY_EAL8W@N:7#]IGG',XU0'8 MK"8?>SR*X.\MG(WR-P[6#%D?)0(O*F$%,[X#S[7I$3Y"*`E5U!6HGJWOUSW3,458QQ$M M+:RW^=L;4`'\]Q(?IL6_2V_?DVO'C_C1UKLWZ:0X7R@'`W;&[M3RSBS/G?OO MC4D0Q\'B%V-B3?^8A\`7^VP:>$'X'H-#L9,.@YI&0]ER*-05.0Q)#'^8.>/9OQCZ!%-*LA3I"R%(RA<.UXTP7/=G M7NT-JO>ZQ=*/X:NXE=^`"99@AF?,$^"-!TPQS.8Y*#K9EE^,W;D_;9]Q]O#+K.,RH-7.G]2H3KS*Q228.;;OP5WA!X@0K[MPB MWRB/)YMOJW[QO(>OHZ=@`VU+&>P87=*Z7$<+$LK,;V[-T0)/`$KS+G9"9=[9-J=_%B*O?VB M4CQ'M_M#JG[EY9H_I#957:[9^$%->_4%]\[KG_!2OM7VR0W0+[\5=Z M^,W\ZN"YWB^2%#",C*45QK+4F*HQ8]D4)875'!MU42R@:PY6X0D+:QQ<'V/,Z+"*_`K8'S_PSYSO$KY.(=NF M1;(P7ZMG7*NO(APRYUF("9^3X+JP5OC%SHHC!"]+M8A!6A2(A:JZ-/.B,*[0SLCR< MWDWQ*TFRB0XIW8:^"DW>SLW6-CC,C<)#M>*A3!6D769J<"MG29R$C/H@,GUV MES5CNYREJ&EKS8OTMY"$%>%Z`MK?]MKD-S9P7-ZQMV:?"[+P[Q;CX3NK6,V; M#)0$Z$NAHM]VNZ38;*]*#%P``(T+D9E3*?XMEU8)!)'868=ZQ?M.9+0%7O9N MF%5"NIO&4`//;7-4?6/ZE\R[RO.?68&%PA.GF!TSH"=^-/Z=P'G$5S^9;21<3+\!Q+V4"231`EI""0/-.@71@F/).+1L!/)-AK$5SX M]P[!RVI2C[]._'1CL@._M/7"H1/\8;QD4,#A%)17XB'?B@89$5&5','=R.3X M&2*_+UG`)T$:(B&;*+F,?4KD2/Q3"7/"5B+]D`)(3?5//H02.@4BFE'@1R%3 MN/!7,)ON-$UG#`2_`JU'#GY)_)X($000T>M*&U\S!P]]7_B1$@M>1]U]5-EZ M]/0I?>E313/CT"7U5[%?%/O:H/\XQ>"?=[=,G]56Q7Q7[ MV*/^,*?@97IY/GUB#[17,E3PJMA_IFT]S*@C$9-^_O^)CP MDN:%K(;^8+'F4>(E3,JZ.HO!Q>`'RBE:DSG?;'=/80'GS<$ID%&9CV>O-^;7 M$5Y'J#K"2QPGHQW>N(_'EUZCU3Z9NI\]CI/S_BDLX+SY8_-Q]^/DSYR^NP9A M&Y.[$E\E6G%:WM:43$J2:S<[JL.A:C8IDX+EB"G`EP^;8^!WZ'[`G9YRLV,^ M)`+=9YO6[TC.18^39'K>$]\N#Y6[_Z'AKA4<&;P#_BZ M&XUGM]Q>B7^%J99.%'VDKF$481CZ]I#1[^'.<`M?QF8O:K*3`M,SF\:7X]N1/W?KOUI MT_B)1:W3_>7)43]B!S;UCR12/_Y,<]#PW)L0IK`2FYH+8!8O=V9S?9%VNE"2 MTT`X1L.R_Y6(CB%$C>\@,#MFHX)%)#Q#`FKTGD6;-A_V%9LY+$7N9Z:[15$. M3A$;KF;[J*'NXC?4(4A,\5II)%S7R.M^VK*S85E\YYC=8G+(!E^$"ZH MWP1"HU(@(UUDT[@4.?7,]B/*2U MM05](T3-,+9!G4Z18;9L&H(4+H'.J;OT0!/3M6%S=2J$(#*PJ>O"C6/N31LE M6-@@NN=1/PJ95)PV'Z!EC;Y/'RU_CCJV6+A4+F#\A)]3$G0_NDREB1/C\;P[ M)"Q[A0QJ&),$BZF`-)15V<0$]UAC MNM8B[[F81T1$`4,%)N=OOJLTF-@R7`"%4ZMI_#-($/\3"R1"+-_AC/)TD1DT MS\(MYI[W_TK\J4H!5SU*"K]`]BB(J=&C$SK41R45(W1LAKZ/B<5W#F:'8[7" M%0@.KG]J\.ZYC*$,MP. MX$+@SF!IH%EHDS"#W)4RCS^0OT,E2O3%64)9>E)-'8`DC^W%@JIZ^"#D0=,8YFP[$<&GMG9J`3-L<*N;7;T1.IKR M!OT7NSJZWV!`J0VN:E)E1)JMDCU4SD!"SI"`EY8'U7R("EE$YY-4JO&:T.!^ MG%PW$HN6M*)_,8E$E,RP]1!Q&-982]D/1KUEHTRF@*FD$_4F/T9:Q(DW)B7H?')DP`3G830(,).2;YH743HFN_N/;"E*3[J2[1,2!* MY[!A^P1-.'CA<+K2=TD<\K.H6BJIAX9H5=TPW%GZ6_A77/19GPIC(G$6T^]@ M10D?U>AAD?S!]D_P4DG;"Y[;OQ-R,$%V(W729`;-?HUKT,`#]&U94.QBB1GU M9I)Y'=TD\![%+N\3GCE^JRI0'"7D])!.2:"%MNFW$(M"D%<2%O+.< M"8>OAVM0KHYUH(N25ZRO#=FIHN,/^0RNBX-K<41OXB6ULM6]S)D+SA=F:X6V MK"3<[A5*IZ;`03.D<\9J)W8_(AO[';?=BH.0A1/N#M8\M);8@AOO.ES)FLHP MP1#$1J&!Q?/<19G`ZE!C'HBR-3#-X+",J3)SRR*(A()K*FEA9D"APR^\NW"7 M'29S+*SD&_L3^9`.7[?(YYE2\^%<5#!59='@^9GO8[)']%@I^'/#^!S;^O5; M?$:_'7WD`E-9")T6:B)0`3>5YH[U:`WDC"K60&<'RF5:!'O>["F_:>*`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`'&$@C>0?K\4\G'MH!/6JIM$#?AW#_&DKY#[V M:9.[A6/A\Q9;-(H%3#T+R'`=T8UNN?3H685C1\YW-Z*`Q#QQ^1F1E%\]DV6B MEPV#'_DBB1@F'(BBR?6W1CX*:9Q(/[KUUS@.-ZQ9B(#DDBM&^S6;.6B14M@L M,B.N`,WAMR[YH@O.H^NS%S3#$U@%39`JAV M0+_$,!6"GN%]57Y!1OW(A[,TVP96;1K+:'_1J7-Y MY\B85I!$Z;:LD"1CJC@&"1M#1F+P"OTW?'`FX$F)G9?N[RHC+"\*4F[D.:%E M$=`YZL)`K,E\#I-.@DY'$2JU>`[?L&*$7$P9)AS==*%/="BO\G`CD]5E;OVT M2*?*I-B@OPS"ES[/BE0\J MU'[$)!-*.HC`Z[J"XXCJHTXST7``Q]+P[FYX6(]H,S&W$K%0BV/8V2"$S"X0 MZI)6?HDW[5`A?7+:B^],.8\60U(I-FDLGAS5>-CVES$W'5!`5ZJPK;:04$;# M)/6%B`)"39RHZYU(%K'P52UM\SYQIA9>ZRGXCHD\=/+3I8FH%%2I:U;FK@*V MB*R;>MA)F4$4)#Z&>#A8@8E)_#0J\4E%5`UN@+`2E6\E%ZV_#;2$/50,`=>$ MXA9PP(OR;O9'8_A24C$4N!NNQ2Z&,1V(YGI-E/"H<17YH77'W\7CAE,/FW M`)]+*:@#Q`Y:[WY)_V;##=;&5]EGU_$059DHP(^$;O0'AVGHX'$05U,`N;:: MYCE\0@1L%$"CAR:"_]X6B=LDG"(-#CBG4!HS_*`H:8=SPV%,HN#MH,UHKI6R MI^"_0/"2CU/ON4$1`+7C]%"'P+[IL^NGDRV([[?@1'=/Q\27I,+>&Y?%RO8M7/A2%DL M@(.KW=-.+8Y!7@-?'IZ7CGZ`7=]&$_E86@$50.``"YI0``%0`<`&UV:7,M,C`Q,3`Y M,S!?8V%L+GAM;%54"0`#JD*P3JI"L$YU>`L``00E#@``!#D!``#M7>MOX[@1 M_UZ@_X.:0]$6J-9VLJ_D=GMP[&1A(+$-)[M[WPZ,1#OLR:2/E//H7]\A];!D MBQ*56"L:N'R(7QQR9G[#F>%3GWYY6@;.`^:",/KYJ/>F>^1@ZC&?T,7GHZ\W M;O]F,!H=.2)$U$S*_@8-7?FG+SI(<=U#2K[AJG/^-?9**WL M/@Q79YW.X^/C&\H>T"/COXLW'C.K[H:MN8?3NJZ_C6Z9H#WT,4PJ_R/*&\47GN-OM=7Z]OKKQ[O$2N81*0#Q\E%#)6HKH M>J>GIQWU:U)TI^33'0^2-DXZ"3MIS?`K*2F?X420,Z'8NV(>"I4]53;C:$O( M3VY2S)5?N;UC]P20$?Y1HGRE0S(WSL2 M$[S$-)S,+PD%S@D*IDP0R>\@0$*0.<$^2*.JON=X_OEH"96XT@JZIR==V?Y/ M`T8%"X@/=?GG*)`*N+G'.!0)8?B\@IXBR'(5@&HZ+^=7U](4<1#B'H?$0\%+ MV2VL9&^L9U0]`I>RQ'783(G%9#Y924<"=>]?O1D>)Z`(/F#+%^<(G#5?*RU=(L)57!H2X05,K`&!2IL!V[CX8TT> M4""K&-$'+$)9VPWVUAQ<*!9]^(V@NP"[EXR[-U`04$C;NL8(&E+M*U%/]BZJ MY(E"SO%<)4M:4#'R=O]]$T-2)1UMG\-+;)JJK7=5K!F0[C&\+%?@H52?F.%` M>H,!$[(3,>_W[(^53$O[]=US"-9^ED[Q_7[O?`_Q7:6+NV)TX=YBOI0L1`K\ ML'=&OB,)4HS/QRJ6BDOO$\TE"6/?!_XN!%\$V3PQZ-HII=@F5;R>-L0KV)OT M*.%S[*/HXA)Y)(`O(@_=-6/KXKW M.G7LC?$Q?NQ['ELKA*><47CK97Q,[[@Z:)G6L+_NSCP5MN3HBB^-'%()R?[" M/:@@?*[!E):@C"7(S;UUH(I?P><67%/*M!X!R).S427`MW@="JHX;@ M.`A%\HU2J]OMQ0/"G^*O?^L+`0P,UEP.;)(&`G2'`]7L;Q*2K3*=]KB5"95T MM_F\JA\.($P\0^=229-&"D/:;>DRQM3GGL.XC_GGHUXW]9"(>SDCVAV9QR4Z M8KV,C-@E8!4)_1P\F5;7L5Y9;3&R@$#[1\XC)HO[$#AO%4!(=TD@'3ADNS+9 MW23"%29836<&W'%KP!F+;A]H4?`2F_`+P[`*O$I)S*`Z:0\J`X&M0RF3',E$ M7N;Q,BWER`O%A$/:L>!H*31XF1*;(?>V->3J*<$Z#--!-MB;!JE\$3,\WK6& M1Y%`UFE=362:)$)%!-\:`GKAK,-AAD7(B0?Y\6:FK`*1?@\A5&BG)J2F?Y*6H<^+I236)$<%^%A M(JEU\!3VVS&C7GU?E:6R(BTV]E.[\EJ'TXB&B"X(9(.1;&!3%T]>L):;-;XP MYC^2(-"`949J13I92VX=;)F4I;)3:5+VE/"E#BLHJ$LPZ( M(9YC,!5_!M8R@%<25G:;2:,U,# MBA$%4;'0>LL]5=[J8D7<1Y4L95NP"DNVG%7M%]W\TH96+];9N-P5S&@E@+O% M6LZWFD-/IQ'KH.O[OMJ+BH(I(OZ(QCEFAG_=W)H!8+=38XPR$B M%/O)^;VO%*U6G*TXD>)K%\#+B5K.9)NS##-M60=R)G?O4W]7/=6#%PV9/1-I MI7)IQC'U\&IO`LI8MCT;?JE:/G6VM7(%GQL\OE/O*']Z>N?8^/2.\\]<5?_Z M8:>1\J?M-ZR?E+&^.2'NL+F3N2B@S5CR@.E:.P6_^;G-.0`(U`DG3:%.T M@G*M+E6K<4ETG5X`HZ"^OR24B%#R^(!C'K6KUV;$+?<1+3+Y9>TZBK#.:\VP MP,"./.T^A)X2,'4NI!R^"IJ6O8(1:D9B6P?6%T2HG-V[3.O,8XK#2L MK3(MFU0AQX7:+RAFL2_&G#RH8)^YR1!DG7(<:E?]S,E;[CB5H-55A'5(;HY; M1H)6;";2%V\YEE8B526H=?79H(L4BE6A_Q^^WE;C@NC-DM5;\R6K7'V.4E:KV^:VA4NV;NQQC^C> M6_DS-:PU$]P(QMFN7=SWK0QY!=JHLZ%I"GD8\X&.RR,P0QR]E@7-AAIL?7FA M<:-J'B[+=GJ8W.Z_"3GO:H0E?0]& M-V5'&>M4\&>`J)>YU43F\'S_$(,;\8A2A0:4?)'VIP9>@4F1M-9!TE_*^!`] M'D1N!LM?^*,!J8JH_7F"5\!FIA'K@&QMZ:3)2857P'B@:RKJ@1X[C_/0+3-K M"K<_"?$*X,HU8'._LV&:O+$K8O?6&U\ZA][Z?&!\!_%W&.;@(7O4= MFDHZ`)"WKO&]Y27JRX`S"!K0#TDFY>5H4A\-;.0]57EW68 M:U00[5Q]Q0)\807M/GO(P]A73UB6^T,F<_V.$8VD]:JP<_F^!->MYQ?5UI9U MIKW;/S=/_(F?-YMY\(^Q0RNOQ,X=`H:POTQC]D\ER$/)!<]Z,H1<2VWGMH(7 M8EVA(_M`WO51VJ>N&3OTDAKLW'SP8G]>J2OKW#F,D)5%WK*^!\QRK+*MVIC7 MK<7.O0NFN+],9_9U=HT:+@E%U,NI0=Y@0N@:OLM<`U8K=36NM-5;!%8QM)-Y M^DCHXLX&\6V<(ZL[.V7@11D-J*,L`7Z&&QCQ!0VJHZTGL.MPUX0M$X[W]FZ-: M$A'J3SD6H*)XWW\L)PHVA[A2F=+37^\=UQD2X05,0-"##]>(HH4J_0^1.1>& MJ.],.8'Z5@&.SQ]G&@?",0NQD]5,`\(GZR%@`VJ/]:X\'[;E`2-0AZ,=`-91 M1`FOQ\WRFJH_LTGX$A&N'J*Q8;$`DX_;,JAS=YDN\&]G,]WB;*95G3[\3N2, MJSMGW)6C=H6;;-51S3K7T%?6/#K0%ZOAI%DUI%MO=^4\W98S+9OP]K;A.Z3Q M`_1VR`;Z'%XBJQ>N;/G=#K>][C:W*;63)4]8?]+8`H/?*7`LO;<[CB4E%LI3Y.@3 M`4Y_A`!@O]&-^VETOD2>7`E]5HKO=7>E>5QB<#'ZUC^_NKAQ+F>3:_CBJG][,72F_=GM M"+Y,Q&DX[H[Q8[SK2!['YXS"6R_C+GO'N\+L1N*+[TY_,)A\'=^.QE^#B^N+\>U&DH:C\I!YZ^AV)0B12XV'5`$X+IA]FR-J-,\!1)KG M,:+8Y3#.3^6_._#O\,W_`5!+`P04````"`"%>&$_-@PR`L``00E#@`` M!#D!``#M75MSV[H1?N],_P/K,YVV,U4DV7$2^R3MR):=T8PM:60G.7W*0"0D MHZ$`%:1\.;^^"_`B4@1X4201\E$>8EO"@KO[+2Z[7"P^_OMYYEJ/F'N$T4]' M[3>M(PM3FSF$3C\=?;EK=.XN>[TCR_,1=9#+*/YT1-G1O__UYS]9\._C7QH- MZYI@USFWNLQN].B$_6KUT0R?6Y\QQ1SYC/]J?47N0GS"?KL8W<"?P>/.K9,W M;60U&B4Z^XJIP_B742_N[,'WY^?-YM/3TQO*'M$3XS^\-S8KU]T=6W`;QWW= M?NW=66=_/>Z>M."_XU:[_>9Y`GQWD0_?BK^;[5;SI'W?/CM_>W;>?E?R*3[R M%U[\E-9S*_P7D']T"?UQ+OX;(P];``3USI\]\NDH(=O3R1O&I\WC5JO=_.WV MYLY^P#/4(%0`8N.CB$KTHJ)KGYV=->6W4=-,R^X5O'CPF2 MC4^;P9?)IB2GZP33'CGWI"0WS$:^-+U"CBQM"_%7(VK6$!\UVL>-$P#1>1"<$.2".[?N!X\NEH!ITTA,&TSDY:XOF_7#+J,9,`^L9&[+KO*3C;&>D+5/9A]9K@* MFS&Q-Y@,YF+.@;XWK]X$CP-0!+]DLSG'#YAZY!'_'->IKFZ8MU7F+Y'W<.VR M)Z]''<*Q[:_-==31QKD=\"FBY'<)Y/+I\$>'.D../7B^_#,Q,)>,%8ESBRB: M!DUC(MDO@8Z`^,R7B%.89'UAIC?/<#@*F*[CWUA&5%SR=7Q MQKF*]=F#R9HOI):N$>%R">L2SW:9MP`$"FT&;./J?PORB%S118\^8L\7O=UA M>\%A"L5>![XC:.SBQC7CC3MH""C$S[K%"!XDGR]%/=FXJ((G"MN3ER)9XH:2 MD;>;'YL8]E]BHNUP^!&:IGS6:1%K)4@WN+S,YC!#R3$QPJZ8#2Z9)P81LW\D MORQD6MBOT[B`Q=I)TDF^WVV<[RX>%TYQ-XQ.&_>8SP0+@0+?;YR1;TB`%.+S MH8@E=>M-HCDC?CCWP7SGPUP$&W]28FC'E-XJJ>3U;$N\@KV)&<5_">UA<\.=V7+9$HX8GY6:D')(-K?<@PK\EPI, M:0GR6$+--14Z=<*-.)2,/T`6W%V/<<,A,;%$%*^&#DF+'O1#J M-Z%I,VS35':P?;[CAS4<-D.D(M-9ZAUP+)_4F.'9&/.*[*9)M\\K*;_SL8^HLXQ6BPTW& M/V"V$AVV6JVVU;!B6O@]Z3]:84S!"F,@(?<1_RZS4TR[(CS$N%+;4DL3Y(VE MJA9>8XK0O"F#==CUO>@3.:LV6NTP'O1+^/'WF$/0%.[!K_'&QT5C[,IG?Q?3 MLJIATP"^[\5NH(CGL-$JOTL[Z?"(\]#(2H[DP++/;=C^@65=N?)I,#KP5/P2 ML36!O4J^)D.M,3WO2;T""T<6XP[FGX[D3BWD`KQ2['PZ`H]5(6P=X-S9F"). M6.>9%-I5NNU&H5(NO;G0I)6N@D4E6A:=XU:]0(1,?J'>'-MRHNJ&Z[@:#'W[ MC0*2W5;DHJ'4-2O%]FL'YGM;(_#J>!^MV M9^SY'"U#QRN@K3;:+$SIK>[Z"XU:E*S&35#XY8*+]R^E])YI:[+Z-8(IEOM: M41#Q;!'M2H>U._XEXOR%T*F,66M0*4EK)DJ5!%>L-O6.G4=$7+&AN69I((HH;>,<_:Q7P!2+HFA^)00,PO-VUJA282> MQ6L2\99$!/W%;.T-^)"S*4=:Y[DLL9EP51,]"]QIK<#%[RW!QC3PI)N8"8)* MC*RJW]4\1F#[0FP?.\LWW05K3#Z)F5"4$3,+S?M:H9&Y.JF]I@8054,S8="+ ME%7^!W.@B^5I?;-CG0C3]`I!/8B869<14 MAXM-6R'ZC-K5%XDDE9D(E116`5*]7GZ/^HA.">SW@O$.!G7U;+L+D0W_F3'G MB;BN=B=5AM1,N*J(K<"L7A\_L1@6#B=-6S-1R15,`4/-#KQD-'>)-U71:=85 MFJW7_[XA:"SRTT3*+'5DMN4#1'RG7*AQM;&9:.2+ID"B7@<=V.4+[&1M2`^&KKVQ M>.0+J("D7K?]`C9\XFQ*C\(^$'OR1(Q7$(XOH#$3FE*"*N"IU\^_1'/B(_<& M(P\/QBZ9!B?>\O$I(C(3H'*BFI?E(MZ[84<0DZ,[$I+;`"JGJ=]G!,1^\VDR?EU/-4NJ69<.0( MI0"@7M^^BR<83,09@5"7\)/XA<,DG\1,2,J(J<#&&+]=AN+N'Q`51N6'1E6( M5)4.S,2MN@H4*-;KYR=$*(9I#W#(472];GS.L6#=@I]'8280)814`%.O,Y\- MF?9H^')GR+C4J.]S,E[X(EITS\2@%DE.3+K&/0J#'7M%,C2H7% MU)U'$*[74MZ\U&9E2S.QRQ'*N$,68IIAM%#[V69FJEXGCD+O]08..HXCE87< M(2).CX:>78)_74RZ!*&9V)0768%6S=G]MKV8+60A#%U!+E$Q29\3WW'^NPB2 M4_K8'TSNT;/^E^6-[!42JU1*-ZX<H0;*H0;*H0:*%I9##91##10#@#G40*D'/W!XP:-ZQ'2!Q?D( M3W^^2MW4S#UFGEC&U>.(CF&'_&HCI*O-S%2]3AS3"FJ$[.E/^T=?FZGF5?9- MJX(ADD\'$SGV[L"[TQKU2BLSE:T1QK3R%M'0"VU#<%TPF:1:FJI[K5"F5:D( MS*1H&D^U,57G"D%,*U3QF8L[)#B;$)V5IUJ8J6F%$*95G1AA#P,WHG16%RS" M9?*`^M6SN.Q`9^4%-&9B44I0T\I2W&$9Y`YN*'.!]8XS`UV*M`R?/.)\F,H2 MFXE7-=%-JW#Q&90@7C\.:)=X\[`6]6"2>_BX@,9,F$H):ER1BS"H3:>A&>D@ M4;0S$P:M0,:5KH@Y7;ZC+U)^LJ7AZL\*95P=BF6EDX#9@I?/^N9F0E$DGG$% M*2(&\Q?S3"M3M:\4QKA:%8EE"W/R*+<4B9OD^M@?:4@QI6B6+(H+ED+CGDC..B1G'9*SM+`Y#LWLC^><9F:TJ@0-A)D@V<--_X4 M,\UG2\K,S=.L+P8A+L6[=MF3UZ,.X3@Q<<;!A],*P0?HS9+='8(.AZ##(>AP M"#J8Z]L>@@Z&`G,(.M05=!#+]U!L%V`W4WNDO5[MIG!MIU'F8G]-M5J MFDO?Q>"$VD0F*6B@3S?9-61;!8/II"SA2]76-7RNB^!<2=ALR)$MW*"E6-8%_1O MJ?%$LJ1[CN(>G48=TQ8P_SR.K%UX,Q2 MOPI$=4HQ[NRP?HT/+R*_Y\BIONE)$^\[I'DJ,>[TL9+]E:O,J^"9(7T%:&K4 M8>+1YA7FP[O/TU>?#R;1#2&E@2WL9]]1+JDHXPX^%RXHZPSCO"[V'>AB]>2? MAC8Z\>BG$X[V#=_JJC$N+5`C0E"+:0-I9;D=F1D;7%\E"G3KC2N!##;&CBRO M(<[4#";Z4S8:7*MUL6M$?P(KMJZ,6JQ-"SJ-0`>)FQ:M$:>A(C.I0:ZE?!\8%RE&`6V\`*SLGP2>PL?!?ABZB/IBH MN)9MGDR'+YRY]A3P]92E M`+WVJGLEM?'3V^U]A;JZBA0HUQL1TXAP32BB]@:![.1H/)#:/3>\QG8=#@1NXXQBZ9AA=PJF&MU(,AH[@,4FQ-$;5`UQL!2\H@ M'4'L=/%8-U:UK?YZW$%?YBGCZ;,:HO-2XQ&Y90[>?`)96 MB`+*>J-7Y>57E8[]Z:54W>E^&L%F5*FPD)HKZP3!&O%#[/D?P044;[ZK%&"J MUH69FZIUU*#`LN:;"95"=,!N.7\!<_R*7/WM;>5H]PD]C>`*V.J-4]TMYO.@ M/`-RHVI%/3IA?";GC@+'IC2UF=!5%%X!7MTI&T$5K"$BNJM`TTUV#D-%!2LN M-$G*I@"@7A\R/#"R#&I0)UZ3I=45!0;*TYLY@BHK0''RN%Z'(_1FY9D?A_C@ M((EW#R*_P[E8^'WF_P?GC:_RY#O?>5:&AJTCEA;6>IT/Z1H)?PD[;=WBE6JR M5_"HI%-`D-C=[[@&XH!/$0W+$"PK&@IE4F<(QB16A.#@>B@TU#F.)XB*) M[ZR&U26>J%<'I@A_W"**IK+UW[Q$^41$'6O("?0'RTYX84/BX4`(IHNM!-Q; MD#U*^X,-?/K>DUB<]ZOB@'\G+Y.PP&>S)%'$ZO%668V5GSB`?(T(EWO6)8<* M1#ZLBB"+4R8VP/^TEJ]IK67^A=6![XE(S6C`-J`AWOI)U,13+?E8ZQ;\G`4/ MJEZ&6CC9JA;BP[M9,<]6Q8S;1JR]W2IK=UA?)IAMMU: M93:FMI+D$>>G6^4\6;+*9400L?=AVU8P M(W(.$"ZRC$U-,6EN5*7$$4P25P\$Y1%S,SX%`[:Q` MF25X='5YU?O:N;BYNK.N1X-;^."FYJV\=/X9$943F: M,PJ_VHEY4IPE794EN_Y>?;,ZEY>#+_W[7O^S-1P-^O#[Y=7M5?]^*YM0,W^2RZ+9VD6`XHL@^&&5/PWAGD=/OD_ M4$L#!!0````(`(5X83_\;]DI!"4``,,``@`5`!P`;79I&UL550)``.J0K!.JD*P3G5X"P`!!"4.```$.0$``.5=;7/#.9WIS.9J]0E@=I%"0DQ3^^2LFKO_SY/_\#L?_]\%^3";J(<1*]1V704;_!Y]P"FF04[H]^CG(-GQ7\C?3JXOV3^+U[U';U\?!V@RL3#V,TXC M0C]>SVIC=WF^?7]X^.7+E]QT2.W,W9$=#7-OZZ>?9#7KWWV_. MWAZQ_WMS='S\^F'%<)\%.7O*_WUX?'3X]OCV^-W[W[U[?_P'R[?D0;[+ZK<< M/1R5_RO4?TCB]/-[_G_+(,.(-42:O7_(XA]?MUK0M>';XZ.C@__]M/E M37B'-\$D3GF#A/A5I<6MR/2.W[U[=RB>5J(#R8O8*I4.78-=8!J3Z#S=#W5?VQ-\]NW0_`D%:.L[+\(MR8-D M+_!M3>>PK_!^-=[HN:]IUI7@_6JZI=F%G?`?+]E?'>#X(6=]$(XJZ-R6QL&) M5PF_6]JNK9.P8S?ASI)0:8T(DZL@6PJ[NVRR#H+MH>B/<))GU2\3_LODZ+CT MCK\I?_Z5]S]X@]/\-E@V=2Z*]^,KE=!A'R\7G](*=$!#0\E+B<.0L&YAFT^2 MHHX+]14E&_6[RWHA*HE?DV5MJ:@]]C(%Y(X8Q9GH\43CS>O_EP+H4]"[!\_'#:V`+""41S/V)^9J9`M02_L&`"5,J26@L>2/C0- M4[@H$K+0Z'(3XC1@7>OT(38RIBOKA30RN%+>M`7A44>"3LF>`U1)HT]<'@B# MIEF&\VRZS'(:A+FBP'TAEYR1`VR3I2L!AB526'UZ%$*0J'"ZHY31U8H1`UGW MQ%#`'?*C)PB,)G)T?;:44B@`Q)K3(+N;IA'_S_D_=_%]D#"$V30_#2A]C-.U MF%]1E-U2UR6K1A6GS3(K13"L&X-VP$*FA((T0B'_`S?J,`@YO0_BA(?T%X3> M,&`W.-S1.(]Q]9&I/D2SGE/W9EN,CJLS*8$AH"W2/OEFZ3W.]E5H> M#()#%8B+;%-']<,+SY-(WX3,N6>SEU M"*-7<4D;&_!M%NGDP7@;"Y!]>E4J12Q=R8OQ'PR62;O@*];`X^.BMI;WT&A8 M!&-TU*B`89P=SC[IK@''1K,T9U!C-BPMO#/[=,X?PF3'LU(_$!)]8>-)Y8C# M1M7MP,V^,-T!G5D/#`='@!T.`"M54#UK*VHT>CJ%K*_5I()@>*1#)P_7 M(7&F`*X--'T$YNJ('&(HKHW!(;7V91PLXT2L#K$X[R8GX><[DD289CSFRQ\- M^0WVZBX9,[90;4[9ZH+Q-B,!]RG94A>A^\U=0'%I`!46P#'5+O=&I^")C199 M.&IIB(P;EX^3-(HP.%6M6"Z"1[Y^9+?@W!?VL=0L!RQ;9.Y*@N&0%IYR87E; M2(,A#]WA:/@UJ(NLDG=,(3WL'HODPI"(I$4HX1*7A^>+3LKUY5EZ+M:II54`0R\;E'V*53K=_(%0EVD`.Z?@--C&?-B#@PS/ETF\ M%CMC#>[.I.0V6]6F`-TT59T&&'I:P52%8UM"N;0@9V$')=P0(HTE&`0468\X M.L-+@T.4"3K=N:,$VMFV,Y`"0R@E-`L2)21=3W),-RABZC"88QV=^0[+[.(Q MSX&8KDY7#KO> M#08I2]]<);ER'ZWWXEU)#_V@#*JD(VR+@2&7&MM@"K73[\'FT!E>808KNF;( M3ME_X]SHT_0J+EEE`[Y-+YT\&)Y9@.P3KE)!M$JQ`ZFT$"N*"O54)S'7ACFX%.8,<#VH$` M."Z)@?(\9XW!?5ZU1[,%N MZ\"@V'"I?I:6V6:+H@N?YCF-E[NP8&8F"XIL8VW"%0#5LR+GJ`M@%%]UP!_?;UT='Q]^C-[P_XP;(93T%B;GN7 MWQ$:_PM'WZ,CX<3K1W&6\35<_AO9Y>)<7T9<&/3C/0])C=P;BKF.$60@^X%! M6P8,Y13`9"$`2=5D.SI2L>WX^(\'?WSW5O#K^.C-P>_^>/PU,&\:13%W[D&R M".)HEI;3G*WJ4N506"@Z35&Q+D@G5\6H!8;!UE`'V2NU(B-T'$WBM%JZ!4+! M,-QM=@E/;A##?5:B+<5W.,WB>SSC&0[XDF29^E2;:?2_NV(;SQ7.YZO;X$&= M]_/\;W*I-B!0[K-OO0@E[#8PO\!KG09SB MZ+Q,+?J8!MLM)5L:<_"*BC0IN=WD:%.`[AY'G088MEK!U!$OPJLXC($D5CS/ M&/-%![!?XVS%R\U2P)H8?M8RR>>4L]9.EF]`S5"8MNR8)],5:I`V61G6*:0Z ML#AJB=:XHB%&BW#96!^]/5]=Q&F0AC$;EI!,C#.,L\LVJEZ.3K MF$AB!%CU*?UDA6IE5&FC3Y4^E'/7JW,C6>Q^1G;+?+5+AD=3&C;>C+/A=!"X M3_$ZP[LQ!L`0>!_4@\BXLH%6A**HM(("V2&D96("#$J/WF0-95OUN(W40+9. MWV.Z)/4E22/K]^M>^EH$=$Z%PX_$//D"4[&[VVHE1ZWL;X',5"#UFIE*$XQ' M'`77?F4-(BU%2;)IO=YB52-#)7\T5!5`3;^^!E#:*6`:Z3980H-+NYE8OQM1 M&Y6";[IU@9NH5DB#IED'HBW%BN57&/1JK=:-[&FM-#VE`XSI8RW4P%#0'JME M'@$X$EKVJUH-3Z2SZ5$UXA!)9MF7=LD%M",=%$O;BRJEO9)+W7\J1.&22MMS M2@D%M-LLBC-O\JAL:Z"CXI56$O!:;K7DX1)L"-**9>`2XGBR1W:-[W&ZP_P` MUTQ]H+A&2AIPD@/#HUW([[<0TC`84U\<5)9!^<7TQ=PZ M(3G(KN/IRH!AB`+8T,$48K#H46)67P-6/7:;,-4%U4V-*I[!6ECOH9(OH(-J M>'[HUWPE/-H-2=21;T_*K5>00NPZA8X(()\@PR6[JHVO6F\A=QPEM3E6@P/L M2/KH/B1093U(2PP085385*0)0?8G!?%-L49'QKU+T489+0%8?8P,FN(0JI(B MH)CQ@9(L8R'R*E;YD8Z$2U9(H+4YT7H,BQ%#8'T^"`FT">@Z!G)\RC7.,*LS M?@?Y&:-G0L2M2N(TYMDP>7R/]<2S579[$-F8`G7/)K/1!,/) M47`'"4U\VN:`>[[/F!^3<8#6A1W!UJ!C"19A/P1QRO=XS=.S.-N66:SSE?82 M&X..T[[4!GZG=]4IN"'CNX*,*5[S%51MCVL!=M`',QU^''8D-!@#662VBA_X MGFM`U^;,MYA_#>FZ_*Y45)/(.;U02P6SCN!9%R63!QE0&@Y")(\1C%0AH*BPI0^O!](.7X@E$9Q-Y=HFT1:,&.')Z2 M'U"C:$SC>Q'GSU(6\>^*>WAQOJ`X5Y[%8:_N*;:V*I0BS-;J@G%3(P$KH^Y: MF3FP6AO0+=[BG(\KDI)>5*B*`93BSN^UU8`>7&TKD87F[@PXY8?_%ITB^K9T M?M_!X!3[.(Q1>4_&)7ND\-J4Z0C`BL%ET/K48#*`SL]IX%ZP5BB.FMTQ>L_K MD<$"TY,@BT-=AO]H*VYCK;V*V(W%1ID`TTWNAUO%6,2TBN1'-$%+KE7,[L?) M+H>2;OL+CM=W#,WTGI5PC:]VFR6F\]4@T5,46E%K(VVXY/)>Q6LS>90!,#S> M!W6?Q96-25`8D:3QCJ4UG%[P#9BFDN."W0FJ3M,;Y;'B MOX:C#ER\V'GD[Z0B!V.(%WTKF*_+65'E`YKN*9!K/HK^EG_&W[W_=_^0G;?' MO\N'Z_:#_7_PH2H^T(\I>YKP393M[Y)/%O>2U11;R??<[X"UC3-RQ1.LFD0Y)')K*BG07:WH.0^ MCG!T\O@QP\S+U.O'TS"/[PN7I(]>]S'D>"9QSX+V!EHCK8#IA/:&/KQ!-KM# MJX1\Z>8-L!%S4)N`0>ZF%\UNR37F+(D3W!F4WI+GH?_+O,KMQ1,O5UG=JRJ> M_SU@/K(7+-SP.HSZ52@G_,C'XF7B2E0Q0\M^Y7^'_'O=L;<@OLY93_8"&:6= M8=8OAK'`I*C4KHC;2W>'X+J7[#;/P7!0`FIXB6XC`H,&TPT/L?X5%%FR+)AB M<&,69FF3F4U*3MVG50$ZCE"K`89.5C`'SJFEQ+.8XUK-(I7YZ\DYAS/3;H?3 M)N&<7\N!:?XHUCWX`:]BJPX,+R'6>$X"UI?Q\10;3.FZ#96PTRTX6L"=+3=2 M23#\TL(;+.B0="*B#G%&SF3)U<1T<:5GDP'XM6?'.?(->^U(L4,^+E$.AH?@ M*6??!X:/X0XR_A\`[`2#.SI^F2N!KV=L2P$^4X=@E<,2J/PJLH:*V[NTT^!VJIY#265A M#$'D0`_:#5HC,"OR*`M)4&=\*`K%!V_[$W*H#8"3JB)9T+*O^I4P4P%;3D[8 MI*R"WT7P*'*R:!"-'^!TE6$,<60%LAODM#7A$U*#6CG0V1:R@#E)=RQ<:>Y` M'E,;`U7O?%04QLC&GMY7P44Y9@D3N6#[FFNH9#R)R^34FJ^*HV'/RY&8 M==T8[?BEJ64Q]9PU&(%/8+L"]-E\4HV_.Z/R4#=^_]I&ZKVP9Q_7K#,!*HH= M[:K5^O`9;\0N#VH3DJXG.:8;>"[Z-E M";P`L^T592T.D7N&K21:0P"H;%%0"TIKK(!9.-T;NFDK25Q9`$=N5M80XT@< MG<*W:LY7ZLV;BEH;9\+MG]A=E>'PR)]P`M/3J\2&^6[*J%0=QAT'3- MH-(X9)$[__RF:=0<\VD?#^N-^(V(;0JHCXEU%N"O?5F@'UQ(R(#=,>6LN`RF MTO^:B,TOO*EPCV>T4MLGE0U%TG%8H0J=O'K8PVU,A1:/BZ6DA<'484^S*/=8 M+%AQ0P,=7+B M:9,27\4\FQJW<9X-[E2$HJP7<1JDX3/,LVD-`:"R14$M**VQ`B;4V!NZ:9YM M55D`1^YKO"T[HOGJDJ3K6TPWY6:,2S%`6";QNCC`0E%IHRRXO1!R=-&ZUT-: MJT.++<9#'X;,,>/K-DA090GMTH@G3Q9F4,+M`.2PF$/$T1E>JKRP4MH7-R60 M53QLB4+FW!"F-;^:I>*(:$[[BU&K@H]7W,' MVF*H9@RD2F`Z;UNDLDAT6\T0%*MBI7:1E\/UBX,58+#1/DB173GPY,A';A1F MF*JK@/U"5IG%KV)D-JXLRM':MC2+EH^`@]IR&8;_AT^@W`<)[V%&G2T]SH33 M\V?W*%SG<-D1^K"HO0=R&9&CUBJ&(#6?+A-_X,:JIY-RY$6T'Q\LZJ@2X?:LA8\0$&.EG@=ISR)5LR/"CS_GBW[ MUD/+GJ?:$<$XX./:%;,'5BWJ\*RTW7:;8#Z6"1(._B(A7V;IBM"-Z%H-H M+X(X4N8+M$5\7-+;!B>[H9<_!\,B"2BI7]NRYXBQ@9_3*11@$*(\*ZI9Q4FC M>MPPR_'&N,!AK^]TP#BV6)VQH:TR&!*.1:QU9EEXAZ-=D3.15J>$M=;J6#\, M>1PH)JO%V6=1G#./G,V*O2O1R2Z_(OG?L<[YV:N['?^-*U0WEK33!U0\Z6$/.5?!(31\>J@*4CXC0JE(#KA'ZMYV"()`$U.*!& M,>TK.NHMK=8W^.,L2`+Z#&YN"0;P7WZ=TW60EJ=YGS*ZDB2. M.F'H-(IPWVN-TG3!ESV*PFDT0LT[N\9C'7BHEC+J:*-*'89+4I:27_N:\:1, MG/&00?RTR^(49]D9SD(:;T5=I%%YH(2XWBF)0_;YW.*'_"11+Z"]\#N='B?K MHOHZ!].^Y`N]?W@N2]G_9'\*TF`MXN-O,G3#;(N_11A1+FN7NY0Z@&!\Q=79 M!`M,Q0GSA@&=6MSEMV,"W::]2A8,8PT`^V2KQ!&31T(!?:I4_@&34R:OKI'W MR2JM-U4*@^65R8OQE3!^.T%#K!<*9B^"F(JI_K-Z7K2>@3A_R-FX3A[*VNDY M"V3'%*,.8VV4O#-H+-(^D[@J$KJHI0S#-\F*9?)/!AV7/LH*?MM/:16\,VT, M2NF\^7E[&;#9KXB:G>-HVKE9F6\8$Y%9BZ0_X8"_\5DN45'XO/JLVZ:`LH]. M*N;,HVE`U@Y,(N.=109@ZNM0&E$8SDE2!I-OTJMXN4]'`UYZLXY$'M[!5T:L M+W:ZM<*C7)&<^4A2+N0$23WN5*W)66LY\S?V1:C=CUD%AC>RQCF\>(K(E%)^"T^Q:6.".(/1[U_(ZS7X1"9_?9_A-4[X?A1QZ87L>[33<^;Y MQA2C]GTV2M[I-1;IX$21)E=JSB=,6U=6EMI(J,-PA38%;2[NK'?X&QSDDZTZ MO:'[>:J@MQP#Q\LU)D*E\WV\E,?%RUP_:.U+N/.B4FB-O^P\ M]LX*-:;AJ4K+'-S8M-HVS,&9')A"UJ5;TL)M.QNIH'>RV*#KTX;+3KBP",%> M:B;KEX"'>_(HJWGFS`?TX=1??_7`>U/*T/2;KGH,XU-O;J?.>*IH-3=K#%N, M:D[C$LM"=`(/@PZT:2E+O"_%-H6'X#NLX^+80+[;1VPJ7>.49U(TG9K-@M^> MAISYGB<5M'94>UF!X=6>`GUX7V5M"S%CJ&.M%0VA"T+RE'5P,'RE5168/.=8 M(TZSR_,Q]"E^?GY[/?IZ>7)[?H(OK M^4_H^OQR>GM^AA;3Z]L9^['B[S$,_K;2CN>K*_REE7A,2GLX_7MW.KCZ@Q?7\BOU] M>O[3^=5M0_^`I"RL;F, MSU:^C?-$U\SE<]?MW('5;VCQ$%1+MQ$IFUH(^6SKF]TR-S1W(^*ZQ?O@^HU> M/0?5[CU0RJ:OY+RV_F-*MEG<7QV2BSAO_1ZX0>N7SV&U?A>4NO5+.:]^GIG5 M.3#QV+F7;X$:.'GV#%1KMP"I73R3\='*4_;VB".X2(*UI`R]YZ[:60JK:NC. M0Q`M+4,TN-^^DD%-#@B>C0`Z6,AIJ;;.4X'`NRH(UX=%4BG7XQY-4"01`<$9-2[E8,AS1%3A M.*58T/6,D553L*Z8:T;(0/8IT98!Q0D),"4I*EG$A7W2HNXT#;SHR;DFAA1F MGQD=(5#4D"%3AE(NF:( M`FJ?(STQ4"R18U/RI!!'7!X)!?],*:AKQY6.K!^V2.#*^=(2!,B8(3H39TH7 MXYTU/V.:Z<>YM81KAO2@]7E1/@;%ABXF)0=*,:]C6K)]I/'ZKIU>IAN@2<6= MCW$UH`=C78DL**YH`*K'OI6.[Q0_OM4EB%,<7<0);F'A_U2D_9E57-')%GQ% M*9,\"%I9@AQN#2G5$!=LT^J@^,57>J&N//H)6FM-"'S33.1:JH%GGWG"UTA" MSQ/!NM(ITJ+,*A#8)TN?,LF#YYLFS^8'&!F+9 MJ+KEF'UANG0SZP%BGC58!0FY/JH-H-H"*DQX9Z2X5K;[E2@&_09YM]PSP.X2 M3B$,B&5ZA`IJ%3<"]SRHL(*$ M&40H:@QY'DNV4/+L>/PR,(J^6QI!R:WQX&WX3FWR&_4 M*6S"I;U`Q-$IJZDEX9:D`VA=[M6/`5&JCTG!E((&7,Y?P_\/V>!3?@@8?9S= MS$])I/9G,E&W5%"#[7)B*`>('$IP"I9P>50J(*:!N(J7_;,!Y1L>&H8K>C^% MG+,=LSJ8]599F1`(DNB0#3;'"EG4<2=^^Y'F1,&;/$BC@/8/C=2+NG4G:K!= M=S*4`\$4`SB%.VGD4:7@Y-,#[R_WR:4!T<@` M4;D$6&JA2LUK#U4%]"&A#%>S_;OL/0VC-:V6ZX&911'Z8S"-"B"BV>!4CJQ: MJ@?%[OPZ,O(];=""Q@=]\U7G)[OJD"IZ9)ZF(!KR2;2@\D\-U8Z"8GA/5MV? MO9R9M=U2\A!O&)ZB3/Q,?5R>YSQ?+2C9D@Q'_`;Z6W)[AQ>[91*'DDK:UY"S M<[>>5-#Z9*Z]K(!@\9.@#T[W:HS57&[;X_^N+")NDL]E%1;]^=IBP76^.AU`I>$I9%.-K:,*O>P*X6=9:< M;`!;IR0KY$"PQ0!ND'Y"JD.:@9Q;^BA@=FG3$P)$%SDR!4UJ M851(>TQP+SK+>K:-SWQ(#]#0BSM.=]>"[F6]2V4!$4<+4)4#7X8XS21IH>6/ M1X+'IZS;7!.JWB;1DW++&BG$+EDZ(H`X(L.EH(80196L/T(40_F+A`3]C7<* M&;=DD,#K4J$E`(@(0U0*&A2"2$AZ[%W(9L.GXDGX^>8N8-4QW^497QID+DOM M$+5*CGL:BP+T^AN-!B`B6<#L,^N36?,?.JJ]0$-5MP].LPSG6=DKMMM%*O#K M&^\-H<ZK:X;7=LS1,=KR+6/`!"TFG>4[C MY2X/EGPQZ8J9)&G.S#-CZUG*\Y8SZ7?P/)8!->@S%ZC/A;;Y;\I+T`]0_0I4 MO@.U7\)7XKJO0=5[_'^JTS0:5IGA^Y7J`.*`-53-EXY8!%:V+YB/7G:0B5D: M4,-8@+3YX`9?5YE=^ZFRYBOVN,;W.-W)^[_J&:#F&$`:7K%2"'BJSE.2Y?-5 M"4)6IQT!0!4KQS4\URD3:1NEG*=*_D!)EBTH6<52O])Z#*B"9:CZU2MD4"'D MJ6[G6\P3S=+U^<,6IYG<,0R$`-6S&EN_MFM)5(GZKG.>Z;?!EXP$VEIOQ"#6 MNP2=NN8+8?0M%__.4_57D6W)`EG5]T0`5;L*6;_**[F*Z[ZHSD\08",+TOM* MI7Q7R`*J?2/$`?/%"0IM#<\-R\8KXJTJ>*FS`:D7>0>_9D'U5^&VI1#RJ.1LKT%JTZJ07P:,(_&@0 MC8QGVIJ@VU,+>&Q,4QHY0,(,I.:D.QP9EHUM]*`WI0JN?4-R"\C_.O2P="=Q M.>@Z?PAQEO$]CGSJ^SR@*?O9LD4-1D`WKRUVR[8NS?$_"X/%/L]BH:`R"J;U M>]W.Z$]9K0^ZS2U@[]OE^O_&KW!^&F1W"TKNXPA')X\?,QRQ,E=3;%-^+;:R MC>VU`;7P'J#[[D*Y\AV5J@";F`3 M8IN6%0OT=*Y->1 M)@`U\+[(A\?Q%7;X)'YIJ>R+*UL'2%@[J//`A$%8?7)!QGW[9(DVH);>`_3( M/KDVY;]/OL;;DI#SU25)U[>8;DZ#;9P'R:7P8\LD7HL3BQ2I9=;J@%IX']3# M!+7*!O?3W,HD9V90:0<)0ZAE"4`#WV`6[./H#"^ESEDA"K3A9`CUC51J(*X" MRYU>Q&F0AAW?PJ]>C-,=^ZV,X!5?X-,L`FK;9RK(2%=#!P'R2Q5F8D(RYJEO\D)\D)/PL'R.IY0&UHQ7,X6BH5$*-%OK$]9!0 M])5E?\9(<\^\P;W8WG$1Q%3&UL550)``.J0K!.JD*P3G5X"P`!!"4.```$ M.0$``.U=;7/;.)+^?E7W'W39NKJ[JE-LV`+R(E@@!IR@UZG0^Q+:'![GZZ\=)L-'[]R],BZ#U@Q@D- M/[\;O#]\U\.A1WT2SC^_^WK3']Z,QN-W/1ZAT$HW;= MW=`5\W#6UY=OXYO>R;\?G1T?BO^.#@>#]T\SP?<9BL2W\N^#P>'!\>!VP*(D']ZXN3SNYQLC\?O M*9L?'!T>#@[^]N7RQKO'"]0GH03$P^]2*ME+&=W@Y.3D0'V;-MUI^73'@O09 MQP?N&+ODGHH4O9D?$Q/VT+^U4^;]>5'_<%1_U@@P_UW MJ?*5!AD-\#6>]>1/82'94Q?$8_2!2%,3AK$XD-\?2$SP`H?19'9!0L$Y0<&4 M'!_*Y_]I1$-.`^*+OOQ3%$@% MW-QC'/&4,%HOA:=PLE@&0C4'S?G5/6F*F!#B'D?$0T%3=DL[:8WUG*K'8DA9 MX#IL9L1\,ILLY4`B^FY?O3D>)T(1;$072X;O<UX6N+BG?*_,CQ.\O M`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`()P1C\6OW`1%KJ%+($3I\(D;]%]MV M"X(B[PD*1]`H)$Q]#?D2>VK".*,+1$(=$OKV+J%19E,%4/1B.`+,D',Q_QHF MNNU&)@@2V0[WJON=P32O^'*QDL`3N&]"Q;Z1T!*][Z\TWPX@I'!IPJ22PA^@`)D87,;J"3"RG)\*>, M?LI@GARL^81-&9TSI-VOV!);(O81$+%Z>G`#N^R5A#`N#4+%)I8X_`2(0YE, M;FC[&HLU#/$B[&_>8QGFFVH22S1^!O4*L\QNH*->QA?6G!I,RAI:(O$+(!)Z M^=S0OXWJFVG]Q)5-3(G"!NO:VD$!&$(SBNH'*J5@QRHSX<2@6DIBK/'QN M>%]@H+%%!S+28"6V&PB-T)+(E0I&'$_N`C*/C]I40V0BLGY1"OJFU$9P-T!2 M+P6Q+]/>JX$I:V@+!F2L0"^@&P!83RO/F$^.(+?^5A-))W=`&C\WA@LLZ&R! MA0P=6(OOAJ,E`T'ZUC9_T*=\J"NVM$4$,L!0(:(;&)PE7GXM)!F)GR0R.DLU MB2TJD+$!&Z'=@"$.PZ3]U53RI1*HXB1NU4DXU:W M5(X$,@^,JNWY.!0C!.:F<&K;#[&U`,@`QGX4ZX;13--12`E9E19>VM(ZIQ@T M/T(KHAL8R!&&AD8`=IO9:A\RF*$3S@W5#WU?';U$P101?QPF&\0M%BM5'$!7I$A6D=$?)!CZ_UC%Z3=7.)K,;M&3_IU(^T^R M-0G00QC[4[$;-G2-(R04X*<5BKZ&:+ED=,F(E%EC#B8B6V0A@RUV@KL!4CN+ MKKVN8NU!AXSEM*O(KF]@35DO#5-_[$W!D=A0I?"M@OSKP8X^!),_]EG6I5Z- MQZRJRY%U59?>?Q:Z^J^W(B\=/TZ^7Z>L6>NE`^?+AT%`'Z4_B,7?&5W=1;-5 ML'LRU)!T5*\/T,(`U9#0QD*YA&GM?-@6,F#WO/6M762I1A)LO9GQ`;,[RC'\ M`J@8#1/3V(0I=?DJ.K-=K+4R!J@G!BXU8$11&QTTZ<,-3RWRK!CDPU5T3QGY M0[N!-1$!UQYHCIE.?G>Q&G.^JH532@!<;>"Y&!7E=@.?7*2SYF!H10E'< M%IL""7#!@VM)S/EL3<*CS+P--!^K36DGMQH!W@U729GS=>"`8'OH+$A(9ZHG( M`ZY&RI:X`\5MZ^G!#>Q^$_M9F5<_"<\(7R;9*I-992E!`TT7JM=:B5U_X#R) M!\X0SV4H''[H3*+OX3RQ/1VB)>VZ4-Y6*U[7I[Q,L,W!%Q-R^99=*'1;(6+7 MT=O46HYE,QP+T3?O0EU,",BMAE)N$G"EFIX@3KRK;M'8O72C< MVU`U;@RIWS&9WXO18/@@F)WCJ]7B#K/);">I3/&O0;5F'UTH]]M(+VL$PFL^]>W&W95(F+*?HL5S%I_2@<2<_>DV:Y7 MN\IM#T>(WU\$])&/0Y\PG!MRLW#%QQKA"M%;3W7G1I@BD\X^)E%"XL*.J[L! M""T&;]$&E[:Z;]$&<`C>H@UOT89:T08YM$[E]"YF_]/U5RZOBL]RLX9>1![B M57'UY->DHT[$+1JJQXU-P1[?U[]%D\H+^Z=[1WY+K[%8_GLDP`6&;VD['K>? M1W5@1[]/';MA16=8J-TC2ND:](M-0'?1>\6#ZD1V":_A0F[__T#Q&0*QT4?A MG(B%6N4A"A,1Z$'8E\+43G-NH`QW4F8_>:4&FJ[EC^\GQ17`C>LFH';`E%W^OOC$3XC#[J M1H*RAJ`GC%_*)O0:(VHQ[E:R6U'56$5 M.U+8P]MMVX!>.=V_'4@CK5R5-K>&76K8<]Y[,0B=BEZC3:0+HBE:JP0[AOSZ MZ\4B,>RQ\GVM&,L4]$H-@JV$&)O[1>N8PPXI[%'U/1B#1CFOT11.29)D>_[D M8MI%8JNTU6LS6]-ED$*GJ`O;,_)[7&J]R4+%/ M]GIV#ER-/!L'S:.^HKI>2T4C<5SZK(4TR3'&O+U8I"^&GW%"VUK8GL)V*Y'Q,QJ*K[MK$[#(I/ MQ%HH6D\#%$;")>3MD*IZN_744=&#K8WL)XBYKYG#J#(W)HXI6B<9&4-/<,BP MVAC5QKMN+[:8[R=,V1+FS537_?'!7GW/WC386\I^8ICM6$I]A;W2_>4%"5'H MM;"_K.S(UF0@*W8V5Y`;\\8U7B;#WV1V2ZK-[TLZ?S\DYM[>!%HXPU M[:`=Q79]A9@$U^0/N45Z$)MFF>A1IQ!T,E<#I;Q.0Q@*'V%L+4S_ M&PKTEX[:T=I"#WH';QTU-,9\J4Q)<,2B?P+D?S^RQQ[T`F!;85I!_SQT8*UX MLUHN`Z49%*2UT,;AC+)%C(RA,ITMM2WZD)>UU%2%&ZO#M/CC%!'=3>C%)K9( M["DH4U/');>1Y25U`X/DC.,FC!CZV2)269LIMF9/;UV[`S*D5E<=;J"8A(#4 M256?1"NAV7&[O2Q/]!- M9(4FM@CM:7?['(3*9'7C,J()FZ,PJ+@B%V>+> MH%%)8*EQ976')\>'RN;D)[_K14V0&_HYU6T7#+`DAJQ^H&-1WH'%Y3OW#9RG M*RXF"\[/,/<862:`)P=*5('K@'@$\UMA4:>!/CBYYV>"5B>L9R^%&@LO@80; MXT=Z=&"*6?'RO&Q(^'E[2+C"D;J5K"NAM(%(DP%+S;N43*E_K+M/ZI@?BX2\M^] M39Y=;Y."VQN*[XG,SNV+G5Q?YEVI:5<^M:<>V_N"D>@SKL2?N.!QFS-NF8`I MEN=;*MPR33M20%\K8]#D;P8:4)^K@U7>_ZSTX(8/9N6K=IWL9-O)LK:I8WQH MTS&RWC?/U(:)2EJZ4"1MPX_)ZJM)0(V^`H?2NF<50K=\(`[BAA\:>-]:?P?=QQF<+CM,!EU+T^>>L_'-KU']LAO:_@*^2%UE>/&G),OEWJ-`YF*),]MGFT2L,IE4)CB':DD!77+1C>+1MB?*!-6^S%!5?I?-/R M<+L1H$^E2;N2)9.G:-K"VG^IOO.67BFA&_;[']4-,PFFI!P\[FZ^ZMF[9%<^/EWZ:F.)4X7"!/EH!: MJY7%1O\;A_U8[K#RPM^XJU[65R_M+'O/?_BZEQTM9LSA?7 MDR_B@\OA[?E9;SJ\OAV+#U-':S6CYK4Z6@Z%]:U8/7/!D#Q=9.]JM7KHGK,U M4)`;[G:%'W.I-8R&XE\/1:/+UZG9\]5MO>CVY$K^/ MSK^<7]UN/*U9,LL_F:?ELIXFLPIPXB36H4^7D7:)W;"O[GG?LY3FAA^>44_E MP.1.&>PZGLI\21KF?\T3M1EPW>7)X%R5%,_V*HZ]]W/Z<.!C$CN4^&7;C\1' M&=]7:*$-$Q>:0%J\A9(+IEXB6YL1K+HZOI7&:5!RT@8VF-U,S07Q(/5\L[J+ M+%2]:09ZD75#;6\+":KP=4B7G&C?Z.XT`[V#NJG"MX0$'4E$MZ:!1#4!O1BZ MZ3B2$PY"R4/!A"\9N0C07*/EK3:@=S/75'.I>*!ZSBU)3>HN-`6]/+FIUDN$ MA5#^E.'SV0S+>B@XX^UJM;C#3(-!)07HK<8UH;`0'001RJ.ZD%22@-XJ7!<3 M"^$A0+G&QUO0^6720NI_6P$M5#_5EO8&W`;ZK]47D@`IIL:4!80 M[+2&O8BV(0@:F>%A.`]]:Q"RMK#WP#X+@BUY(0&X(-Q#P=\Q8A?B$U-<:*>OHL*$KDA@3C&V;,-I0\5LR@JY$ MZ7+-R/R^["VA;D5:2@)[B6?3E6F%]!"HR#1&1$+L7Y``YWB2?U:\>C23P5Z= M61,=6RVXAI!Y0VU-#7N798MX.;+QKF*QXBV1F0SV)LD6@8)^G53I]%4!1!M" MV*LAVQS^3-%#B/)4842B=666T4DQRRBFV%>.T0X_IC)3^O8O9OTQ#VGDN#+/ MJ+PI9+Z14>&%6E(5DD*,.S$_(R$BDX6C?/ST5[RN5/U.6]@Z7O65KQ$63ONW MZ&GL"Z;(C'A*ALH!WT`#FJ74``V#\'"HG*$(?0W)@]BLHB!FBH3SF[6L$6(! MD`TY:()3`ZSL50('F[H#LFA1%2M<`PUH8E0#@`S".X5*U>42)B+03*IV<-%= M)_+"P.07V.(7S"[Q'`43%J]0,,.^<2UFVP5H(E8#T.JIQ@D(Y9N=6SJZE\71 M6H#3NCO0Q*[G05M397`P*[8DAY7HY5J!9G8U`&5'0#A=_R]=X)$\\,36XYO) MB/K5+E/6'#1EJX'V]2*#I#DJ$7-V43%L:=K")FK50J!26C@OV!SZNXE0Z".F M.Q:I;PZ;L-7`#?0RP^%PC9>4299&\L*5T+,:D_1$L$E#5:45EHPA&@Y))O,BM\9(]5*3%L/MASX:K0!\B)G^62 MT2B2T]GJ[N`N)I$&S:&6QR62U$GZD[#H*_AO0QO,&(TQ#[ZCZ]ZO<\6AK8G+,& MHY-!>CA8OM%`+"416\L4$%8]3>RTA4TE:P"#1EK`Y(!XT,QV87)UKTT2KR:! M31=K`$:U['"8*-L8B4%SGKMKJ!2*K9:PJ6`-$"B5%$[Q\>+Y(J"H.I^JT,Y6 MZ<[LYDND!!Q_Q'9&QA2H]T-=\L`GJXC+X)SPQ^I1J)+0%A1G]NPV>JB5$IE\ M(_^[0QR+3_X?4$L#!!0````(`(5X83\UEQ_'2`<``$PQ```1`!P`;79IV^?"L8B7:(2J1+4DZR7[\C)4KR MF^)D+1K,[8=4(N\>WMUSI(XF3]_>12%:$B$I9V<5KUJK(,)\'E`V/ZN\GSCM M2:??KZ"W;W[]!<&_T]\Q M;N&?SL<#>$WP6ZA1]3!RG#W`/A`6]6X&=G>Q@E[][GHUM^%-O6;KJ-GR M3O8<16$5RVR4VETM_9>HGTK_AD080>**-TJ>I*(4BL:2V>.\2*3G6%Y;633#E?SX=0\I^$55`0/B=RJ8WJV M*#'.6!QM=S=0PE7W"^*"D`-21%`_TWM8:54!;-#-VZTS/5NLBY8T5XBH+S@T MP*2!%(]2\:;3T-,S)!%AZH*+J$MF.`Z!D*\Q#NF,DJ""%!9SHG0^R@7VR3Z0 M-K,Q8QPR&"32%MVV6%#(<&AX<:K3IZ6C.P4?D'Z`^;ES`-WOZAEAS!W-+BB# M7*(XO.*2ZD$Z(98RM9H&9Y4.9Y*'-`"-X!R'.O$F-X0HJ0U\`;:8\0,RH\SH MOX&)Y2$'96/`H5(Q$G/,Z#_&M#Q0\-)FP57!U<+'/@]APM4E9GB>-&1=1IN"^`(*-SVC M"LC.D"OBE1`(I3GJ4NF'7,:"P$L^PA^R0"UF`>VRC8:->PL;+=38`P*Q>"+XTRR-7R7L/'20D?W@8?!214A+*4G!PJ)5URG1;(`\[FSI2(2`I1`I9250EF_7!-A6PB.O: M3]VG)2N;7V"?AM"0;,MJ15X>%M[-SO%V=O0>/,%$&2BRJ-F.K7:H)(V)3Z`P MAZI;7@@>I9_=*RR4G1&>ES"TE^1N>C;VV.->I]?_T#X?]";H8CRZA(9!>]KK MHJOV>-J'1LO-P6ZGA^2V[?L\-HO*E>`,'OU"S>G5[0;[0;G=O&SNMGL?4;O3 M&;T?3OO#=^AJ/!K"A>%5D1#EYSC&VK6HY$.;"&P\#=0-NX9 M``A?$//5<*WQ%@!HTNK%WX&1'@>*-_=;N!SBZ\>Z#"HD_(Z^#C3^-W42LN^Q M3JXE['=RM9./\DT=AJGS6(=79]MW\K>;#5)T-[T4X>:W(M+W]9L3I^`X%PJQ MC7L89;=LDOM!`^X;J!(5_>98/4*=_(?C7F:(0]9D5ZP,H6+7JP^[S[VO)9*8%^U M@T!?8M)VGU7VE<;IZUE%B1CF':-AJ'=H]MU0[P>.%%:0@4N;FMC,H:W/O3A%6<'(_V6?G8G9< MDIMM/=K:]>P<,+^_3OF6XW4;?>O//I+/SKT\]LG%FFTG"M;!_62?GXOD6FUF MWWKKLS/;_DAM#2Z\_VC32GX6SD.Z:R%[JO*/=GK++Q;K*T"IR+-+L(V?"-;= M*1'X@`Q0````(`(5X83\C0Y#F83D``*J]`0`1`!@` M``````$```"D@0````!M=FES+3(P,3$P.3,P+GAM;%54!0`#JD*P3G5X"P`! M!"4.```$.0$``%!+`0(>`Q0````(`(5X83^5A:`15`X``+FE```5`!@````` M``$```"D@:PY``!M=FES+3(P,3$P.3,P7V-A;"YX;6Q55`4``ZI"L$YU>`L` M`00E#@``!#D!``!02P$"'@,4````"`"%>&$_-@PR&UL550%``.J0K!.=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`A7AA/_QOV2D$)0``PP`"`!4`&``` M`````0```*2!+5H``&UV:7,M,C`Q,3`Y,S!?;&%B+GAM;%54!0`#JD*P3G5X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`(5X83_=3%"G^Q@``#IP`0`5`!@` M``````$```"D@8!_``!M=FES+3(P,3$P.3,P7W!R92YX;6Q55`4``ZI"L$YU M>`L``00E#@``!#D!``!02P$"'@,4````"`"%>&$_-9`L` A`00E#@``!#D!``!02P4&``````8`!@`:`@``7:`````` ` end XML 20 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
Cash Equivalents, Investment Securities Avaliable-for-Sale and Fair Value Measurments - Note 3
9 Months Ended
Sep. 30, 2011
Fair Value Disclosures 
Cash Equivalents, Investment Securities Available-for-Sale and Fair Value Measurements

3. CASH EQUIVALENTS, INVESTMENT SECURITIES AVAILABLE-FOR-SALE AND FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between informed market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-level fair value inputs hierarchy, and requires an entity to maximize the use of observable valuation inputs and minimize the use of unobservable inputs. When estimating fair values, we use market data, assumptions and risks we believe market participants would use in measuring the fair value of the asset or liability, including the risks inherent in the inputs and the valuation techniques. The authoritative guidance establishes a three-level fair value inputs hierarchy, and requires us to use observable valuation inputs where possible.

Our cash equivalents and investment securities available-for-sale are comprised of money market savings accounts and equity securities. The corporate equity securities are valued using inputs and common methods with sufficient levels of transparency and observability to be classified at Level 2.

The valuation inputs hierarchy classification for our assets measured at fair value on a recurring basis are summarized below as of September 30, 2011. This table does not include cash held in our money market savings accounts. As of September 30, 2011, we did not have any liabilities measured at fair value on a recurring basis.

As of September 30, 2011:     Level 1     Level 2     Level 3     Total
Assets                        
     Corporate equity securities         8,000          8,000 
    $   $ 8,000    $   $ 8,000 

 

As December 31, 2010:     Level 1     Level 2     Level 3     Total
Assets                        
     Corporate equity securities         13,000          13,000 
    $   $ 13,000    $   $ 13,000 

 

XML 21 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
Commitments and Contingencies - Note 9
9 Months Ended
Sep. 30, 2011
Commitments and Contingencies

9. COMMITMENTS AND CONTINGENCIES

Litigation

We are subject to various claims and pending or threatened lawsuits in the normal course of business. We are not currently party to any legal proceedings that management believes are reasonably possible to have a material adverse effect on our consolidated financial position, results of operations or cash flows.

XML 22 R19.htm IDEA: XBRL DOCUMENT v2.3.0.15
Entity Information (USD $)
In Thousands, except Share data
9 Months Ended
Sep. 30, 2011
Oct. 26, 2011
Jun. 30, 2010
Entity Information   
Entity Registrant NameMicrovision Inc  
Entity Central Index Key0000065770  
Entity Tax Identification Number911600822  
Current Fiscal Year End Date--12-31  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Filer CategoryAccelerated Filer  
Entity Public Float  $ 262,700,000
[EntityCommonStockSharesOutstanding] 117,833,000 
XML 23 R15.htm IDEA: XBRL DOCUMENT v2.3.0.15
Committed Equity Financing Facility - Note 10
9 Months Ended
Sep. 30, 2011
Notes to Financial Statements 
Committed Equity Financing Facility - Note 10

10. COMMITTED EQUITY FINANCING FACILITY

In August 2010, we entered into a committed equity financing facility (CEFF) with Azimuth, under which we could sell to Azimuth up to the lesser of $60.0 million or 17,771,901 of our shares of common stock over a 24-month term, which began on September 9, 2010. During 2011, we completed two draws from this facility and raised a total of $5.6 million in gross proceeds from the sale of approximately 4.5 million shares of our common stock. In July 2011, we cancelled this facility.

In May 2011, we entered into a CEFF with Azimuth, under which we may sell to Azimuth up to the lesser of $40.0 million or 21,018,431 of our shares of common stock over a 24-month term, which began on July 8, 2011. We paid Azimuth 225,000 shares of our common stock in consideration for entering into the CEFF with us. In August 2011, we raised $1.5 million in gross proceeds from the sale of approximately 1.6 million shares of our common stock under this facility.

From time to time over the agreement term, and at our sole discretion, we may present Azimuth with draw-down notices requiring Azimuth to purchase shares of our common stock over 10 consecutive trading days (the "Draw-Down Period") at a pre-determined purchase price. The per share purchase price is the daily volume-weighted average price (VWAP) of our common stock on each trading day of the Draw-Down Period, less a discount ranging from 3.50% to 10.0%. The discount is determined by a minimum threshold price that we specify which cannot be less than $0.75. If the daily VWAP of our common stock falls below the threshold price on any trading day during a Draw-Down Period, Azimuth will not purchase the pro rata portion of shares for that day. We will determine, in our sole discretion, the timing, the dollar amount and the price per share of each draw under this facility, subject to certain conditions.

We can require Azimuth to purchase the greater of the daily allocation amount specified in the draw-down notice or a percentage of the daily trading volume of our common stock for each trading day during the Draw-Down Period, subject to certain limitations. The total dollar amount of each draw is subject to certain agreed-upon limitations based on the market price of our common stock at the time of the draw. We are allowed to present Azimuth with up to 24 draw-down notices during the agreement term. Only one draw-down notice is allowed per Draw-Down Period with a minimum of five trading days required between each Draw-Down Period.

In September 2011, we entered into another CEFF with Azimuth, under which we may sell to Azimuth up to the lesser of $35.0 million or 22,030,737 of our shares of common stock over a 24-month term, which began on September 13, 2011. This facility provides additional flexibility in the types and timing of draw downs, compared to the May 2011 CEFF. In September 2011, we raised $5.0 million in gross proceeds from the sale of approximately 7.6 million shares of our common stock under this CEFF.

As in our May 2011 CEFF, from time to time over the term of our September 2011 CEFF, we may present Azimuth with draw-down notices requiring Azimuth to purchase shares of our common stock over the Draw-Down Period at a pre-determined purchase price. Once presented with a draw-down notice, Azimuth must purchase a pro rata portion of the shares on each trading day during the Draw-Down Period on which the daily VWAP for our common stock exceeds the threshold price specified in the draw-down notice. We can require Azimuth to purchase the greater of the daily allocation amount specified in the draw-down notice or a percentage of the daily trading volume of our common stock for each trading day during the Draw-Down Period, subject to certain limitations.

The per share purchase price for these shares is the daily VWAP of our common stock on each day of the Draw-Down Period, less a discount ranging from 3.5% to 6.5%. The discount is determined by the threshold price that we specify in the draw-down notice. If the daily VWAP of our common stock falls below the threshold price on any trading day during a Draw-Down Period, Azimuth will not be required to purchase the pro rata portion of shares for that day. However, Azimuth may elect to buy the pro-rata portion of shares allocated to that day at the threshold price less the discount described above.

The agreement also provides that from time to time, and at our sole discretion, we may grant Azimuth the option to purchase additional shares of our common stock during each Draw-Down Period up to an aggregate amount we specify. If Azimuth exercises this option, we would sell to Azimuth the shares of our common stock at the greater of the daily VWAP of our common stock on the day Azimuth exercises its option or the threshold price for the option we determined, less the same discount applied to the fixed amount in the draw-down notices. We are allowed to present Azimuth with up to 24 draw-down notices during the 24-month term, with only one draw-down notice allowed per Draw-Down Period and a minimum of five trading days required between each Draw-Down Period, unless we and Azimuth otherwise agree.

Reedland Capital Partners is acting as placement agent and receives a fee for its services equal to 1% of the aggregate dollar amount of common stock purchased by Azimuth upon settlement of any draws under these facilities.

XML 24 R13.htm IDEA: XBRL DOCUMENT v2.3.0.15
Warrants - Note 8
9 Months Ended
Sep. 30, 2011
Notes to Financial Statements 
Warrants

8. WARRANTS

Prior to 2011, we had common stock warrants outstanding that were issued in connection with certain notes. The warrants met the definition of derivative instruments that must be accounted for as liabilities because we could not engage in certain corporate transactions affecting the common stock unless we made a cash payment to the holders of the warrants. During 2010 these warrants expired unexercised. We recorded changes in the fair values of the warrants in the statement of operations each period. We valued the warrants at September 30, 2010 using the Black-Scholes option pricing model with the following assumptions: expected volatility of 80%; expected dividend yield of 0%; risk free interest rate of 0.15%; and contractual lives of 0.2 years. The change in value of the warrants of $338,000 and $829,000 for the three and nine months ended September 30, 2010, respectively, was recorded as a non-operating gain and is included in "Gain on derivative instruments, net" in the consolidated statement of operations.

XML 25 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
Management's Statement and Principles of Consolidation - Note 1
9 Months Ended
Sep. 30, 2011
Organization Consolidation Abstract 
Management's Statement and Principles of Consolidation

1. MANAGEMENT'S STATEMENT AND PRINCIPLES OF CONSOLIDATION 

Management's Statement

The Consolidated Balance Sheet as of September 30, 2011, the Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2011 and 2010, and Consolidated Statements of Cash Flows for the nine months ended September 30, 2011 and 2010 have been prepared by MicroVision, Inc. ("we" or "us") and have not been audited. In the opinion of management, all adjustments necessary to state fairly the financial position at September 30, 2011 and the results of operations, comprehensive loss and cash flows for all periods presented have been made and consist of normal recurring adjustments. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the rules of the Securities and Exchange Commission (the "SEC"). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. You should read these condensed consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010. The results of operations for the three and nine months ended September 30, 2011 are not necessarily indicative of the operating results that may be attained for the entire fiscal year.

We have incurred significant losses since inception. We have funded operations to date primarily through the sale of common stock, convertible preferred stock, warrants, the issuance of convertible debt and, to a lesser extent, from development contract revenues and product sales. At September 30, 2011, MicroVision had $9.4 million in cash, cash equivalents and investment securities available-for-sale.

Based on our current operating plan, we anticipate that we have sufficient cash and cash equivalents to fund our operations through January 2012. We will require additional cash to fund our operating plan past that time. We are introducing new products into an emerging market which creates significant uncertainty about our ability to accurately project revenue, costs and cash flows. If the level of sales anticipated by our financial plan is not achieved or our working capital requirements are higher than planned, we will need to raise additional cash sooner or take actions to reduce operating expenses. We plan to obtain additional cash through the issuance of equity or debt securities. There can be no assurance that additional cash will be available or that, if available, it will be available on terms acceptable to us on a timely basis. If adequate funds are not available on a timely basis, we intend to consider limiting our operations substantially to extend our funds as we pursue other financing opportunities and business relationships. This limitation of operations could include reducing our planned investment in working capital to fund revenue growth and delaying development projects resulting in reductions in staff, operating costs, capital expenditures and investment in research and development.

We have received a report from our independent public accounting firm regarding the consolidated financial statements for the year ended December 31, 2010 that includes an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. Our consolidated financial statements have been prepared on a going concern basis.

In August 2010, we entered into a committed equity financing facility with Azimuth Opportunity, Ltd. ("Azimuth"). During 2011 we completed two draws from this facility and raised a total of $5.6 million before placement agent and other issuance costs from the sale of approximately 4.5 million shares of our common stock. In July 2011, we cancelled this facility.

In May 2011, we entered into a committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $40.0 million or 21,018,431 of our shares of common stock over a 24-month term, which began on July 8, 2011. In August 2011, we raised $1.5 million before placement agent and other issuance costs from the sale of approximately 1.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $ 38.5 million or 19.2 million shares of common stock remaining available under the facility.

In September 2011, we entered into a another committed equity financing facility with Azimuth, under which we may sell to Azimuth up to the lesser of $35.0 million or 22,030,737 of our shares of common stock over a 24-month term, which began on September 13, 2011. In September 2011, we raised $5.0 million before placement agent and other issuance costs from the sale of approximately 7.6 million shares of our common stock. As of September 30, 2011, we have the lesser of approximately $30 million or 14.4 million shares of common stock remaining available under this facility.

We may use these facilities as part of our plan to raise additional cash, though we may not be able to sell shares under either facility in the amounts desired or at all. We are not obligated to use these facilities and remain free to enter into and consummate other equity and debt financing transactions. See Note 10 for more information.

Principles of Consolidation

Our consolidated financial statements include the accounts of MicroVision, Inc. and MicroVision Innovations Singapore Pte. Ltd. ("MicroVision Singapore"), a wholly owned foreign subsidiary. MicroVision Singapore was incorporated in April 2011 and is engaged in advanced research and development activities and operational support functions for MicroVision, Inc. There were no material intercompany accounts and transactions during the nine months ended September 30, 2011.

XML 26 R9.htm IDEA: XBRL DOCUMENT v2.3.0.15
Inventory - Note 4
9 Months Ended
Sep. 30, 2011
Inventory Disclosure 
Inventory

4. INVENTORY

Inventory consists of the following:

      September 30,     December 31,
      2011     2010
Raw materials   $ 3,151,000    $ 3,924,000 
Finished goods                                                       1,292,000      2,151,000 
    $ 4,443,000    $ 6,075,000 

The inventory at September 30, 2011 and December 31, 2010 consisted of raw materials primarily for our accessory pico projectors and PicoP display engine, and finished goods primarily composed of our accessory pico projectors. Historically our cost has been higher than our selling price for our accessory pico projectors and we have recognized write downs for lower of cost or market adjustments primarily comprised of adjustments to reflect our current estimated selling prices for our inventory. During the three and nine months ended September 30, 2011, we recognized zero and $944,000 in write downs for lower of cost or market adjustments.

Inventory is stated at the lower of cost or market, with cost determined on a net realizable value basis. Management periodically assesses the need to provide for obsolescence of inventory and adjusts the carrying value of inventory to its net realizable value when required. In addition, we reduce the value of our inventory to our estimated scrap value when management determines that it is not probable that the inventory will be consumed through normal production during the next twelve months.

XML 27 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Severance Arrangements - Note 5
9 Months Ended
Sep. 30, 2011
Notes to Financial Statements 
Severance Arrangements - Note 5

5. SEVERANCE ARRANGEMENTS

In January 2011, we reduced our workforce by approximately 20%, recorded an expense of $372,000 and paid $341,000 related to the severance agreements for these employees during the first half of 2011. The remaining payments of $31,000 for outplacement services expired unused and during the three months ended September 30, 2011 we reduced the recorded expense related to severance agreements accordingly.

XML 28 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 29 R18.htm IDEA: XBRL DOCUMENT v2.3.0.15
Document Information
9 Months Ended
Sep. 30, 2011
Document Information 
Document Type10-Q
Amendment Flagfalse
Document Effective DateSep. 30, 2011
Document Period Start DateJan. 01, 2011
Document Period End DateSep. 30, 2011
Document Fiscal Year Focus2011
Document Fiscal Period FocusQ3
XML 30 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Shared-Based Compensation - Note 6
9 Months Ended
Sep. 30, 2011
Disclosure Of Compensation Related Costs 
Share-Based Compensation

6. SHARE-BASED COMPENSATION

We use the straight-line attribution method to allocate the fair value of share-based compensation awards over the requisite service period for each award. The following table shows the amount of stock-based employee compensation expense included in the consolidated statements of operations:

      Three Months Ended     Nine Months Ended
      September 30,     September 30,
      2011     2010     2011     2010
Cost of contract revenue   $ 56,000    $ 5,000    $ 97,000    $ 12,000 
Cost of product revenue     60,000      7,000      100,000      37,000 
Research and development expense     337,000      274,000      1,075,000      1,084,000 
Sales, marketing, general and administrative expense     447,000      415,000      1,337,000      1,657,000 
Total share-based employee compensation expense   $ 900,000    $ 701,000    $ 2,609,000    $ 2,790,000 

As part of our 2011 plan to conserve cash used in operations, we implemented two share-based compensation programs during the three months ended June 30, 2011 under which we issued shares of our common stock as compensation instead of cash.

In May 2011, we issued 418,000 shares of our common stock as incentive awards to non-executive employees under the 2006 Incentive Plan. The shares were valued using our closing stock price on the date of grant. We expensed $560,000 of share-based employee compensation for these awards at grant in May 2011.

In June 2011, we implemented a voluntary program in which certain non-executive senior professional employees could elect to receive a portion of their 2011 salary in stock instead of cash. In June 2011 we issued 510,000 shares of our common stock under the 2006 Incentive Plan as prepayment of salary for future service. The shares were valued using our closing stock price on the date of grant. The total share-based compensation expense for these awards was $627,000, of which $179,000 was amortized during the three months ended June 30, 2011 and the remaining $448,000 was amortized during the three months ended September 30, 2011 for service completed as of that date. In September 2011, we issued 241,000 shares of our common stock under this program. A total of $212,000 of share-based compensation expense for these awards will be amortized during the fourth quarter of 2011. Program participants who voluntarily leave employment prior to completion of the service period must repay the pro-rata portion of the prepaid salary for the uncompleted service period.

Options Activity and Positions

The following table summarizes shares, weighted average exercise price, weighted average remaining contractual term and aggregate intrinsic value of options outstanding and options exercisable as of September 30, 2011:

              Weighted      
              Average      
          Weighted   Remaining      
          Average   Contractual     Aggregate
          Exercise   Term     Intrinsic
Options   Shares     Price   (years)     Value
Outstanding as of September 30, 2011   7,898,000    $ 3.24    5.8    $
                     
Exercisable as of September 30, 2011   6,024,000    $ 3.57    5.0    $

As of September 30, 2011, our unamortized share-based employee compensation was $2.3 million which we plan to amortize over the next 2.3 years, and our unamortized nonvested equity share-based employee compensation was $968,000 which we plan to amortize over the next 1.7 years.

XML 31 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Cash Flows (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Net loss$ (26,002)$ (32,040)
Adjustments to reconcile net loss to net cash used in operations:  
Depreciation1,9411,127
Amortization of intangible assets1391
Gain on disposal of property and equipment110
Non-cash stock-based compensation expense2,7592,806
Gain on derivative instruments0(875)
Inventory write-downs9443,830
Non-cash deferred rent(297)(207)
Change in:  
Accounts receivable, net239(888)
Costs and estimated earnings in excess of billings on uncompleted contracts(120)63
Inventory688(10,617)
Other current assets(344)(178)
Other assets(12)0
Accounts payable(1,518)2,384
Accrued liabilities150(575)
Billings in excess of costs and estimated earnings on uncompleted contracts(31)2
Other long-term liabilities(330)139
Net cash used in operating activities(21,805)(35,028)
Cash flows from investing activities  
Sales of investment securities0100
Purchases of restricted investment securities0(305)
Decrease in restricted investment4760
Proceeds on sale of property and equipment110
Purchases of property and equipment(492)(1,659)
Net cash used in investing activities(5)(1,864)
Cash flows from financing activities  
Principal payments under capital leases(30)(51)
Principal payments under long-term debt(62)(58)
Net proceeds from issuance of common stock11,85812,634
Net cash provided by financing activities11,76612,525
Net decrease in cash and cash equivalents(10,044)(24,367)
Cash and cash equivalents, at beginning of period19,41343,025
Cash and cash equivalents, at end of period9,36918,658
Supplemental disclosure of cash flow information  
Cash paid for interest3448
Supplemental schedule of non-cash investing and financing activities  
Other non-cash additions to property and equipment211273
Issuance of common stock for prepayment of salaries$ 212$ 0
XML 32 R7.htm IDEA: XBRL DOCUMENT v2.3.0.15
Net Loss per Share - Note 2
9 Months Ended
Sep. 30, 2011
Earnings Per Share [Abstract] 
Net Loss Per Share

2. NET LOSS PER SHARE

Basic net loss per share is calculated using the weighted-average number of common shares outstanding during the reporting periods. Diluted net loss per share is calculated using the weighted-average number of common shares outstanding and taking into account the dilutive effect of all potentially dilutive securities, including common stock equivalents and convertible securities outstanding. Potentially dilutive common stock equivalents primarily consist of warrants, employee stock options and nonvested equity shares. Diluted net loss per share for the three and nine months ended September 30, 2011 and 2010 is equal to basic net loss per share because the effect of all potential common stock outstanding during the periods, including options, warrants and nonvested equity shares is anti-dilutive. The components of basic and diluted net loss per share were as follows (in thousands, except loss per share data):

      Three Months Ended     Nine Months Ended
      September 30,     September 30,
      2011     2010     2011     2010
Numerator:                        
Net loss available for common shareholders - basic and diluted   $ (7,790)   $ (11,850)   $ (26,002)   $ (32,040)
                         
Denominator:                        
Weighted-average common shares outstanding - basic and diluted       109,238      89,376      106,061      88,948 
                         
Net loss per share - basic and diluted     $ (0.07)   $ (0.13)   $ (0.25)   $ (0.36)

 

On September 30, 2011 and 2010, we excluded the following convertible securities from diluted net loss per share, as the effect of including them would have been anti-dilutive: publicly traded warrants exercisable for 6,025,000 and 6,025,000 shares of common stock, respectively, options and private warrants exercisable into a total of 10,195,000 and 12,536,000 shares of common stock, respectively, and 1,017,000 and 485,000 shares of nonvested equity shares, respectively.

XML 33 R16.htm IDEA: XBRL DOCUMENT v2.3.0.15
RECEIVABLES FROM RELATED PARTIES - Note 11
9 Months Ended
Sep. 30, 2011
Notes to Financial Statements 
RECEIVABLES FROM RELATED PARTIES - Note 11

11. RECEIVABLES FROM RELATED PARTIES

Our accounts receivable balance at September 30, 2011 and revenue for the nine months ended September 30, 2011, include $409,000 from a sale of PicoP engines to Walsin Lihwa Corporation which has informed us of its plans to integrate the engines into its product scheduled for commercial release in China in late 2011. Based on filings with the SEC as of September 30, 2011, Walsin Lihwa beneficially owns approximately 8.4% of our common stock as determined in accordance with SEC rules, through its wholly owned subsidiary Max Display Enterprises Limited.

XML 34 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Balance Sheet (Parenthetical) (USD $)
In Thousands, except Share data
Sep. 30, 2011
Dec. 31, 2010
Current assets  
Allowance for doubtful accounts receivable, current$ 308$ 588
Stockholders equity  
Preferred stock, par value$ 0.001$ 0.001
Preferred stock, shares authorized25,000,00025,000,000
Preferred stock, shares issued00
Common stock, par value$ 0.001$ 0.001
Common stock, shares authorized200,000,000200,000,000
Common stock, shares issued117,793,000102,471,000
Common stock, shares outstanding117,793,000102,471,000
XML 35 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.15 Html 10 119 1 false 0 0 false 3 true false R1.htm 0001 - Statement - Consolidated Balance Sheets Sheet http://microvision.com/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets false false R2.htm 0002 - Statement - Consolidated Balance Sheet (Parenthetical) Sheet http://microvision.com/role/ConsolidatedBalanceSheetParenthetical Consolidated Balance Sheet (Parenthetical) false false R3.htm 0003 - Statement - Consolidated Statements of Operations Sheet http://microvision.com/role/StatementOfIncome Consolidated Statements of Operations false false R4.htm 0004 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://microvision.com/role/StatementOfOtherComprehensiveIncome Consolidated Statements of Comprehensive Loss false false R5.htm 0005 - Statement - Consolidated Statements of Cash Flows Sheet http://microvision.com/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows false false R6.htm 0006 - Disclosure - Management's Statement and Principles of Consolidation - Note 1 Sheet http://microvision.com/role/OrganizationConsolidationAndPresentationOfFinancialStatements Management's Statement and Principles of Consolidation - Note 1 false false R7.htm 0007 - Disclosure - Net Loss per Share - Note 2 Sheet http://microvision.com/role/EarningsPerShare Net Loss per Share - Note 2 false false R8.htm 0008 - Disclosure - Cash Equivalents, Investment Securities Avaliable-for-Sale and Fair Value Measurments - Note 3 Sheet http://microvision.com/role/FinancialInstrumentsFairValueDisclosures Cash Equivalents, Investment Securities Avaliable-for-Sale and Fair Value Measurments - Note 3 false false R9.htm 0009 - Disclosure - Inventory - Note 4 Sheet http://microvision.com/role/Inventory Inventory - Note 4 false false R10.htm 0010 - Disclosure - Severance Arrangements - Note 5 Sheet http://microvision.com/role/SeveranceArrangements-Note5 Severance Arrangements - Note 5 false false R11.htm 0011 - Disclosure - Shared-Based Compensation - Note 6 Sheet http://microvision.com/role/CompensationRelatedCostsStockCompensation Shared-Based Compensation - Note 6 false false R12.htm 0012 - Disclosure - Long-Term Notes - Note 7 Notes http://microvision.com/role/Debt Long-Term Notes - Note 7 false false R13.htm 0013 - Disclosure - Warrants - Note 8 Sheet http://microvision.com/role/Warrants-Note8 Warrants - Note 8 false false R14.htm 0014 - Disclosure - Commitments and Contingencies - Note 9 Sheet http://microvision.com/role/CommitmentAndContingencies Commitments and Contingencies - Note 9 false false R15.htm 0015 - Disclosure - Committed Equity Financing Facility - Note 10 Sheet http://microvision.com/role/CommittedEquityFinancingFacility-Note10 Committed Equity Financing Facility - Note 10 false false R16.htm 0016 - Disclosure - RECEIVABLES FROM RELATED PARTIES - Note 11 Sheet http://microvision.com/role/ReceivablesFromRelatedParties-Note11 RECEIVABLES FROM RELATED PARTIES - Note 11 false false R17.htm 0017 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS - Note 12 Sheet http://microvision.com/role/NewAccountingPronouncements-Note12 NEW ACCOUNTING PRONOUNCEMENTS - Note 12 false false R18.htm 0018 - Document - Document Information Sheet http://microvision.com/role/DocumentInformation Document Information false false R19.htm 0019 - Document - Entity Information Sheet http://microvision.com/role/EntityInformation Entity Information false false All Reports Book All Reports Process Flow-Through: 0001 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 0002 - Statement - Consolidated Balance Sheet (Parenthetical) Process Flow-Through: 0003 - Statement - Consolidated Statements of Operations Process Flow-Through: 0004 - Statement - Consolidated Statements of Comprehensive Loss Process Flow-Through: 0005 - Statement - Consolidated Statements of Cash Flows mvis-20110930.xml mvis-20110930.xsd mvis-20110930_cal.xml mvis-20110930_def.xml mvis-20110930_lab.xml mvis-20110930_pre.xml true true EXCEL 36 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Q9F4Q.3(S,%]C.3!B7S0U,S5?.#(T-E\T9&4T M93-D-#9E9C(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=F5N=&]R>5].;W1E7S0\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-H87)E9$)A#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DQO;F=497)M7TYO=&5S7TYO=&5? M-SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S7SPO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D-O;6UI='1E9%]%<75I='E? M1FEN86YC:6YG7T9A8SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)%0T5)5D%"3$537T923TU?4D5,051%1%]005)423PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY%5U]!0T-/54Y424Y' M7U!23TY/54Y#14U%3E137SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1O8W5M96YT7TEN9F]R;6%T:6]N/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E M=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!A;F0@97%U:7!M M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XR-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%SF5D/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XR,#`L,#`P+#`P,#QS<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q9F4Q.3(S,%]C.3!B7S0U,S5?.#(T M-E\T9&4T93-D-#9E9C(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,69E,3DR,S!?8SDP8E\T-3,U7S@R-#9?-&1E-&4S9#0V968R+U=O'0O:'1M;#L@8VAA M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T M:6]N(&]F(&EN=&%N9VEB;&4@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ,SD\2!W6UE;G1S('5N9&5R(&-A<&ET86P@;&5A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE&-H86YG M92!#;VUM:7-S:6]N("AT:&4@)B,S-#M314,F(S,T.RDN(%1H92!Y96%R+65N M9"!C;VYD96YS960@8F%L86YC90T*2!A8V-E<'1E9"!I;B!T:&4@56YI M=&5D(%-T871E2!B92!A='1A:6YE9"!F;W(@ M=&AE(&5N=&ER92!F:7-C86P@>65A6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!P'!E;G-E2!O0T*=&\@97AT96YD(&]U65A2!T;R!C;VYT:6YU92!A2P@3'1D+B`H M)B,S-#M!>FEM=71H)B,S-#LI+B!$=7)I;F<@,C`Q,2!W92!C;VUP;&5T960@ M='=O(&1R87=S(&9R;VT@=&AI0T*86YD(')A:7-E9"!A('1O M=&%L(&]F("9N8G-P.R0U+C8@;6EL;&EO;B!B969O&EM871E;'D@-"XU(&UI;&QI;VX@2!W:71H($%Z:6UU M=&@L('5N9&5R('=H:6-H('=E(&UA>2!S96QL('1O($%Z:6UU=&@@=7`@=&\@ M=&AE(&QE&EM871E;'D@,2XV(&UI;&QI;VX@2`W+C8@;6EL;&EO;B!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C M:RX@07,@;V8@4V5P=&5M8F5R#0HS,"P@,C`Q,2P@=V4@:&%V92!T:&4@;&5S M&EM871E;'D@)FYB2X\+W`^#0H-"CQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!U6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2X@36EC2!A8V-O=6YT7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M0T*9&EL=71I=F4@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L M:6=N.B!C96YT97(G/E1H6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@8V]L'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M+C5P="!S;VQI9#L@9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q+C5P="!S;VQI9#L@9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L M:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S M;VQI9#L@9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD M.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)W9E M6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF;F)S<#LD/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T M97AT+6%L:6=N.B!R:6=H="<^,3`Y+#(S."8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF;F)S<#LD M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)FYB M6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF;F)S<#LD/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2P@86YD(#$L,#$W M+#`P,"!A;F0@-#@U+#`P,"!S:&%R97,@;V8-"FYO;G9E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2!C;&%S2!M M87)K970@6QE/3-$)W9E6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V)O6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@9F]N M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXX M+#`P,"8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I M9VAT)SXM)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@ M6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)FYB6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF;F)S<#LD/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF;F)S<#LD/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@9F]N="UW96EG:'0Z(&)O M;&0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD)SY!6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@2!S96-U6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@ M6QE/3-$ M)V)O6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)FYB6QE/3-$)V)O M'0M86QI9VXZ M(')I9VAT)SXM)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF;F)S<#LD/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)FYB6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXM)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF;F)S<#LD/"]T9#X- M"B`@("`\=&0@3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Q9F4Q.3(S,%]C.3!B7S0U,S5?.#(T-E\T M9&4T93-D-#9E9C(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,69E M,3DR,S!?8SDP8E\T-3,U7S@R-#9?-&1E-&4S9#0V968R+U=O'0O:'1M;#L@8VAA2`M($YO=&4@-#QB2!$:7-C;&]S=7)E M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@ M8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R)SY397!T96UB97(@,S`L/"]T9#X- M"B`@("`\=&0@'0M86QI M9VXZ(&-E;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF;F)S<#LD/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M;F)S<#LD/"]T9#X-"B`@("`\=&0@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!E;F=I;F4L(&%N9"!F:6YIF5D('=R:71E(&1O=VYS(&9O2X@1'5R M:6YG('1H92!T:')E92!A;F0@;FEN92!M;VYT:',@96YD960@4V5P=&5M8F5R M(#,P+"`R,#$Q+"!W92!R96-O9VYI>F5D#0IZ97)O(&%N9"`F;F)S<#LD.30T M+#`P,"!I;B!WF%B;&4@=F%L=64@8F%S:7,N($UA;F%G96UE M;G0@<&5R:6]D:6-A;&QY(&%S6EN9R!V86QU92!O9B!I;G9E;G1O6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2!A M<'!R;WAI;6%T96QY(#(P)2P@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT M97(G/E1H6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M8V]L'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI M9#L@9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P M="!S;VQI9#L@9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT M97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@9F]N M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L M:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF;F)S<#LD/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)FYB6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXU+#`P,"8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)FYB6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXY-RPP,#`F(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXV,"PP,#`F(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXW+#`P,"8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXS M-RPP,#`F(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXR-S0L,#`P)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^,2PP-S4L,#`P M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^,2PP.#0L,#`P)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@'0M86QI9VXZ(')I9VAT)SXT-#6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P M="!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@65E(&-O;7!E;G-A=&EO M;B!E>'!E;G-E/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF;F)S<#LD/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)FYB6QE/3-$)V)O6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2`R,#$Q+"!W92!I65E65E(&-O;7!E;G-A=&EO;B!F;W(@=&AE2`R,#$Q+CPO<#X-"@T*/'`@2!P&5C=71I=F4@6UE;G0@;V8@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&-E;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L M:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT M+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T M97AT+6%L:6=N.B!C96YT97(G/D%V97)A9V4\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L M9#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R M)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L M:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT M+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/E=E:6=H M=&5D/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E M;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@ M=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L M9#L@=&5X="UA;&EG;CH@8V5N=&5R)SY!=F5R86=E/"]T9#X-"B`@("`\=&0@ M'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT M.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C M96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N M.B!C96YT97(G/D5X97)C:7-E/"]T9#X-"B`@("`\=&0@'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT M+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/DEN=')I M;G-I8SPO=&0^/"]T6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^-RPX.3@L,#`P)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF;F)S<#LD/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)FYB6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXM)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@&5R8VES86)L92!A6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)FYB6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXS+C4W)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXU+C`F M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE MF5D#0IS:&%R M92UB87-E9"!E;7!L;WEE92!C;VUP96YS871I;VX@=V%S("9N8G-P.R0R+C,@ M;6EL;&EO;B!W:&EC:"!W92!P;&%N('1O(&%M;W)T:7IE(&]V97(@=&AE(&YE M>'0@,BXS('EE87)S+"!A;F0@;W5R('5N86UOF5D(&YO;G9E65E(&-O;7!E;G-A=&EO;B!W87,@ M)FYB7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`E.R!R:7-K(&9R964@:6YT97)E2P@ M=V%S(')E8V]R9&5D(&%S(&$@;F]N+6]P97)A=&EN9R!G86EN(&%N9"!I6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2!L96=A;"!P3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q9F4Q.3(S,%]C M.3!B7S0U,S5?.#(T-E\T9&4T93-D-#9E9C(-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,69E,3DR,S!?8SDP8E\T-3,U7S@R-#9?-&1E-&4S9#0V M968R+U=O'0O:'1M;#L@8VAA'0^/'`@2`H0T5&1BD@=VET:"!!>FEM=71H+"!U;F1E M2!A;F0@2`T+C4@;6EL;&EO;B!S:&%R97,@;V8@;W5R(&-O;6UO;@T*FEM=71H('5P M('1O('1H92!L97-S97(@;V8@)FYB2`X+"`R,#$Q+B!7 M92!P86ED($%Z:6UU=&@@,C(U+#`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`@("`\=&%B;&4@ M8VQA6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2!-87@@1&ES<&QA>2!%;G1E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\Q9F4Q.3(S,%]C.3!B7S0U,S5?.#(T-E\T9&4T93-D-#9E9C(- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,69E,3DR,S!?8SDP8E\T M-3,U7S@R-#9?-&1E-&4S9#0V968R+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'`@ M6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2`R,#$Q+"!T:&4@1D%30B!I M'!E8W0@=&AI M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^,3`M43QS<&%N/CPO'0^4V5P(#,P+`T*"0DR,#$Q M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^2F%N(#$L#0H)"3(P,3$\'0^4V5P M(#,P+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,3QS<&%N/CPO'0^43,\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M.3$Q-C`P.#(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!#=7)R96YT(%)E M<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S4-O;6UO;E-T;V-K4VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL M('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC